Original Article
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
N Engl J Med 2002; 347:161-167July 18, 2002
- Abstract
Background
B-type natriuretic peptide is released from the cardiac ventricles in response to increased wall tension.
Methods
We conducted a prospective study of 1586 patients who came to the emergency department with acute dyspnea and whose B-type natriuretic peptide was measured with a bedside assay. The clinical diagnosis of congestive heart failure was adjudicated by two independent cardiologists, who were blinded to the results of the B-type natriuretic peptide assay.
Results
The final diagnosis was dyspnea due to congestive heart failure in 744 patients (47 percent), dyspnea due to noncardiac causes in 72 patients with a history of left ventricular dysfunction (5 percent), and no finding of congestive heart failure in 770 patients (49 percent). B-type natriuretic peptide levels by themselves were more accurate than any historical or physical findings or laboratory values in identifying congestive heart failure as the cause of dyspnea. The diagnostic accuracy of B-type natriuretic peptide at a cutoff of 100 pg per milliliter was 83.4 percent. The negative predictive value of B-type natriuretic peptide at levels of less than 50 pg per milliliter was 96 percent. In multiple logistic-regression analysis, measurements of B-type natriuretic peptide added significant independent predictive power to other clinical variables in models predicting which patients had congestive heart failure.
Conclusions
Used in conjunction with other clinical information, rapid measurement of B-type natriuretic peptide is useful in establishing or excluding the diagnosis of congestive heart failure in patients with acute dyspnea.
Media in This Article
Figure 3
Receiver-Operating-Characteristic Curve for Various Cutoff Levels of B-Type Natriuretic Peptide (BNP) in Differentiating between Dyspnea Due to Congestive Heart Failure and Dyspnea Due to Other Causes.Figure 1
Box Plots Showing Median Levels of B-Type Natriuretic Peptide Measured in the Emergency Department in Three Groups of Patients.Article Activity
- Article
Currently, there are 5 million Americans with congestive heart failure, with nearly 500,000 new cases every year.1 The prevalence of symptomatic heart failure in the general European population ranges from 0.4 percent to 2.0 percent.2 Because of the high total direct costs of care for heart failure, estimated at $10 billion to $38 billion per year, the Health Care Financing Administration (now the Centers for Medicare and Medicaid Services) targeted heart failure as the disease most worthy of cost-effective management.3 To provide cost-effective treatment for patients with congestive heart failure, rapid and accurate differentiation of congestive heart failure from other causes of dyspnea must be accomplished. Heart failure is often difficult to diagnose in the emergency department or urgent care setting, however. The symptoms may be nonspecific, and physical findings are not sensitive enough to use as a basis for an accurate diagnosis.4,5 Although echocardiography is considered the gold standard for the detection of left ventricular dysfunction, it is expensive, is not always easily accessible, and may not always reflect an acute condition.6 Misdiagnosis of congestive heart failure can be life-threatening, because treatments for congestive heart failure are hazardous to patients with other conditions, such as chronic obstructive pulmonary disease, that have the same primary symptoms at presentation.1,7
B-type natriuretic peptide is a cardiac neurohormone specifically secreted from the ventricles in response to volume expansion and pressure overload.8,9 Levels of B-type natriuretic peptide have been shown to be elevated in patients with left ventricular dysfunction and correlate with the New York Heart Association class, as well as with prognosis.10-15 A previous study, using a radioimmunoassay for the detection of B-type natriuretic peptide, suggested that B-type natriuretic peptide may be useful in distinguishing between cardiac and noncardiac causes of acute dyspnea.16 Recently, a pilot study using a rapid (15-minute) whole-blood assay for B-type natriuretic peptide demonstrated that bedside measurement of B-type natriuretic peptide added to the ability of the physician to diagnose congestive heart failure in the urgent care setting.17 We performed a seven-center, multinational trial to validate and characterize the use of B-type natriuretic peptide levels in the diagnosis of congestive heart failure in a broad population of patients with dyspnea.
Methods
Study Population
The study was approved by the institutional review boards of participating study centers. A total of 1586 patients from seven sites (five in the United States, one in France, and one in Norway) were enrolled from April 1999 to December 2000. To be eligible for the study, a patient had to have shortness of breath as the most prominent symptom. Patients under 18 years of age and those whose dyspnea was clearly not secondary to congestive heart failure (for example, those with trauma or cardiac tamponade) were excluded. Patients with acute myocardial infarction or renal failure were also excluded. Patients with unstable angina were excluded unless their predominant symptom at presentation was dyspnea.
Once the patient was identified as having dyspnea, written informed consent was obtained, and a blood sample was collected for measurement of B-type natriuretic peptide. A research assistant collected other data, including information from the medical history, the physical examination, results of other blood tests, interpretations of chest roentgenograms, and interpretations of other diagnostic tests. Echocardiograms were strongly encouraged in the emergency department on an outpatient basis or in the hospital if the patient was admitted.
For each patient enrolled in the study, physicians assigned to the emergency department (emergency department specialists or general-medicine internists), who were blinded to the results of the measurements of B-type natriuretic peptide, assessed the probability that the patient had congestive heart failure (by assigning a value of 0 to 100 percent clinical certainty) as the cause of his or her symptoms. If a patient had a history of congestive heart failure, the physician classified the patient as having either an acute exacerbation of congestive heart failure or dyspnea from another cause, with underlying left ventricular dysfunction (as, for example, in the case of a patient with left ventricular dysfunction who was seen for bronchitis).
Confirmation of the Diagnosis
To determine the actual diagnosis, two cardiologists reviewed all medical records pertaining to the patient and independently classified the diagnosis as dyspnea due to congestive heart failure, acute dyspnea due to noncardiac causes in a patient with a history of left ventricular dysfunction, or dyspnea not due to congestive heart failure. The cardiologists were presented with the components and a summary of the Framingham congestive-heart-failure score (two major or one major and two minor criteria) and the National Health and Nutrition Examination Survey (NHANES) congestive heart failure score (scores of 3 or more) calculated from the case-report form. Both cardiologists were blinded to the B-type natriuretic peptide level as well as to the emergency department physicians' diagnosis. They did have access to the emergency department data sheets and any additional information that became available after the evaluation in the emergency department. This information included the reading of the chest roentgenogram in the emergency department by a radiologist; medical history obtained from a medical chart that was not available to the emergency department physicians at the time of presentation; the results of subsequent tests, such as echocardiography, radionuclide angiography, or left ventriculography, performed at the time of cardiac catheterization; and the hospital course for patients admitted to the hospital. For patients with a diagnosis other than congestive heart failure, confirmation on the basis of the following observations was attempted: normal chest roentgenogram (absence of heart enlargement and pulmonary venous hypertension); roentgenographic signs of chronic obstructive lung disease, pneumonia, or lung cancer; normal heart function according to echocardiography, radionuclide ventriculography, or left ventriculography performed at the time of cardiac catheterization; abnormal pulmonary-function test results or follow-up results in the pulmonary clinic; response to treatment with nebulizers, corticosteroids, or antibiotics in the emergency department or hospital; and the absence of admission to the hospital for congestive heart failure over the next 30 days. In all cases of congestive heart failure, the two cardiologists were asked to agree on the severity according to the New York Heart Association class.
Measurement of Levels of B-Type Natriuretic Peptide
During the initial evaluation, a blood sample was collected into a tube containing potassium EDTA. B-type natriuretic peptide was measured with use of a fluorescence immunoassay kit (Triage, Biosite) for the quantitative determination of B-type natriuretic peptide in whole-blood and plasma specimens. The precision, analytic sensitivity, and stability characteristics of the system have been previously described.18,19 Values for B-type natriuretic peptide were determined on site by the bedside method with either whole-blood or plasma samples.
Statistical Analysis
Comparisons of B-type natriuretic peptide values among diagnostic groups were performed by the t-test for independent samples and analysis of variance. Log-transformed values for B-type natriuretic peptide were used in these analyses to reduce the effects of skewness in the distribution of B-type natriuretic peptide levels. To evaluate the value of B-type natriuretic peptide measurements in the diagnosis of congestive heart failure, we compared the sensitivity, specificity, and accuracy of B-type natriuretic peptide measurements with those of individual clinical findings. We also used a multiple logistic-regression model combining clinical findings and B-type natriuretic peptide values to predict the final diagnosis. For each of the different clinical and roentgenographic findings identified by emergency department physicians, and for different threshold B-type natriuretic peptide levels, we computed the sensitivity, specificity, and accuracy, defined as the sum of the concordant cells divided by the sum of all cells in the two-by-two table. To determine the most parsimonious combination of indicators to predict the presence or absence of congestive heart failure, we applied multiple stepwise logistic regression with the use of a P value of 0.05 or less for entry into the model. The predictors included historical, clinical, and roentgenographic findings, along with information on B-type natriuretic peptide (100 pg per milliliter or above). We also evaluated the unique contribution of B-type natriuretic peptide over and above other predictors by entering B-type natriuretic peptide last in a separate model. Finally, we constructed receiver-operating-characteristic curves to illustrate various cutoff values of B-type natriuretic peptide.
The academic investigators designed the study, analyzed the data, and wrote the manuscript. Biosite supplied the diagnostic kits and managed the technical aspects of data accrual and storage.
Results
The base-line characteristics of the overall study group of 1586 patients are shown in Table 1Table 1
Base-Line Characteristics of 1586 Patients with Dyspnea.. The mean age was 64 years. There were 883 men (56 percent) and 703 women (44 percent); 773 patients were white (49 percent), 715 were black (45 percent), and 98 were members of other races (6 percent). On examination, 7 percent of patients had an S3 gallop, 43 percent had rales in the lower lung fields, 22 percent had jugular venous distention, and 42 percent had edema of the legs or feet.The final diagnosis was congestive heart failure in 744 patients (47 percent), dyspnea due to noncardiac causes in 72 patients with a history of left ventricular dysfunction (5 percent), and no finding of congestive heart failure in 770 patients (49 percent). In 97 percent of patients with congestive heart failure, the final diagnosis of congestive heart failure was confirmed by other tests (chest roentgenogram in 79 percent of patients, echocardiography in 77 percent, radionuclide ejection fraction in 15 percent, cardiac catheterization in 19 percent, and response to treatment in 86 percent). Figure 1Figure 1
Box Plots Showing Median Levels of B-Type Natriuretic Peptide Measured in the Emergency Department in Three Groups of Patients. presents a box plot of B-type natriuretic peptide values for the three groups of patients. The difference among groups was significant (P<0.001 for each pairwise comparison). Patients with a diagnosis of acute congestive heart failure had mean (±SD) B-type natriuretic peptide levels of 675±450 pg per milliliter, whereas those without congestive heart failure had B-type natriuretic peptide levels of 110±225 pg per milliliter. The 72 patients who had base-line ventricular dysfunction without an acute exacerbation had a mean B-type natriuretic peptide level of 346±390 pg per milliliter.Ninety-nine patients met the clinical criteria for cor pulmonale. Cor pulmonale was a derived variable that required a history of obstructive or restrictive lung disease and the presence of hepatic congestion and peripheral edema on physical examination. The final diagnoses, as adjudicated by the reviewing cardiologists, were as follows: 78 patients (79 percent) were considered to have congestive heart failure as the primary cause of dyspnea, 19 (19 percent) to have dyspnea not due to congestive heart failure, and 2 (2 percent) to have stable left ventricular dysfunction with dyspnea from a noncardiac cause.
Figure 2Figure 2
Box Plots Showing Median Levels of B-Type Natriuretic Peptide among Patients in Each of the Four New York Heart Association Classifications. shows B-type natriuretic peptide values in relation to New York Heart Association functional class, as determined by both cardiologists together. B-type natriuretic peptide values differed significantly as a function of the severity of congestive heart failure (P<0.001). The mean B-type natriuretic peptide levels were 244±286 pg per milliliter among patients in class I, 389±374 pg per milliliter among those in class II, 640±447 pg per milliliter among those in class III, and 817±435 pg per milliliter among those in class IV.The best clinical predictor of congestive heart failure was an increased heart size on chest roentgenogram (accuracy, 81 percent), followed by a history of congestive heart failure (75 percent). Rales were the most accurate finding on physical examination (69 percent accuracy), and a history of paroxysmal nocturnal dyspnea had an accuracy of 60 percent.
The B-type natriuretic peptide level was the single most accurate predictor of the presence or absence of congestive heart failure. The capacity of B-type natriuretic peptide to differentiate congestive heart failure from other causes of dyspnea was assessed with a receiver-operating-characteristic curve analysis (Figure 3Figure 3
Receiver-Operating-Characteristic Curve for Various Cutoff Levels of B-Type Natriuretic Peptide (BNP) in Differentiating between Dyspnea Due to Congestive Heart Failure and Dyspnea Due to Other Causes.). The area under the receiver-operating-characteristic curve when B-type natriuretic peptide was used to differentiate congestive heart failure from other causes of dyspnea was 0.91 (95 percent confidence interval, 0.90 to 0.93; P<0.001). A B-type natriuretic peptide cutoff value of 100 pg per milliliter had a sensitivity of 90 percent, a specificity of 76 percent, and an accuracy of 83 percent for differentiating congestive heart failure from other causes of dyspnea. Lower values were associated with more accurate negative predictive values (for a B-type natriuretic peptide value of 50 pg per milliliter, the negative predictive value was 96 percent). For the diagnosis of congestive heart failure in our study population, a B-type natriuretic peptide cutoff of 100 pg per milliliter was more accurate (83 percent) than either the NHANES criteria (67 percent) or the Framingham criteria (73 percent), the two most commonly used sets of criteria for diagnosing congestive heart failure.20 In multiple logistic-regression analyses, we determined that the addition of B-type natriuretic peptide increased the combined explanatory power of the history, symptoms, signs, radiologic studies, and laboratory findings (Table 2Table 2
Multiple Logistic-Regression Analysis of Factors Used for Differentiating between Patients with and Those without Congestive Heart Failure.). The model showed that a history of heart failure and cephalization of vessels on chest roentgenography were strong independent predictors of congestive heart failure. A value of 100 pg per milliliter or more for B-type natriuretic peptide was the strongest independent predictor of congestive heart failure, with an odds ratio of 29.60. B-type natriuretic peptide also added significant additional information when it was entered after other clinical indicators (P<0.001).Discussion
Our findings validate and extend the observations made in a pilot study using a B-type natriuretic peptide test to aid in the diagnosis of congestive heart failure.17 The B-type natriuretic peptide cutoff point we judged to be optimal for making the diagnosis of congestive heart failure was slightly higher than that found in the pilot study (100 vs. 80 pg per milliliter), but it corresponds to the manufacturer's recommended cutoff level for the diagnosis of congestive heart failure. Furthermore, B-type natriuretic peptide levels by themselves were more accurate than any other finding in the history, physical finding, or laboratory value in delineating the cause of dyspnea. B-type natriuretic peptide performed better than either the NHANES or the Framingham criteria, arguably the most widely accepted criteria for the diagnosis of congestive heart failure. The calculated area under the curve of 0.91 was similar to that of prostate-specific antigen for the detection of prostate cancer (area under the curve, 0.94) and was superior to those of Papanicolaou smears and mammography (area under the curve, 0.70 and 0.85, respectively).21-23
The accuracy of the diagnosis of congestive heart failure by clinical means and standard testing is often inadequate.24-26 Echocardiographic imaging may be difficult to perform in a patient who cannot remain still because of dyspnea or who has a coexisting condition such as obesity or lung disease. Echocardiography may also not be sensitive enough to delineate cardiac causes of acute dyspnea — for example, when severe hypertension leads to pulmonary edema.
Unlike acute coronary syndromes, in which biomarkers such as cardiac troponins and creatine kinase MB fraction not only establish the diagnosis but also are correlated with both severity and prognosis, congestive heart failure in the urgent care setting has not had a gold standard for either diagnosis or prognosis. This fact is underscored by Rame et al., who found a paucity of indicators of the severity of disease or outcome in patients with congestive heart failure who were examined and discharged in an urban county emergency department, accounting for the subsequent 61 percent rate of failure of outpatient treatment.27
The source of B-type natriuretic peptide in plasma is mainly the ventricles, which suggests that B-type natriuretic peptide may be a more sensitive and specific indicator of ventricular disorders than other natriuretic peptides.7,28 The promoter region of the B-type natriuretic peptide gene contains the rapid-turnover nucleic acid sequence TATTTAT, which suggests that the rate of turnover of B-type natriuretic peptide messenger RNA is high and that B-type natriuretic peptide is synthesized in bursts.29,30 This release appears to be directly proportional to the degree of ventricular-volume expansion and pressure overload.31
Our study, along with others, demonstrates the relation of B-type natriuretic peptide levels with the severity of heart failure,15,28,32 and it underscores the prognostic importance of this peptide in a number of settings.11,13,15,33,34 In a population similar to ours, Harrison et al. followed 325 patients for six months after they presented to the emergency department with dyspnea.15 B-type natriuretic peptide levels (according to the same B-type natriuretic peptide assay we used) determined at the initial emergency department visit were closely correlated with outcomes, with 54 percent of the patients who had B-type natriuretic peptide levels of more than 480 pg per milliliter having a subsequent congestive-heart-failure event at six months. A B-type natriuretic peptide level of more than 230 pg per milliliter was associated with a relative risk of 7.0 for a congestive-heart-failure event in patients whose doctors failed to make the diagnosis of congestive heart failure.
The value of natriuretic peptides has already been recognized by their inclusion in the recent European guidelines for the diagnosis of chronic heart failure.35 The present study addresses the diagnosis of heart failure in a large, heterogeneous population of patients with dyspnea in the acute care setting. These results supplement the established “rule-out” value of B-type natriuretic peptide stated in the European guidelines by offering valuable information concerning the positive predictive value of B-type natriuretic peptide, as well as the assessment of the severity of disease. The results demonstrate that rapid measurement of the B-type natriuretic peptide level in the blood will improve the ability of clinicians to differentiate patients with dyspnea due to congestive heart failure from those with dyspnea due to other causes in acute care settings. This should be especially true among patients in whom the diagnosis of congestive heart failure is not clinically straightforward. The B-type natriuretic peptide test is now available in a rapid format, thus making diagnostic information immediately available to the acute care physician. Use of this test, in conjunction with other clinical information, should lead to more accurate initial diagnoses of congestive heart failure.
Presented in part at the 51st Scientific Sessions of the American College of Cardiology, Atlanta, March 17–20, 2002.
Triage devices and meters and some financial support were provided by Biosite, San Diego, Calif. Drs. Maisel and McCullough have received honorariums from Biosite for speaking and consulting.
We are indebted to the emergency department staff at the following study centers for their efforts: San Diego Veterans Affairs Medical Center, San Diego, Calif.; Henry Ford Hospital, Detroit; Hospital of the University of Pennsylvania, Philadelphia; Hôpital Bichat, Paris; Ullevål University Hospital, Oslo, Norway; the University of Cincinnati Medical Center, Cincinnati; and Hartford Hospital, Hartford, Conn.; and to Roberta A. Sullivan, B.S.N., M.P.H., for assistance with the preparation of the manuscript.
Source Information
From the University of California, San Diego, Veterans Affairs Medical Center, San Diego (A.S.M, P.K., P.C., R.K.); Henry Ford Hospital, Detroit (R.M.N., J.M.); the University of Pennsylvania, Philadelphia (J.E.H., H.C.H.); Hôpital Bichat, Paris (P.D., P.G.S.); Ullevål University Hospital, Oslo, Norway (T.O., A.W., C.W.K.); the University of Cincinnati College of Medicine, Cincinnati (A.B.S.); the University of Kentucky College of Medicine, Lexington (W.T.A.); Hartford Hospital, Hartford, Conn. (A.H.B.W., A.P.); and the University of Missouri–Kansas City School of Medicine, Truman Medical Center, Kansas City (P.A.M.).
Address reprint requests to Dr. Maisel at Veterans Affairs Medical Center Cardiology 111-A, 3350 La Jolla Village Dr., San Diego, CA 92161, or at amaisel@ucsd.edu.
Additional investigators are listed in the Appendix.
Appendix
Additional investigators include the following: the University of California, San Diego, Veterans Affairs Medical Center, San Diego: P. Hlavin, A. Lenert, and A.Y. Chiu; Henry Ford Hospital, Detroit: M. Whitican and J. Babiarz (study coordinators); the University of Pennsylvania, Philadelphia: E. Loh and F.D. Sites (study coordinator); Hôpital Bichat, Paris: M.C. Aumont, V. Beaumesnil, L. Hafi, A. Desplanques, and J. Benessiano (coinvestigators); Ullevål University Hospital, Oslo, Norway: A. Finsen, J.S. Riis, and T.O. Klemsdal (site coinvestigators); the University of Kentucky College of Medicine, Lexington: S. Lamba (coinvestigator).
- References
References
1
Packer M ,Cohn JN , eds. Consensus recommendations for the management of chronic heart failure. Am J Cardiol 1999;83:Suppl:1A-38A
CrossRef | Web of Science | Medline2
Cowie MR ,Struthers AD ,Wood DA , et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-1353
CrossRef | Web of Science | Medline3
O'Connell JB ,Bristow M . Economic impact of heart failure in the United States: a time for a different approach. J Heart Lung Transplant 1994;13:S107-S112
Web of Science | Medline4
Stevenson LW ,Perloff JK . The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 1989;261:884-888
CrossRef | Web of Science | Medline5
Remes J ,Miettinen H ,Reunanen A ,Pyorala K . Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-321
CrossRef | Web of Science | Medline6
Devereaux RB ,Liebson PR ,Horan MJ . Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension 1987;9:II-977
Bales AC ,Sorrentino MJ . Causes of congestive heart failure: prompt diagnosis may affect prognosis. Postgrad Med 1997;101:44-9, 54
CrossRef | Web of Science | Medline8
Nakagawa O ,Ogawa Y ,Itoh H , et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an “emergency“ cardiac hormone against ventricular overload. J Clin Invest 1995;96:1280-1287
CrossRef | Web of Science | Medline9
Maeda K ,Tsutamota T ,Wada A ,Hisanaga T ,Kinoshita M . Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-832
CrossRef | Web of Science | Medline10
Clerico A ,Iervasi G ,Del Chicca MG , et al. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest 1998;21:170-179
Web of Science | Medline11
Omland T ,Aakvaag A ,Bonarjee VVS , et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 1996;93:1963-1969
Web of Science | Medline12
Krishnaswamy P ,Lubien E ,Clopton P , et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001;111:274-279
CrossRef | Web of Science | Medline13
Cheng VL ,Kazanagra R ,Garcia A , et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-391
CrossRef | Web of Science | Medline14
Maisel AS ,Koon J ,Krishnaswamy P , et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001;141:367-374
CrossRef | Web of Science | Medline15
Harrison A ,Morrison LK ,Krishnaswamy P , et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002;39:131-138
CrossRef | Web of Science | Medline16
Davis M ,Espiner E ,Richards G , et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 1994;343:440-444
CrossRef | Web of Science | Medline17
Dao Q ,Krishnaswamy P ,Kazanegra R , et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-385
CrossRef | Web of Science | Medline18
Morrison LK ,Harrison A ,Krishnaswamy P ,Kazanegra R ,Clopton P ,Maisel AS . Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-209
CrossRef | Web of Science | Medline19
Mair J ,Hammerer-Lercher A ,Puschendorf B . The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-588
CrossRef | Web of Science | Medline20
Schocken DD ,Arrieta MI ,Leaverton PE ,Ross EA . Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 1992;20:301-306
CrossRef | Web of Science | Medline21
Jacobsen SJ ,Bergstralh EJ ,Guess HA , et al. Predictive properties of serum-prostate-specific antigen testing in a community-based setting. Arch Intern Med 1996;156:2462-2468
CrossRef | Web of Science | Medline22
Swets JA ,Getty DJ ,Pickett RM ,D'Orsi CJ ,Seltzer SE ,McNeil BJ . Enhancing and evaluating diagnostic accuracy. Med Decis Making 1991;11:9-18
CrossRef | Web of Science | Medline23
Fahey MT ,Irwig L ,Macaskill P . Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-689
Web of Science | Medline24
Wheeldon NM ,MacDonald TM ,Flucker CJ ,McKendrick AD ,McDevitt DG ,Struthers AD . Echocardiography in chronic heart failure in the community. Q J Med 1993;86:17-23
Web of Science | Medline25
Davie AP ,Francis CM ,Love MP , et al. Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996;312:222-222
CrossRef | Web of Science | Medline26
Cohn JN ,Johnson GR ,Shabetai R , et al. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993;87:Suppl VI:VI-527
Rame JE ,Sheffield MA ,Dries DL , et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J 2001;142:714-719
CrossRef | Web of Science | Medline28
Tsutamoto T ,Wada A ,Maeda K , et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-516
Web of Science | Medline29
Sudoh T ,Maekawa K ,Kojima M ,Minamino N ,Kangawa K ,Matsuo H . Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 1989;159:1427-1434
CrossRef | Web of Science | Medline30
Kojima M ,Minamino N ,Kangawa K ,Matsuo H . Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem Biophys Res Commun 1989;159:1420-1426
CrossRef | Web of Science | Medline31
Luchner A ,Stevens TL ,Borgeson DD , et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 1998;274:H1684-H1689
Web of Science | Medline32
Yasue H ,Yoshimura M ,Sumida H , et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994;90:195-203
Web of Science | Medline33
de Lemos JA ,Morrow DA ,Bentley JH , et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-1021
Full Text | Web of Science | Medline34
Sodian R ,Loebe M ,Schmitt C , et al. Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems. J Am Coll Cardiol 2001;38:1942-1949
CrossRef | Web of Science | Medline35
Remme WJ ,Swedberg K . Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-1560[Erratum, Eur Heart J 2001;22:2217-8.]
CrossRef | Web of Science | Medline
- Citing Articles (839)
Citing Articles
1
Marica Bordicchia, Dianxin Liu, Ez-Zoubir Amri, Gerard Ailhaud, Paolo Dessì-Fulgheri, Chaoying Zhang, Nobuyuki Takahashi, Riccardo Sarzani, Sheila Collins. (2012) Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. Journal of Clinical Investigation
CrossRef2
Sean Diepen, Matthew T. Roe, Renato D. Lopes, Amanda Stebbins, Stefan James, L. Kristin Newby, David J. Moliterno, Franz-Josef Neumann, Justin A. Ezekowitz, Kenneth W. Mahaffey, Judith S. Hochman, Christian W. Hamm, Paul W. Armstrong, Pierre Theroux, Christopher B. Granger. (2012) Baseline NT-proBNP and biomarkers of inflammation and necrosis in patients with ST-segment elevation myocardial infarction: insights from the APEX-AMI trial. Journal of Thrombosis and Thrombolysis
CrossRef3
Adonis Saremi, Dipika Gopal, Alan S Maisel. (2012) Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure. Expert Review of Cardiovascular Therapy 10:2, 191-203
CrossRef4
O. P. Almeida, G. J. Garrido, C. Beer, N. T. Lautenschlager, L. Arnolda, L. Flicker. (2012) Cognitive and brain changes associated with ischaemic heart disease and heart failure. European Heart Journal
CrossRef5
Sheng-Ling Jan, Yun-Ching Fu, Betau Hwang, Shing-Jong Lin. (2012) B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study. Biomarkers000-000
CrossRef6
Rakesh S. Engineer, Justin L. Benoit, Caitlin W. Hicks, Sunny J. Kolattukudy, Daniel Burkhoff, W. Frank Peacock. (2012) Hemodynamic changes as a diagnostic tool in acute heart failure—a pilot study. The American Journal of Emergency Medicine 30:1, 174-180
CrossRef7
Sunu S. Thomas, Anju Nohria. (2012) Hemodynamic Classifications of Acute Heart Failure and Their Clinical Application. Circulation Journal 76:2, 278-286
CrossRef8
Tomoko S. Kato, Aalap Chokshi, Parvati Singh, Tuba Khawaja, Shinichi Iwata, Shunichi Homma, Hirokazu Akashi, Faisal Cheema, Jonathan Yang, Hiroo Takayama, Yoshifumi Naka, Maryjane Farr, Donna Mancini, P. Christian Schulze. (2012) Markers of extracellular matrix turnover and the development of right ventricular failure after ventricular assist device implantation in patients with advanced heart failure. The Journal of Heart and Lung Transplantation 31:1, 37-45
CrossRef9
Jose F. Rueda, David H. Ellison. 2012. Management of the patient with congestive heart failure. , 187-196.
CrossRef10
Michael R. Bristow. (2012) Pharmacogenetic targeting of drugs for heart failure. Pharmacology & Therapeutics
CrossRef11
B. B. Heinisch, G. Vila, M. Resl, M. Riedl, B. Dieplinger, T. Mueller, A. Luger, G. Pacini, M. Clodi. (2011) B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men. Diabetologia
CrossRef12
T. A. McDonagh, M. Komajda, A. P. Maggioni, F. Zannad, M. Gheorghiade, M. Metra, H. J. Dargie. (2011) Clinical trials in acute heart failure: simpler solutions to complex problems. Consensus document arising from a European Society of Cardiology cardiovascular round-table think tank on acute heart failure, 12 May 2009. European Journal of Heart Failure 13:12, 1253-1260
CrossRef13
Stephanie Neuhold, Michael Resl, Martin Huelsmann, Guido Strunk, Christopher Adlbrecht, Claus Rath, Rudolf Prager, Anton Luger, Martin Clodi, Richard Pacher. (2011) Repeat measurements of glycated haemoglobin A1c and N-terminal pro-B-type natriuretic peptide: divergent behaviour in diabetes mellitus. European Journal of Clinical Investigation 41:12, 1292-1298
CrossRef14
Jennifer Franke, Lutz Frankenstein, Dieter Schellberg, Amer Bajrovic, Jan Sebastian Wolter, Philipp Ehlermann, Andreas O. Doesch, Manfred Nelles, Hugo A. Katus, Christian Zugck. (2011) Is there an additional benefit of serial NT-proBNP measurements in patients with stable chronic heart failure receiving individually optimized therapy?. Clinical Research in Cardiology 100:12, 1059-1067
CrossRef15
Stephane Ederhy, Hassan Izzedine, Christophe Massard, Ghislaine Dufaitre, Jean Philippe Spano, Gerard Milano, Catherine Meuleman, Benjamin Besse, Franck Boccara, David Kahyat, Ariel Cohen, Jean Charles Soria. (2011) Cardiac side effects of molecular targeted therapies: Towards a better dialogue between oncologists and cardiologists. Critical Reviews in Oncology/Hematology 80:3, 369-379
CrossRef16
Devin W. Kehl, Navaid Iqbal, Arrash Fard, Ben A. Kipper, Alejandro De La Parra Landa, Alan S. Maisel. (2011) Biomarkers in acute myocardial injury. Translational Research
CrossRef17
H. O. Ventura, M. A. Silver. (2011) Natriuretic Peptides as Markers of Cardiovascular Risk: The Story Continues. Mayo Clinic Proceedings 86:12, 1143-1145
CrossRef18
P. M. McKie, A. Cataliotti, S. J. Sangaralingham, T. Ichiki, V. Cannone, K. R. Bailey, M. M. Redfield, R. J. Rodeheffer, J. C. Burnett. (2011) Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follow-up Study. Mayo Clinic Proceedings 86:12, 1154-1160
CrossRef19
Yukihito Sato, Hisayoshi Fujiwara, Yoshiki Takatsu. (2011) Biochemical markers in heart failure. Journal of Cardiology
CrossRef20
Kevin Reed, Amal Mattu. 2011. Acute Heart Failure. , 161-184.
CrossRef21
Paolo Mercantini, Salvatore Di Somma, Laura Magrini, Andrea Kazemi Nava, Andrea Scarinci, Marco La Torre, Mario Ferri, Enrico Ferri, Niccolò Petrucciani, Vincenzo Ziparo. (2011) Preoperative Brain Natriuretic Peptide (BNP) Is a Better Predictor of Adverse Cardiac Events Compared to Preoperative Scoring System in Patients Who Underwent Abdominal Surgery. World Journal of Surgery
CrossRef22
Dinna N. Cruz, Ching Yan Goh, Alberto Palazzuoli, Leo Slavin, Anna Calabrò, Claudio Ronco, Alan Maisel. (2011) Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes. Heart Failure Reviews 16:6, 545-551
CrossRef23
Timothy Jang, Chandra Aubin, Rosanne Naunheim, Lawrence M. Lewis, Amy H. Kaji. (2011) Jugular venous distension on ultrasound: sensitivity and specificity for heart failure in patients with dyspnea. The American Journal of Emergency Medicine 29:9, 1198-1202
CrossRef24
Christophe Meune, Adeline Vermillet, Karim Wahbi, Sylvie Guerin, Hélène Aelion, Simon Weber, Camille Chenevier-Gobeaux. (2011) Mid-regional pro atrial natriuretic peptide allows the accurate identification of patients with atrial fibrillation of short time of onset: A pilot study. Clinical Biochemistry 44:16, 1315-1319
CrossRef25
Michael Böhm, Adriaan A. Voors, Jean-Marie Ketelslegers, Stephan H. Schirmer, Eva Turgonyi, Peter Bramlage, Faiez Zannad. (2011) Biomarkers: optimizing treatment guidance in heart failure. Clinical Research in Cardiology 100:11, 973-981
CrossRef26
Ningzheng Dong, Shenghan Chen, Wei Wang, Yiqing Zhou, Qingyu Wu. (2011) Corin in clinical laboratory diagnostics. Clinica Chimica Acta
CrossRef27
Ikuo Misumi, Kazuteru Fujimoto, Yuji Miyao, Mitsuhiro Matsumoto, Taku Rokutanda, Yousuke Hanaoka, Koichi Kaikita, Megumi Yamamuro, Seigo Sugiyama, Hisao Ogawa. (2011) Marked decrease in BNP levels in 2 related patients with reversible dilated cardiomyopathy. Journal of Cardiology Cases
CrossRef28
Christopher R. Carpenter, Samuel M. Keim, Andrew Worster, Peter Rosen. (2011) Brain Natriuretic Peptide in the Evaluation of Emergency Department Dyspnea: Is There a Role?. The Journal of Emergency Medicine
CrossRef29
Choni Rinat, Rachel Becker-Cohen, Amiram Nir, Sofia Feinstein, Nurit Algur, Efrat Ben-Shalom, Benjamin Farber, Yaacov Frishberg. (2011) B-type natriuretic peptides are reliable markers of cardiac strain in CKD pediatric patients. Pediatric Nephrology
CrossRef30
Hidekatsu Fukuta, Nobuyuki Ohte, Kazuaki Wakami, Toshihiko Goto, Tomomitsu Tani, Genjiro Kimura. (2011) Decreased plasma B-type natriuretic peptide levels in obesity are not explained by altered left ventricular hemodynamics. Obesity Research & Clinical Practice 5:4, e351-e359
CrossRef31
J.A. Sevillano Fernández, J.A. Nuevo González, M. Calderón Moreno, M.E. García Leoni. (2011) Disnea. Insuficiencia respiratoria aguda. Medicine - Programa de Formación Médica Continuada Acreditado 10:88, 5923-5931
CrossRef32
M. Calderón Moreno, A.I. Castuera Gil, F.J. de Castro Martínez, E. Gargallo García. (2011) Insuficiencia cardiaca aguda. Medicine - Programa de Formación Médica Continuada Acreditado 10:88, 5932-5939
CrossRef33
Ramazan Danis, Sehmus Ozmen, Senay Arikan, Deniz Gokalp, Omer Alyan. (2011) Predictive value of serum NT-proBNP levels in type 2 diabetic people with diabetic nephropathy. Diabetes Research and Clinical Practice
CrossRef34
Robert G Fassett, Sree K Venuthurupalli, Glenda C Gobe, Jeff S Coombes, Matthew A Cooper, Wendy E Hoy. (2011) Biomarkers in chronic kidney disease: a review. Kidney International 80:8, 806-821
CrossRef35
Aileen Andreu, Maya Guglin. (2011) Exaggerated NT-proBNP Production in Patients With Hematologic Malignancies: A Case Series. Congestive Heart Failureno-no
CrossRef36
J.A. Sevillano Fernández, E. Gargallo García, F.J. Gil Gómez, S. Gordo Remartínez. (2011) Protocolo diagnóstico de la disnea aguda. Medicine - Programa de Formación Médica Continuada Acreditado 10:88, 5955-5958
CrossRef37
Tsuneaki Sadanaga, Shun Kohsaka, Hideo Mitamura, Satoshi Ogawa. (2011) Elevated B-type natriuretic peptide level as a marker of subsequent thromboembolic events in patients with atrial fibrillation. Heart and Vessels 26:5, 530-535
CrossRef38
Nobutaka Ikeda, Masato Nakamura, Yoshiyuki Yazaki, Tsuyoshi Ono, Masaya Yamamoto, Shingo Ito, Itaru Yokouchi, Suguru Yajima, Raisuke Iijima, Hidehiko Hara, Takuro Takagi, Hisao Hara, Toshiyuki Asahara, Hideyuki Sakai, Kaoru Sugi. (2011) A slightly elevated level of N-terminal pro-brain natriuretic peptide can predict coronary artery disease in a population with normal left ventricular function. Heart and Vessels 26:5, 473-479
CrossRef39
Christophe Meune, Karim Wahbi, Camille Gobeaux, Denis Duboc, Françoise Pecker, Gisèle Bonne. (2011) N-terminal Pro brain natriuretic peptide is a reliable biomarker of reduced myocardial contractility in patients with lamin A/C gene mutations. International Journal of Cardiology 151:2, 160-163
CrossRef40
P. Ray, Y. Manach, B. Riou, T. T. Houle. (2011) Évaluation statistique d’un biomarqueur. Annales françaises de médecine d'urgence 1:5, 355-372
CrossRef41
Heidi B. Kellihan, Brian A. MacKie, Rebecca L. Stepien. (2011) NT-proBNP, NT-proANP and cTnI concentrations in dogs with pre-capillary pulmonary hypertension. Journal of Veterinary Cardiology 13:3, 171-182
CrossRef42
Noriaki Iwahashi, Satoshi Nakatani, Satoshi Umemura, Kazuo Kimura, Masafumi Kitakaze. (2011) Usefulness of Plasma B-Type Natriuretic Peptide in the Assessment of Disease Severity and Prediction of Outcome after Aortic Valve Replacement in Patients with Severe Aortic Stenosis. Journal of the American Society of Echocardiography 24:9, 984-991
CrossRef43
Ozge Aydemir, Cumhur Aydemir, Yusuf Unal Sarikabadayi, Nahide Altug, Omer Erdeve, Nurdan Uras, Serife Suna Oguz, Ugur Dilmen. (2011) The role of plasma N-terminal pro-B-type natriuretic peptide in predicting the severity of transient tachypnea of the newborn. Early Human Development
CrossRef44
A. S. Maisel, C. Mueller, R. Fitzgerald, R. Brikhan, B. C. Hiestand, N. Iqbal, P. Clopton, D. J. van Veldhuisen. (2011) Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial. European Journal of Heart Failure 13:8, 846-851
CrossRef45
Philip Haaf, Cathrin Balmelli, Tobias Reichlin, Raphael Twerenbold, Miriam Reiter, Julia Meissner, Nora Schaub, Claudia Stelzig, Michael Freese, Patricia Paniz, Christophe Meune, Beatrice Drexler, Heike Freidank, Katrin Winkler, Willibald Hochholzer, Christian Mueller. (2011) N-terminal Pro B-type Natriuretic Peptide in the Early Evaluation of Suspected Acute Myocardial Infarction. The American Journal of Medicine 124:8, 731-739
CrossRef46
A. Mark Richards. (2011) Tailored therapy for heart failure: neurohormones. Canadian Journal of Physiology and Pharmacology 89:8, 603-607
CrossRef47
Ravindra L Mehta. (2011) Biomarker explorations in acute kidney injury: the journey continues. Kidney International 80:4, 332-334
CrossRef48
Won Joon Seong, Seung Chan Kim, Dae Gy Hong, Tae Bon Koo, Il Soo Park. (2011) Amino-Terminal Pro-Brain Natriuretic Peptide Levels in Hypertensive Disorders Complicating Pregnancy. Hypertension in Pregnancy 30:3, 287-294
CrossRef49
Monica R. Shah, Robert M. Califf, Anju Nohria, Manju Bhapkar, Margaret Bowers, Donna M. Mancini, Mona Fiuzat, Lynne W. Stevenson, Christopher M. O’Connor. (2011) The STARBRITE Trial: A Randomized, Pilot Study of B-Type Natriuretic Peptide–Guided Therapy in Patients With Advanced Heart Failure. Journal of Cardiac Failure 17:8, 613-621
CrossRef50
Micha T. Maeder, David M. Kaye. (2011) Transcardiac gradients of B-type natriuretic peptides are increased in human pulmonary arterial hypertension. International Journal of Cardiology 151:1, 117-119
CrossRef51
Jianhao Peng, Jingjing Jiang, Wei Wang, Xiaofei Qi, Xue-Long Sun, Qingyu Wu. (2011) Glycosylation and processing of pro-B-type natriuretic peptide in cardiomyocytes. Biochemical and Biophysical Research Communications 411:3, 593-598
CrossRef52
Christopher F. Spurney. (2011) Cardiomyopathy of duchenne muscular dystrophy: Current understanding and future directions. Muscle & Nerve 44:1, 8-19
CrossRef53
Krista L. Turner, Laura J. Moore, S. Rob Todd, Joseph F. Sucher, Stephen A. Jones, Bruce A. McKinley, Alicia Valdivia, R. Matthew Sailors, Frederick A. Moore. (2011) Identification of Cardiac Dysfunction in Sepsis with B-Type Natriuretic Peptide. Journal of the American College of Surgeons 213:1, 139-146
CrossRef54
Maryna Krawczuk-Rybak, Łucja Dakowicz, Andrzej Hryniewicz, Agnieszka Maksymiuk, Beata Żelazowska-Rutkowska, Jolanta Wysocka. (2011) Cardiac function in survivors of acute lymphoblastic leukaemia and Hodgkin's lymphoma. Journal of Paediatrics and Child Health 47:7, 455-459
CrossRef55
José M Porcel. (2011) Utilization of B-type natriuretic peptide and NT-proBNP in the diagnosis of pleural effusions due to heart failure. Current Opinion in Pulmonary Medicine 17:4, 215-219
CrossRef56
R. Kakkar, R. T. Lee. (2011) Directions from Hecate: towards a multi-marker approach for heart failure assessment. European Journal of Heart Failure 13:7, 691-693
CrossRef57
Janko Pejović, Svetlana Ignjatović, Marijana Dajak, Nada Majkić-Singh, Žarko Vučinić. (2011) N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Hypertensive Heart Disease. Journal of Medical Biochemistry 30:3, 244-249
CrossRef58
Vijaiganesh Nagarajan, W. H. Wilson Tang. (2011) Biomarkers in Advanced Heart Failure: Diagnostic and Therapeutic Insights. Congestive Heart Failure 17:4, 169-174
CrossRef59
Andrew M. Atz, Victor Zak, Roger E. Breitbart, Steven D. Colan, Sara K. Pasquali, Daphne T. Hsu, Minmin Lu, Lynn Mahony, Stephen M. Paridon, Michael D. Puchalski, Tal Geva, Brian W. McCrindle, . (2011) Factors Associated with Serum Brain Natriuretic Peptide Levels after the Fontan Procedure. Congenital Heart Disease 6:4, 313-321
CrossRef60
Y.K. Kim, S.H. Seong, I.G. Jun, J.H. Chin, B.H. Sang, Y.S. Park, G.S. Hwang. (2011) Preoperative Echocardiographic Indices Associated With Elevated Brain Natriuretic Peptide in Liver Transplant Recipients. Transplantation Proceedings 43:5, 1691-1695
CrossRef61
G. Tasevska-Dinevska, L.M. Kennedy, A. Cline-Iwarson, C. Cline, L. Erhardt, R. Willenheimer. (2011) Gender differences in variables related to B-natriuretic peptide, left ventricular ejection fraction and mass, and peak oxygen consumption, in patients with heart failure. International Journal of Cardiology 149:3, 364-371
CrossRef62
Shahab Nozohoor, Johan Nilsson, Lars Algotsson, Johan Sjögren. (2011) Postoperative Increase in B-Type Natriuretic Peptide Levels Predicts Adverse Outcome After Cardiac Surgery. Journal of Cardiothoracic and Vascular Anesthesia 25:3, 469-475
CrossRef63
Y.K. Kim, W.J. Shin, J.G. Song, Y. Kim, W.J. Kim, S.H. Kim, G.S. Hwang. (2011) Evaluation of Intraoperative Brain Natriuretic Peptide as a Predictor of 1-Year Mortality After Liver Transplantation. Transplantation Proceedings 43:5, 1684-1690
CrossRef64
Patrick Ray. (2011) Intérêt et limites des biomarqueurs en médecine d’urgence. Le Praticien en Anesthésie Réanimation 15:3, 154-164
CrossRef65
Maria P. D’Errico, Luca Grimaldi, Maria F. Petruzzelli, Emilio A.L. Gianicolo, Francesco Tramacere, Antonio Monetti, Roberto Placella, Giorgio Pili, Maria Grazia Andreassi, Rosa Sicari, Eugenio Picano, Maurizio Portaluri. (2011) N-Terminal Pro-B–Type Natriuretic Peptide Plasma Levels as a Potential Biomarker for Cardiac Damage After Radiotherapy in Patients with Left-Sided Breast Cancer. International Journal of Radiation Oncology*Biology*Physics
CrossRef66
José M. Lobos Bejarano, Cristina Horrillo García, Ana I. González-González, Ángel Castellanos Rodríguez, Santiago Díaz Sánchez, Javier Castellanos Maroto, Ricardo Rodriguez-Barrientos, Miguel A. García-Fernández. (2011) Validez y utilidad del péptido ventricular natriurético tipo B (BNP) en la detección de disfunción ventricular izquierda en pacientes de alto riesgo en atención primaria. Atención Primaria
CrossRef67
Tsuneaki Sadanaga, Hideo Mitamura, Shun Kohsaka, Satoshi Ogawa. (2011) Steady-state B-type natriuretic peptide levels in patients with atrial fibrillation of various clinical backgrounds. Heart and Vessels
CrossRef68
P. Ray, C. Chenevier-Gobeaux, Y. -E. Claessens. (2011) Peptides natriurétiques, biomarqueurs de l’insuffisance cardiaque aux urgences. Annales françaises de médecine d'urgence 1:3, 200-205
CrossRef69
Sergio Manzano-Fernández, James L. Januzzi, Miguel Boronat García, Juan C. Bonaque-González, Carmen Muñoz-Esparza, María D. Albaladejo-Otón, Francisco J. Pastor-Pérez, Patricia Pastor, Mariano Valdés, Domingo A. Pascual-Figal. (2011) Valor pronóstico comparativo del pro-péptido natriurético tipo B aminoterminal urinario en pacientes con insuficiencia cardiaca aguda descompensada. Revista Española de Cardiología 64:5, 365-372
CrossRef70
Philip Haaf, Tobias Reichlin, Nils Corson, Raphael Twerenbold, Miriam Reiter, Stephan Steuer, Stefano Bassetti, Katrin Winkler, Claudia Stelzig, Corinna Heinisch, Beatrice Drexler, Heike Freidank, Christian Mueller. (2011) B-type Natriuretic Peptide in the Early Diagnosis and Risk Stratification of Acute Chest Pain. The American Journal of Medicine 124:5, 444-452
CrossRef71
Ali Ahmed. (2011) Chronic Heart Failure in Older Adults. Medical Clinics of North America 95:3, 439-461
CrossRef72
José A. Tallaj, Ish Singla, Robert C. Bourge. (2011) Implantable Hemodynamic Monitors. Cardiology Clinics 29:2, 289-299
CrossRef73
Mauro Feola, Enrico Lombardo, Camillo Taglieri, Salvatore Piccolo, Antonello Vado. (2011) Plasma BNP and renal failure as prognostic factors of mid-term clinical outcome in congestive heart failure patients. International Journal of Cardiology 149:1, 114-115
CrossRef74
Rieko Takahashi, Kazuaki Negishi, Atai Watanabe, Masashi Arai, Fumio Naganuma, Yoshiaki Ohyama, Masahiko Kurabayashi. (2011) Serum syndecan-4 is a novel biomarker for patients with chronic heart failure. Journal of Cardiology 57:3, 325-332
CrossRef75
Sanjay S. Bhandari, J. E. Davies, J. Struck, L. L. Ng. (2011) Influence of confounding factors on plasma Mid-Regional pro-Adrenomedullin and Mid-Regional pro-A-type Natriuretic Peptide concentrations in healthy individuals. Biomarkers 16:3, 281-287
CrossRef76
Jonathan G. Howlett. (2011) Acute Heart Failure: Lessons Learned So Far. Canadian Journal of Cardiology 27:3, 284-295
CrossRef77
Lucio Cagini, Rosanna Capozzi, Valentina Tassi, Claudia Savignani, Giuseppe Quintaliani, Gianpaolo Reboldi, Francesco Puma. (2011) Fluid and electrolyte balance after major thoracic surgery by bioimpedance and endocrine evaluation. European Journal of Cardio-Thoracic Surgery
CrossRef78
Richard W. Troughton, Lynley K. Lewis, Timothy G. Yandle, Christopher J. Pemberton, M. Gary Nicholls. (2011) B-type natriuretic peptides: Looking to the future. Annals of Medicine 43:3, 188-197
CrossRef79
Luis Valdés, Esther San José, Antonio Pose, Francisco J. González-Barcala, José M. Álvarez-Dobaño, Lucía Ferreiro, Christian Anchorena, Marco F. Pereyra, José R. González-Juanatey, Steven A. Sahn. (2011) Valor diagnóstico de los niveles del N-terminal pro-péptido natriurético cerebral en los derrames pleurales de origen cardiaco. Archivos de Bronconeumología 47:5, 246-251
CrossRef80
Carlos E. Sanchez, David R. Richards. (2011) Contemporary In-Hospital Management Strategies for Acute Decompensated Heart Failure. Cardiology in Review 19:3, 122-129
CrossRef81
Richard Ro, Henry C. Thode, Maria Taylor, Janet Gulla, Ellen Tetrault, Adam J. Singer. (2011) Comparison of the Diagnostic Characteristics of Two B-Type Natriuretic Peptide Point-of-Care Devices. The Journal of Emergency Medicine
CrossRef82
Megumi Koizumi, Hiroyuki Watanabe, Yoshihiro Kaneko, Kenji Iino, Masaru Ishida, Toshimitsu Kosaka, Yutaka Motohashi, Hiroshi Ito. (2011) Impact of obesity on plasma B-type natriuretic peptide levels in Japanese community-based subjects. Heart and Vessels
CrossRef83
FELIPE C.A. MARINHO, FRANCISCO S. VARGAS, JOSÉ FABRI JR, MILENA M.P. ACENCIO, EDUARDO H. GENOFRE, LEILA ANTONANGELO, ROBERTA K.B. SALES, LISETE R. TEIXEIRA. (2011) Clinical usefulness of B-type natriuretic peptide in the diagnosis of pleural effusions due to heart failure. Respirology 16:3, 495-499
CrossRef84
Dan Wen, Xian-Liang Zhou, Jian-Jun Li, Ru-Tai Hui. (2011) Biomarkers in aortic dissection. Clinica Chimica Acta 412:9-10, 688-695
CrossRef85
Mauro Feola, Ornella Garrone, Marcella Occelli, Antonella Francini, Alberto Biggi, Gianluca Visconti, Fabrizia Albrile, Marco Bobbio, Marco Merlano. (2011) Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: Effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide. International Journal of Cardiology 148:2, 194-198
CrossRef86
Fima Macheret, Guido Boerrigter, Paul McKie, Lisa Costello-Boerrigter, Brian Lahr, Denise Heublein, Sharon Sandberg, Yasuhiro Ikeda, Alessandro Cataliotti, Kent Bailey, Richard Rodeheffer, John C. Burnett. (2011) Pro–B-Type Natriuretic Peptide1–108 Circulates in the General Community. Journal of the American College of Cardiology 57:12, 1386-1395
CrossRef87
Logan Stuckey, David Ward, Paul Negus. (2011) Correlation Between Point-of-Care and Laboratory-Analyzed B-Type Natriuretic Peptide in Adult Patients Presenting to Nambour Hospital Emergency Department With Shortness of Breath. Point of Care: The Journal of Near-Patient Testing & Technology 10:1, 25-27
CrossRef88
Lluís Zapata, Paula Vera, Antoni Roglan, Ignasi Gich, Jordi Ordonez-Llanos, Antoni J. Betbesé. (2011) B-type natriuretic peptides for prediction and diagnosis of weaning failure from cardiac origin. Intensive Care Medicine 37:3, 477-485
CrossRef89
K. Thygesen, J. Mair, C. Mueller, K. Huber, M. Weber, M. Plebani, Y. Hasin, L. M. Biasucci, E. Giannitsis, B. Lindahl, W. Koenig, M. Tubaro, P. Collinson, H. Katus, M. Galvani, P. Venge, J. S. Alpert, C. Hamm, A. S. Jaffe. (2011) Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. European Heart Journal
CrossRef90
Alberto Palazzuoli, Giovanni Antonelli, Ilaria Quatrini, Ranuccio Nuti. (2011) Natriuretic peptides in heart failure: where we are, where we are going. Internal and Emergency Medicine 6:1, 63-68
CrossRef91
Angela Yee-Moon Wang, John E. Sanderson. (2011) Current Perspectives on Diagnosis of Heart Failure in Long-term Dialysis Patients. American Journal of Kidney Diseases 57:2, 308-319
CrossRef92
M. Noveanu, H. Pargger, T. Breidthardt, T. Reichlin, C. Schindler, A. Heise, R. Schoenenberger, P. Manndorff, M. Siegemund, A. Mebazaa, S. Marsch, C. Mueller. (2011) Use of B-type natriuretic peptide in the management of hypoxaemic respiratory failure. European Journal of Heart Failure 13:2, 154-162
CrossRef93
Marta Codognotto, Antonio Piccoli, Camilla Rubini, Vito Cianci, Gianna Vettore, Monica M. Mion, Carlo Artusi, Mario Plebani. (2011) Determinants of circulating asymmetric and symmetric dimethylarginines in patients evaluated for acute dyspnea. Clinical Chemistry and Laboratory Medicine 49:2, 237-242
CrossRef94
Ami N. Shah, Savina Nodari, Mihai Gheorghiade. (2011) Biomarkers in Acute Heart Failure Syndromes – Are They Fulfilling Their Promise. Cardiology 120:1, 19-21
CrossRef95
Massimo de Cal, Mikko Haapio, Dinna N. Cruz, Paolo Lentini, Andrew A. House, Ilona Bobek, Grazia M. Virzì, Valentina Corradi, Flavio Basso, Pasquale Piccinni, Angela D'Angelo, Jamie W. Chang, Mitchell H. Rosner, Claudio Ronco. (2011) B-Type Natriuretic Peptide in the Critically Ill with Acute Kidney Injury. International Journal of Nephrology 2011, 1-6
CrossRef96
Cathy R. Kessenich. (2011) BNP and heart failure. The Nurse Practitioner 36:1, 13-14
CrossRef97
Kosaku Komiya, Hiroshi Ishii, Shinji Teramoto, Osamu Takahashi, Nobuoki Eshima, Ou Yamaguchi, Noriyuki Ebi, Junji Murakami, Hidehiko Yamamoto, Jun-ichi Kadota. (2011) Diagnostic utility of C-reactive Protein combined with brain natriuretic peptide in acute pulmonary edema: a cross sectional study. Respiratory Research 12:1, 83
CrossRef98
Magda Cepkova, Vineet Kapur, Xiushui Ren, Thomas Quinn, Hanjing Zhuo, Elyse Foster, Michael A Matthay, Kathleen D Liu. (2011) Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort study. Annals of Intensive Care 1:1, 18
CrossRef99
Luis Valdés, Esther San José, Antonio Pose, Francisco J. González-Barcala, José M. Álvarez-Dobaño, Lucía Ferreiro, Christian Anchorena, Marco F. Pereyra, José R. González-Juanatey, Steven A. Sahn. (2011) Diagnostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Pleural Effusions of Cardiac Origin. Archivos de Bronconeumología (English Edition) 47:5, 246-251
CrossRef100
Felix Hennig, Alexander V. Stepanenko, Hans B. Lehmkuhl, Marian Kukucka, Michael Dandel, Thomas Krabatsch, Roland Hetzer, Evgenij V. Potapov. (2011) Neurohumoral and inflammatory markers for prediction of right ventricular failure after implantation of a left ventricular assist device. General Thoracic and Cardiovascular Surgery 59:1, 19-24
CrossRef101
G. Selim, O. Stojceva-Taneva, G. Spasovski, L. Georgievska-Ismail, B. Zafirovska-Ivanovska, S. Gelev, P. Dzekova, L. Trajcevska, S. Trojacanec-Piponska, A. Sikole. (2011) Brain Natriuretic Peptide between Traditional and Nontraditional Risk Factors in Hemodialysis Patients: Analysis of Cardiovascular Mortality in a Two-Year Follow-Up. Nephron Clinical Practice 119:2, c162-c170
CrossRef102
W. Frank Peacock, Ileana L. Piña. (2011) Primary Role of B-Type Natriuretic Peptide Across the Clinical Spectrum: From Emergency Medicine to Transitional Care and Beyond Into the Community. Congestive Heart Failure 17:1, 8-13
CrossRef103
Yoshitaka ARAMAKI, Syuuichi CHIMURA, Yasutomo HORI, Tokuhiro EGUCHI. (2011) Therapeutic Changes of Plasma N-Terminal Pro-Brain Natriuretic Peptide Concentrations in 9 Dogs with Patent Ductus Arteriosus. Journal of Veterinary Medical Science 73:1, 83-88
CrossRef104
Alan S. Maisel, Kazuwa Nakao, Piotr Ponikowski, W. Frank Peacock, Michihiro Yoshimura, Toru Suzuki, Takayoshi Tsutamoto, Gerasimos S. Filippatos, Yoshihiko Saito, Yoshihiko Seino, Naoto Minamino, Yasunobu Hirata, Masashi Mukoyama, Toshio Nishikimi, Ryozo Nagai. (2011) Japanese-Western Consensus Meeting on Biomarkers. International Heart Journal 52:5, 253-265
CrossRef105
Ricardo León de la Fuente, Patrycja A Naesgaard, Stein Nilsen, Leik Woie, Torbjoern Aarsland, Patricio Gallo, Heidi Grundt, Harry Staines, Dennis WT Nilsen. (2011) B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovascular Disorders 11:1, 57
CrossRef106
Wei Kong. (2011) Matrix Metalloproteinase-9 vs. Troponin T. Circulation Journal
CrossRef107
S Chen, T Tacy, R Clyman. (2010) How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude?. Journal of Perinatology 30:12, 780-785
CrossRef108
Han-Na Kim, James L. Januzzi. (2010) Biomarkers in the Management of Heart Failure. Current Treatment Options in Cardiovascular Medicine 12:6, 519-531
CrossRef109
Giovanni Casazza, Giorgio Costantino, Piergiorgio Duca. (2010) Clinical decision making: an introduction. Internal and Emergency Medicine 5:6, 547-552
CrossRef110
Luc W.M. Eurlings, Petra E.J. van Pol, Wouter E. Kok, Sandra van Wijk, Cara Lodewijks-van der Bolt, Aggie H.M.M. Balk, Dirk J.A. Lok, Harry J.G.M. Crijns, Dave J.W. van Kraaij, Nicolaas de Jonge, Joan G. Meeder, Martin Prins, Yigal M. Pinto. (2010) Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets. Journal of the American College of Cardiology 56:25, 2090-2100
CrossRef111
Jaquelini Sauer, Eneida R Rabelo, Raquel A Castro, Livia Goldraich, Luis E Rohde, Nadine Clausell, Luis Beck-da-Silva. (2010) Nurses’ performance in classifying heart failure patients based on physical exam: comparison with cardiologist’s physical exam and levels of N-terminal pro-B-type natriuretic peptide. Journal of Clinical Nursing 19:23-24, 3381-3389
CrossRef112
Ningzheng Dong, Jing Dong, Peng Liu, Luyao Xu, Sengseng Shi, Qingyu Wu. (2010) Effects of anticoagulants on human plasma soluble corin levels measured by ELISA. Clinica Chimica Acta 411:23-24, 1998-2003
CrossRef113
B. Drexler, C. Mueller. (2010) Natriuretic peptide-guided management by the general practitioner: how to interpret the SIGNAL. European Journal of Heart Failure 12:12, 1265-1267
CrossRef114
Wesley H. Self, Tyler W. Barrett. (2010) Novel Biomarkers: Help or Hindrance to Patient Care in the Emergency Department?. Annals of Emergency Medicine 56:6, 692-700
CrossRef115
S. Vink, A.H. Jin, K.J. Poth, G.A. Head, P.F. Alewood. (2010) Natriuretic peptide drug leads from snake venom. Toxicon
CrossRef116
Motaz Baibars, Ahmed Ibrahim, James C Fang, Ilke Sipahi. (2010) Natriuretic peptide-guided management of patients with heart failure: a decade of progress but still a controversy. Future Cardiology 6:6, 743-747
CrossRef117
T. Socrates, C. DeFilippi, T. Reichlin, R. Twerenbold, T. Breidhardt, M. Noveanu, M. Potocki, M. Reiter, N. Arenja, C. Heinisch, J. Meissner, C. Jaeger, R. Christenson, C. Mueller. (2010) Interleukin family member ST2 and mortality in acute dyspnoea. Journal of Internal Medicine 268:5, 493-500
CrossRef118
Douglas L. Kosmicki, Sean P. Collins, Michael C. Kontos, Michel Zuber, Peter Kipfer, Christine Attenhofer Jost, Andrew D. Michaels. (2010) Noninvasive Prediction of Left Ventricular Systolic Dysfunction in Patients With Clinically Suspected Heart Failure Using Acoustic Cardiography. Congestive Heart Failure 16:6, 249-253
CrossRef119
K Kataoka, Y Nannya, H Iwata, S Seo, K Kumano, T Takahashi, R Nagai, M Kurokawa. (2010) Plasma brain natriuretic peptide is associated with hepatic veno-occlusive disease and early mortality after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 45:11, 1631-1637
CrossRef120
Toshiaki Otsuka, Tomoyuki Kawada, Yoshihiko Seino, Chikao Ibuki, Masao Katsumata, Eitaro Kodani. (2010) Relation of Smoking Status to Serum Levels of N-Terminal Pro–Brain Natriuretic Peptide in Middle-Aged Men Without Overt Cardiovascular Disease. The American Journal of Cardiology 106:10, 1456-1460
CrossRef121
John R. Teerlink. 2010. Treatment of Acutely Decompensated Heart Failure. , 327-356.
CrossRef122
Leo Slavin, Thomas K. Ro, Alan S. Maisel. 2010. Biomarkers in Heart Failure. , 27-43.
CrossRef123
Willibald Hochholzer, David A. Morrow, Robert P. Giugliano. (2010) Novel biomarkers in cardiovascular disease: Update 2010. American Heart Journal 160:4, 583-594
CrossRef124
Antoni Bayes-Genis. (2010) Péptidos natriuréticos: ¿nuevas indicaciones?. Medicina Clínica 135:10, 450-451
CrossRef125
David Tanous, Samuel C. Siu, Jennifer Mason, Matthias Greutmann, Rachel M. Wald, John D. Parker, Mathew Sermer, Jack M. Colman, Candice K. Silversides. (2010) B-Type Natriuretic Peptide in Pregnant Women With Heart Disease. Journal of the American College of Cardiology 56:15, 1247-1253
CrossRef126
John Lynn Jefferies, Timothy M. Hoffman, David P. Nelson. (2010) Heart Failure Treatment in the Intensive Care Unit in Children. Heart Failure Clinics 6:4, 531-558
CrossRef127
Paolo G. Rusconi, David A. Ludwig, Christopher Ratnasamy, Robert Mas, William G. Harmon, Steven D. Colan, Steven E. Lipshultz. (2010) Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure. American Heart Journal 160:4, 776-783
CrossRef128
C. Lüers, A. Schmidt, R. Wachter, F. Fritzsche, A. Sutcliffe, S. Kleta, A. Zapf, G. Hagenah, L. Binder, B. Maisch, B. Pieske. (2010) Serial NT-proBNP measurements for risk stratification of patients with decompensated heart failure. Herz 35:7, 488-496
CrossRef129
A. Oude Lansink-Hartgring, J. Eshuis, M.K. Nieuwenhuis, G.I.J.M. Beerthuizen, W.M.T. Janssen. (2010) Adult respiratory distress syndrome or congestive heart failure in severe burn: A role for brain natriuretic peptide. Burns 36:6, e87-e90
CrossRef130
Santiago Garcia, Muhammad S. Akbar, Syed S. Ali, Forum Kamdar, Michael Y. Tsai, Daniel A. Duprez. (2010) N-terminal pro B-type natriuretic peptide predicts mortality in patients with left ventricular hypertrophy. International Journal of Cardiology 143:3, 349-352
CrossRef131
Claus Lüers, Gerrit Hagenah, Rolf Wachter, Sibylle Kleta, Jens Schaumberg, Sebastian Riedel, Lutz Binder, Klaus Jung, Albrecht Schmidt, Burkert Pieske. (2010) Bedeutung der Surfactant-Proteine B und D in der Differentialdiagnostik der akuten Dyspnoe. Medizinische Klinik 105:9, 611-618
CrossRef132
Mira Katan, Felix Fluri, Philipp Schuetz, Nils G. Morgenthaler, Christian Zweifel, Roland Bingisser, Ludwig Kappos, Andreas Steck, Stefan T. Engelter, Beat Müller, Mirjam Christ-Crain. (2010) Midregional Pro-Atrial Natriuretic Peptide and Outcome in Patients With Acute Ischemic Stroke. Journal of the American College of Cardiology 56:13, 1045-1053
CrossRef133
Catherine Law, Charles Glover, Kaaron Benson, Maya Guglin. (2010) Extremely High Brain Natriuretic Peptide Does Not Reflect the Severity of Heart Failure. Congestive Heart Failure 16:5, 221-225
CrossRef134
Nathalie Aujollet, Marjorie Meyer, Romain Cailliod, Fanny Combier, Yann Coignet, Sebastien Campard, Olivier Facy, Alain Bernard, Claude Girard. (2010) High N-Terminal Pro–B-Type Natriuretic Peptide: A Biomarker of Lung Cancer?. Clinical Lung Cancer 11:5, 341-345
CrossRef135
Robb D. Kociol, Peter S. Pang, Mihai Gheorghiade, Gregg C. Fonarow, Christopher M. O'Connor, G. Michael Felker. (2010) Troponin Elevation in Heart Failure. Journal of the American College of Cardiology 56:14, 1071-1078
CrossRef136
H. Aksoy, S. Okutucu, E. B. Kaya, O. S. Deveci, B. Evranos, K. Aytemir, G. Kabakci, L. Tokgozoglu, H. Ozkutlu, A. Oto. (2010) Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy. Europace 12:9, 1256-1261
CrossRef137
Mads Halbirk, Helene Nørrelund, Niels Møller, Ole Schmitz, Hans Erik Bøtker, Henrik Wiggers. (2010) Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients. International Journal of Cardiology 144:1, 140-142
CrossRef138
Emmet E. McGrath, David Warriner, Paul B. Anderson. (2010) The use of non-routine pleural fluid analysis in the diagnosis of pleural effusion. Respiratory Medicine 104:8, 1092-1100
CrossRef139
Jorien D.C. HANNINK, Hanneke A.C. Van HELVOORT, P.N. Richard DEKHUIJZEN, Yvonne F. HEIJDRA. (2010) Heart failure and COPD: Partners in crime?. Respirology 15:6, 895-901
CrossRef140
J. Paul Rocchiccioli, John J. V. McMurray, Anna F. Dominiczak. (2010) Biomarkers in heart failure: a clinical review. Heart Failure Reviews 15:4, 251-273
CrossRef141
Kathy Hebert, Ron Horswell, Paul Heidenreich, Jennifer Miranda, Lee Arcement. (2010) Handheld Ultrasound, B-Natriuretic Peptide for Screening Stage B Heart Failure. Southern Medical Journal 103:7, 616-622
CrossRef142
Larry A. Allen, G. Michael Felker. (2010) Multi-marker strategies in heart failure: clinical and statistical approaches. Heart Failure Reviews 15:4, 343-349
CrossRef143
Pam R. Taub, Paulette Gabbai-Saldate, Alan Maisel. (2010) Biomarkers of Heart Failure. Congestive Heart Failure 16, S19-S24
CrossRef144
Tujana Boldanova, Markus Noveanu, Tobias Breidthardt, Mihael Potocki, Tobias Reichlin, Anne Taegtmeyer, Michael Christ, Kirsten Laule, Claudia Stelzig, Christian Mueller. (2010) Impact of history of heart failure on diagnostic and prognostic value of BNP: Results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) Study. International Journal of Cardiology 142:3, 265-272
CrossRef145
W. Frank Peacock, Eugene Braunwald, William Abraham, Nancy Albert, John Burnett, Rob Christenson, Sean Collins, Deborah Diercks, Greg Fonarow, Judd Hollander, Art Kellerman, Mihai Gheorghiade, Doug Kirk, Phil Levy, Alan Maisel, Barry M. Massie, Christopher O'Connor, Peter Pang, Monica Shah, George Sopko, Lynne Stevenson, Alan Storrow, John Teerlink. (2010) National Heart, Lung, and Blood Institute Working Group on Emergency Department Management of Acute Heart Failure. Journal of the American College of Cardiology 56:5, 343-351
CrossRef146
H.-D. Dungen, M. Platzeck, J. Vollert, J. Searle, C. Muller, J. Reiche, F. Mehrhof, R. Muller, M. Mockel. (2010) Autoantibodies against cardiac troponin I in patients with congestive heart failure. European Journal of Heart Failure 12:7, 668-675
CrossRef147
Kirkwood F. Adams, G. Michael Felker, Ghassan Fraij, J. Herbert Patterson, Christopher M. O’Connor. (2010) Biomarker guided therapy for heart failure: focus on natriuretic peptides. Heart Failure Reviews 15:4, 351-370
CrossRef148
Kimberly D Tran, Niraj V Parekh, Alan S Maisel. (2010) Natriuretic peptides in heart failure. Therapy 7:4, 355-365
CrossRef149
Salvatore Di Somma, Benedetta De Berardinis, Cristina Bongiovanni, Rossella Marino, Enrico Ferri, Barbara Alfei. (2010) Use of BNP and Bioimpedance to Drive Therapy in Heart Failure Patients. Congestive Heart Failure 16, S56-S61
CrossRef150
Jun R. Chiong, Geoffrey T. Jao, Kirkwood F. Adams. (2010) Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure. Heart Failure Reviews 15:4, 275-291
CrossRef151
M. Cabiati, M. Campan, C. Caselli, T. Prescimone, D. Giannessi, S. Del Ry. (2010) Sequencing and cardiac expression of natriuretic peptide receptors A and C in normal and heart failure pigs. Regulatory Peptides 162:1-3, 12-17
CrossRef152
(2010) Section 11: Evaluation and Management of Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction. Journal of Cardiac Failure 16:6, e126-e133
CrossRef153
Mladen Sokolovic, Stephen M Pastores. (2010) Transfusion therapy and acute lung injury. Expert Review of Respiratory Medicine 4:3, 387-393
CrossRef154
(2010) Section 12: Evaluation and Management of Patients with Acute Decompensated Heart Failure. Journal of Cardiac Failure 16:6, e134-e156
CrossRef155
Ulrike Weber, Agnes Reitinger, Tomasz Erdeii, Christian Hellmich, Barbara Steinlechner, Helmut Hager, Michael Selzer, Michael Hiesmayr, Angela Rajek, Alexander Kober. (2010) Effects of high-urgency ambulance transportation on pro-B-type natriuretic peptide levels in patients with heart failure. The American Journal of Emergency Medicine 28:5, 568-576
CrossRef156
Aaron L. Baggish, Roland R. J. van Kimmenade, Yigal Pinto, A. Mark Richards, John Lainchbury, Antoni Bayes-Genis, Miquel Santaló, Jordi Ordonez-Llanos, James L. Januzzi. (2010) New York Heart Association class versus amino-terminal pro-B type natriuretic peptide for acute heart failure prognosis. Biomarkers 15:4, 307-314
CrossRef157
Heart Failure Society of America. (2010) Section 4: Evaluation of Patients for Ventricular Dysfunction and Heart Failure. Journal of Cardiac Failure 16:6, e44-e56
CrossRef158
Geoffrey de Couto, Maral Ouzounian, Peter P. Liu. (2010) Early detection of myocardial dysfunction and heart failure. Nature Reviews Cardiology 7:6, 334-344
CrossRef159
David E. Lanfear. (2010) Genetic variation in the natriuretic peptide system and heart failure. Heart Failure Reviews 15:3, 219-228
CrossRef160
Christopher Moriates, Alan Maisel. (2010) The Utility of Biomarkers in Sorting Out the Complex Patient. The American Journal of Medicine 123:5, 393-399
CrossRef161
W.H. Wilson Tang. (2010) Contemporary Challenges in Translating Biomarker Evidence Into Clinical Practice
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 55:19, 2077-2079
CrossRef162
Paul M. McKie, Alessandro Cataliotti, Brian D. Lahr, Fernando L. Martin, Margaret M. Redfield, Kent R. Bailey, Richard J. Rodeheffer, John C. Burnett. (2010) The Prognostic Value of N-Terminal Pro–B-Type Natriuretic Peptide for Death and Cardiovascular Events in Healthy Normal and Stage A/B Heart Failure Subjects. Journal of the American College of Cardiology 55:19, 2140-2147
CrossRef163
Larry A. Allen. (2010) Use of Multiple Biomarkers in Heart Failure. Current Cardiology Reports 12:3, 230-236
CrossRef164
Solange B. Tatani, Antonio Carlos C. Carvalho, Adagmar Andriolo, Rogério Rabelo, Orlando Campos, Valdir A. Moises. (2010) Echocardiographic Parameters and Brain Natriuretic Peptide in Patients after Surgical Repair of Tetralogy of Fallot. Echocardiography 27:4, 442-447
CrossRef165
Patrick Ray, Yannick Le Manach, Bruno Riou, Tim T. Houle. (2010) Statistical Evaluation of a Biomarker. Anesthesiology 112:4, 1023-1040
CrossRef166
Britta Goldmann, Thomas Meinertz. (2010) Benefits of biomarkers in heart failure. Clinical Research in Cardiology Supplements 5:S1, 21-26
CrossRef167
Pompilio Faggiano, Roberto Valle, Nadia Aspromonte, Antonio D'Aloia, Giuseppe Di Tano, Sabrina Barro, Prospero Giovinazzo, Loredano Milani, Roberto Lorusso, Livio Dei Cas. (2010) How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure?. International Journal of Cardiology 140:1, 88-94
CrossRef168
Salim Hayek, Mona Nemer. (2010) Cardiac Natriuretic Peptides: From Basic Discovery to Clinical Practice. Cardiovascular Therapeuticsno-no
CrossRef169
Abelardo A. Martinez-Rumayor, Josue Vazquez, Shafiq U. Rehman, James L. Januzzi. (2010) Relative value of amino-terminal pro-B-type natriuretic peptide testing and radiographic standards for the diagnostic evaluation of heart failure in acutely dyspneic subjects. Biomarkers 15:2, 175-182
CrossRef170
Apostolos Karavidas, John T. Parissis, Vassiliki Matzaraki, Sophia Arapi, Christos Varounis, Ignatios Ikonomidis, Panagiotis Grillias, Ioannis Paraskevaidis, Vlassios Pirgakis, Gerasimos Filippatos, Dimitios T. Kremastinos. (2010) Functional Electrical Stimulation is More Effective in Severe Symptomatic Heart Failure Patients and Improves Their Adherence to Rehabilitation Programs. Journal of Cardiac Failure 16:3, 244-249
CrossRef171
Michael Yelland, William E. Cayley, Werner Vach. (2010) An Algorithm for the Diagnosis and Management of Chest Pain in Primary Care. Medical Clinics of North America 94:2, 349-374
CrossRef172
Andrea Ballotta, Marco Ranucci, Alessia Kunkl, Hisham El Baghdady, Eduardo Bossone, Serenella Castelvecchio, Alessandro Frigiola, Lorenzo Menicanti, Marisa Di Donato, Rajendra H. Mehta. (2010) N-Terminal Pro–Brain Natriuretic Peptide and Outcomes in Patients Undergoing Surgical Ventricular Restoration. The American Journal of Cardiology 105:5, 640-644
CrossRef173
C. Goff, J. -F. Kaux, C. Bovy, A. Silva, J. -P. Chapelle. (2010) Comparaison des taux de BNP et NT-proBNP chez des patients insuffisants rénaux pour prévenir l’insuffisance cardiaque. Bio tribune magazine 34:1, 6-9
CrossRef174
John Lynn Jefferies, Jeffrey A Towbin. (2010) Dilated cardiomyopathy. The Lancet 375:9716, 752-762
CrossRef175
Robert S. Mckelvie, Michel Komajda, John Mcmurray, Michael Zile, Agata Ptaszynska, Mark Donovan, Peter Carson, Barry M. Massie. (2010) Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial. Journal of Cardiac Failure 16:2, 128-134
CrossRef176
Yvette RBM van Gestel, Dustin Goei, Sanne E. Hoeks, Don D. Sin, Willem-Jan Flu, Henk Stam, Frans W. Mertens, Jeroen J. Bax, Ron T. van Domburg, Don Poldermans. (2010) Predictive Value of NT-proBNP in Vascular Surgery Patients with COPD and Normal Left Ventricular Systolic Function. COPD: Journal of Chronic Obstructive Pulmonary Disease 7:1, 70-75
CrossRef177
Marko Banovic, Zorana Vasiljevic-Pokrajcic, Bosiljka Vujisic-Tesic, Sanja Stankovic, Ivana Nedeljkovic, Olga Petrovic, Petar Otasevic, Marija Boricic-Kostic, Milan Petrovic, Danijela Trifunovic, Miodrag Ostojic. (2010) Are de novo acute heart failure and acutely worsened chronic heart failure two subgroups of the same syndrome?. Srpski arhiv za celokupno lekarstvo 138:3-4, 162-169
CrossRef178
G. C.M. Linssen, S. J.L. Bakker, A. A. Voors, R. T. Gansevoort, H. L. Hillege, P. E. de Jong, D. J. van Veldhuisen, R. O.B. Gans, D. de Zeeuw. (2010) N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population. European Heart Journal 31:1, 120-127
CrossRef179
M. Potocki, T. Breidthardt, T. Reichlin, S. Hartwiger, N. G. Morgenthaler, A. Bergmann, M. Noveanu, H. Freidank, A. B. Taegtmeyer, K. Wetzel, T. Boldanova, C. Stelzig, R. Bingisser, M. Christ, C. Mueller. (2010) Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic ⨠peptide in the diagnosis of heart failure. Journal of Internal Medicine 267:1, 119-129
CrossRef180
Kyung-Hoon Lee, Jang-Young Kim, Sang-Baek Koh, Seung-Hwan Lee, Junghan Yoon, Sang-Woo Han, Jong-Ku Park, Kyung-Hoon Choe, Byung-Su Yoo. (2010) N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population. Korean Circulation Journal 40:12, 645
CrossRef181
Kensaku Higashi, Hideki Tanaka, Hiroto Shimokawahara, Norihito Nuruki, Katsuro Kashima, Masahiro Sonoda, Kazuhiko Nakamura, Hirohito Tsubouchi. (2010) Irrelevant B-Type Natriuretic Peptide Levels in Patients With Mechanical Prostheses in the Mitral Position Presenting With Congestive Heart Failure. Circulation Journal 74:8, 1584-1590
CrossRef182
Sascha N. Goonewardena, John E.A. Blair, Amin Manuchehry, J. Matthew Brennan, Michael Keller, Ryan Reeves, Adam Price, Kirk T. Spencer, Jyothy Puthumana, Mihai Gheorghiade. (2010) Use of Hand Carried Ultrasound, B-type Natriuretic Peptide, and Clinical Assessment in Identifying Abnormal Left Ventricular Filling Pressures in Patients Referred for Right Heart Catheterization. Journal of Cardiac Failure 16:1, 69-75
CrossRef183
Stefan Suttner, Joachim Boldt. (2010) Prediction of sepsis after multiple trauma: Does C-type natriuretic peptide do the trick?*. Critical Care Medicine 38:1, 323-324
CrossRef184
Wade Farrow. (2010) Phlebolymphedema–A Common Underdiagnosed and Undertreated Problem in the Wound Care Clinic. The Journal of the American College of Certified Wound Specialists 2:1, 14-23
CrossRef185
Christopher M. Shuford, Daniel L. Comins, Jerry L. Whitten, John C. Burnett, Jr., David C. Muddiman. (2010) Improving limits of detection for B-type natriuretic peptide using PC-IDMS: An application of the ALiPHAT strategy. The Analyst 135:1, 36
CrossRef186
Zaklina Davicevic, Dragan Tavciovski, Radomir Matunovic, Snjezana Vukotic, Zdravko Mijailovic. (2010) Role of natriuretic peptides in the assessment of aortic stenosis severity. Vojnosanitetski pregled 67:8, 622-626
CrossRef187
Mitja Lainscak, Markus S. Anker, Stephan Haehling, Stefan D. Anker. (2009) Biomarkers for Chronic Heart Failure. Herz 34:8, 589-593
CrossRef188
Dominik Berliner, Christiane E. Angermann, Georg Ertl, Stefan Störk. (2009) Biomarkers in Heart Failure – Better than History or Echocardiography?. Herz 34:8, 581-588
CrossRef189
Maria Gabriella Matera, Luigino Calzetta, Vincenzo Parascandolo, Giacomo Curradi, Paola Rogliani, Mario Cazzola. (2009) Relaxant effect of brain natriuretic peptide in nonsensitized and passively sensitized isolated human bronchi. Pulmonary Pharmacology & Therapeutics 22:6, 478-482
CrossRef190
Armen Kocharian, Reza Shabanian, Mitra Rahimzadeh, Abdolrazagh Kiani, Ahmad Hosseini, Keyhan Sayadpour Zanjani, Giv Heidari-Bateni, Nasrollah Hosseini-Navid. (2009) N-terminal Pro-B-type Natriuretic Peptide and Ventricular Dysfunction in Children and Adolescents. Cardiology in the Young 19:06, 580
CrossRef191
Irma B. Ancheta, Cynthia Battie, Sarah Cobb, Christine Ancheta, Alan Miller, Jun R. Chiong. (2009) The Impact of B-type Natriuretic Peptide, New York Heart Association Classification and Depression on Quality of Life in Nonhospitalized Heart Failure Patients. Progress in Cardiovascular Nursing 24:4, 124-130
CrossRef192
Anju Bhardwaj, James L. Januzzi. (2009) Natriuretic Peptide-Guided Management of Acutely Destabilized Heart Failure. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 8:4, 146-150
CrossRef193
Alan Maisel. (2009) Natriuretic Peptide-Guided Therapy for Heart Failure. Journal of the American College of Cardiology 55:1, 61-64
CrossRef194
E. M. Kanoupakis, E. G. Manios, P. E. Vardas. (2009) Predicting future shocks in implantable cardioverter defibrillator recipients: the role of biomarkers. Europace 11:11, 1434-1439
CrossRef195
Michael A. Paul, Carl L. Backer, Helen J. Binns, Constantine Mavroudis, Catherine L. Webb, Ram Yogev, Wayne H. Franklin. (2009) B-Type Natriuretic Peptide and Heart Failure in Patients with Ventricular Septal Defect: A Pilot Study. Pediatric Cardiology 30:8, 1094-1097
CrossRef196
R. K. Rogers, J. Stehlik, G. J. Stoddard, T. Greene, S. P. Collins, W. F. Peacock, A. D. Maisel, P. Clopton, A. D. Michaels. (2009) Adjusting for clinical covariates improves the ability of B-type natriuretic peptide to distinguish cardiac from non-cardiac dyspnoea: a sub-study of HEARD-IT. European Journal of Heart Failure 11:11, 1043-1049
CrossRef197
Yuk M. Law, Andrew W. Hoyer, Mark D. Reller, Michael Silberbach. (2009) Accuracy of Plasma B-Type Natriuretic Peptide to Diagnose Significant Cardiovascular Disease in Children. Journal of the American College of Cardiology 54:15, 1467-1475
CrossRef198
Andreas S. Pahle, Daniel Sørli, Torbjørn Omland, Cathrine Wold Knudsen, Arne Westheim, Alan H.B. Wu, Philippe Gabriel Steg, James McCord, Richard M. Nowak, Judd E. Hollander, Alan B. Storrow, William T. Abraham, Peter A. McCullough, Alan Maisel. (2009) Impact of Systemic Hypertension on the Diagnostic Performance of B-Type Natriuretic Peptide in Patients With Acute Dyspnea. The American Journal of Cardiology 104:7, 966-971
CrossRef199
Stefania Greco, Federica Troisi, Natale Daniele Brunetti, Matteo Di Biase. (2009) Tei Index Correlates with Tissue Doppler Parameters and Reflects Neurohormonal Activation in Patients with an Abnormal Transmitral Flow Pattern. Echocardiography 26:9, 1012-1018
CrossRef200
Romain Pirracchio, Reda Salem, Alexandre Mebazaa. (2009) Use of B-type natriuretic peptide in critically ill patients. Biomarkers in Medicine 3:5, 541-547
CrossRef201
Ana Garcia-Alvarez, Marta Sitges, Victoria Delgado, Jose Ortiz, Bárbara Vidal, Silvia Poyatos, Teresa Maria de Caralt, Magda Heras, Xavier Bosch, Manel Azqueta, Carles Pare, Josep Brugada. (2009) Relation of Plasma Brain Natriuretic Peptide Levels on Admission for ST-Elevation Myocardial Infarction to Left Ventricular End-Diastolic Volume Six Months Later Measured by Both Echocardiography and Cardiac Magnetic Resonance. The American Journal of Cardiology 104:7, 878-882
CrossRef202
WH Wilson Tang. (2009) Biomarkers of risk stratification in congestive heart failure: North American view. Biomarkers in Medicine 3:5, 443-452
CrossRef203
Asim A. Mohammed, James L. Januzzi. (2009) Natriuretic Peptides in the Diagnosis and Management of Acute Heart Failure. Heart Failure Clinics 5:4, 489-500
CrossRef204
EVELYN LECHNER, GABRIELE WIESINGER-EIDENBERGER, OLIVER WAGNER, MARTIN WEISSENSTEINER, ELISABETH SCHREIER-LECHNER, DORIS LEIBETSEDER, WOLFGANG ARZT, GERALD TULZER. (2009) Amino Terminal pro B-Type Natriuretic Peptide Levels Are Elevated in the Cord Blood of Neonates With Congenital Heart Defect. Pediatric Research 66:4, 466-469
CrossRef205
R. Kevin Rogers, Gregory J. Stoddard, Tom Greene, Andrew D. Michaels, Genaro Fernandez, Andrew Freeman, John Nord, Josef Stehlik. (2009) Usefulness of Adjusting for Clinical Covariates to Improve the Ability of B-Type Natriuretic Peptide to Distinguish Cardiac from Noncardiac Dyspnea. The American Journal of Cardiology 104:5, 689-694
CrossRef206
Kathryn K. Collins. (2009) The Spectrum of Long-term Electrophysiologic Abnormalities in Patients with Univentricular Hearts. Congenital Heart Disease 4:5, 310-317
CrossRef207
Micha T. Maeder, Martin H. Brutsche, Andreas Christ, Tobias Reichlin, Daniel Staub, Markus Noveanu, Tobias Breidthardt, Mihael Potocki, Christian Mueller. (2009) Natriuretic peptides for the prediction of severely impaired peak VO2 in patients with lung disease. Respiratory Medicine 103:9, 1337-1345
CrossRef208
Rajeev Garg, Avneet Singh, Azam Khaja, Alpert Martin, Kul Aggarwal. (2009) How Does Volume Status Affect BNP and Troponin Levels as Markers of Cardiovascular Status in Peritoneal Dialysis?. Congestive Heart Failure 15:5, 240-244
CrossRef209
Dave Milzman, Anthony Napoli, Christopher Hogan, Alex Zlidenny, Tim Janchar. (2009) Thoracic impedance vs chest radiograph to diagnose acute pulmonary edema in the ED. The American Journal of Emergency Medicine 27:7, 770-775
CrossRef210
Haim Shmilovich, Jeremy Ben-Shoshan, Reshef Tal, Arnon Afek, Iris Barshack, Sofia Maysel-Auslander, Dror Harats, Gad Keren, Jacob George. (2009) B-Type Natriuretic Peptide Enhances Vasculogenesis by Promoting Number and Functional Properties of Early Endothelial Progenitor Cells. Tissue Engineering Part A 15:9, 2741-2749
CrossRef211
İlker Çetin, Kürşad Tokel, Birgül Varan, Utku Örün, Sait Aşlamaci. (2009) Evaluation of Right Ventricular Function by Using Tissue Doppler Imaging in Patients after Repair of Tetralogy of Fallot. Echocardiography 26:8, 950-957
CrossRef212
Kursat Tigen, Tansu Karaahmet, Cihan Cevik, Emre Gurel, Selcuk Pala, Bulent Mutlu, Yelda Basaran. (2009) Prognostic Utility of Right Ventricular Systolic Functions Assessed by Tissue Doppler Imaging in Dilated Cardiomyopathy and Its Correlation With Plasma NT-pro-BNP Levels. Congestive Heart Failure 15:5, 234-239
CrossRef213
Reichlin, Tobias, Hochholzer, Willibald, Bassetti, Stefano, Steuer, Stephan, Stelzig, Claudia, Hartwiger, Sabine, Biedert, Stefan, Schaub, Nora, Buerge, Christine, Potocki, Mihael, Noveanu, Markus, Breidthardt, Tobias, Twerenbold, Raphael, Winkler, Katrin, Bingisser, Roland, Mueller, Christian, . (2009) Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays. New England Journal of Medicine 361:9, 858-867
Full Text214
Tobias Breidthardt, Markus Noveanu, Sevgi Cayir, Martina Viglino, Kirsten Laule, Willibald Hochholzer, Tobias Reichlin, Mihael Potocki, Michael Christ, Christian Mueller. (2009) The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea. International Journal of Cardiology 136:2, 193-199
CrossRef215
Felipe Villar Álvarez, Manuel Méndez Bailón, Javier de Miguel Díez. (2009) Enfermedad pulmonar obstructiva crónica e insuficiencia cardíaca. Archivos de Bronconeumología 45:8, 387-393
CrossRef216
Suhas Lele, Sudhir Shah, Peter McCullough, Mohan Rajapurkar. (2009) Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes. EuroIntervention 5:3, 336-342
CrossRef217
Sean P. Collins, Phillip D. Levy, Christopher J. Lindsell, Peter S. Pang, Alan B. Storrow, Chadwick D. Miller, Allen J. Naftilan, Vinay Thohan, William T. Abraham, Brian Hiestand, Gerasimos Filippatos, Deborah B. Diercks, Judd Hollander, Richard Nowak, W. Frank Peacock, Mihai Gheorghiade. (2009) The Rationale for an Acute Heart Failure Syndromes Clinical Trials Network. Journal of Cardiac Failure 15:6, 467-474
CrossRef218
Jun Funami, Toshio Hayashi, Hideki Nomura, Qun-Fang Ding, Asako Ishitsuka-Watanabe, Hisako Matsui-Hirai, Koichiro Ina, Jie Zhang, Ze-Yun Yu, Akihisa Iguchi. (2009) Clinical factors such as B-type natriuretic peptide link to factor VII, endothelial NO synthase and estrogen receptor α polymorphism in elderly women. Life Sciences 85:7-8, 316-321
CrossRef219
Afshan Batool Hameed, Kenneth Chan, Mark Ghamsary, Uri Elkayam. (2009) Longitudinal Changes in the B-Type Natriuretic Peptide Levels in Normal Pregnancy and Postpartum. Clinical Cardiology 32:8, E60-E62
CrossRef220
A. Oscarsson, M. Fredrikson, M. Sorliden, S. Anskar, C. Eintrei. (2009) N-terminal fragment of pro-B-type natriuretic peptide is a predictor of cardiac events in high-risk patients undergoing acute hip fracture surgery. British Journal of Anaesthesia 103:2, 206-212
CrossRef221
Athanassios Manginas, Anastasia Tsiavou, Petros Sfyrakis, Gregory Giamouzis, Loukas Tsourelis, Evangelos Leontiadis, Dimitrios Degiannis, Dennis V. Cokkinos, Petros A. Alivizatos. (2009) Increased Number of Circulating Progenitor Cells After Implantation of Ventricular Assist Devices. The Journal of Heart and Lung Transplantation 28:7, 710-717
CrossRef222
Jesper K. Jensen, Dan Atar, Søren R. Kristensen, Hans Mickley, James L. Januzzi. (2009) Usefulness of Natriuretic Peptide Testing for Long-Term Risk Assessment Following Acute Ischemic Stroke. The American Journal of Cardiology 104:2, 287-291
CrossRef223
O. James Ekundayo, Virginia J. Howard, Monika M. Safford, Leslie A. McClure, Donna Arnett, Richard M. Allman, George Howard, Ali Ahmed. (2009) Value of Orthopnea, Paroxysmal Nocturnal Dyspnea, and Medications in Prospective Population Studies of Incident Heart Failure. The American Journal of Cardiology 104:2, 259-264
CrossRef224
Christian Mueller. (2009) Cost-Effectiveness of B-Type Natriuretic Peptide in the Management of Dyspnea. Clinical Pulmonary Medicine 16:4, 199-201
CrossRef225
K. B. Shah, W. J. Kop, R. H. Christenson, D. B. Diercks, D. Kuo, S. Henderson, K. Hanson, S.-Y. Li, C. R. deFilippi. (2009) Natriuretic peptides and echocardiography in acute dyspnoea: implication of elevated levels with normal systolic function. European Journal of Heart Failure 11:7, 659-667
CrossRef226
Daniel Staub, Daniel Jauslin, Heike Freidank, Anne Taegtmeyer, Tobias Breidthardt, Michael J. Zellweger, Jan Mueller-Brand, Michael Christ, Christian Mueller. (2009) Use of changes in B-type natriuretic peptides to detect ischemia in selected patients. International Journal of Cardiology 136:1, 40-46
CrossRef227
Esther Roselló-Lletí, Miguel Rivera, Vicente Miró, Raquel Cortés, Luís Martínez-Dolz, Manuel Portolés. (2009) Valor pronóstico de big endotelina-1 en pacientes con insuficiencia cardíaca y clase funcional moderadamente sintomática. Medicina Clínica 133:5, 173-176
CrossRef228
Subha V. Raman, Orlando P. Simonetti. (2009) The CMR Examination in Heart Failure. Heart Failure Clinics 5:3, 283-300
CrossRef229
Michelle M. Kittleson, Diane V. Skojec, Ilan S. Wittstein, Hunter C. Champion, Daniel P. Judge, Lili A. Barouch, Marc Halushka, Joshua M. Hare, Edward K. Kasper, Stuart D. Russell. (2009) The Change in B-Type Natriuretic Peptide Levels Over Time Predicts Significant Rejection in Cardiac Transplant Recipients. The Journal of Heart and Lung Transplantation 28:7, 704-709
CrossRef230
S. Krüger. (2009) Biomarker im Management pulmonaler Infektionen. Der Pneumologe 6:4, 203-212
CrossRef231
Johan Sundström. (2009) Troponin and heart failure: an early warning system worth listening to?. Future Cardiology 5:4, 321-324
CrossRef232
Larry H. Bernstein, Michael Y. Zions, Salman A. Haq, Stuart Zarich, James Rucinski, Bette Seamonds, Stanley Berger, Daniel Y. Lesley, William Fleischman, John F. Heitner. (2009) Effect of renal function loss on NT-proBNP level variations. Clinical Biochemistry 42:10-11, 1091-1098
CrossRef233
Yunxia Chen, Chunsheng Li. (2009) Prognostic significance of brain natriuretic peptide obtained in the ED in patients with SIRS or sepsis. The American Journal of Emergency Medicine 27:6, 701-706
CrossRef234
Osamu Tsukamoto, Masashi Fujita, Mahoto Kato, Satoru Yamazaki, Yoshihiro Asano, Akiko Ogai, Hidetoshi Okazaki, Mitsutoshi Asai, Yoko Nagamachi, Norikazu Maeda, Yasunori Shintani, Tetsuo Minamino, Masanori Asakura, Ichiro Kishimoto, Tohru Funahashi, Hitonobu Tomoike, Masafumi Kitakaze. (2009) Natriuretic Peptides Enhance the Production of Adiponectin in Human Adipocytes and in Patients With Chronic Heart Failure. Journal of the American College of Cardiology 53:22, 2070-2077
CrossRef235
Christopher A. Paciullo, Steven P. Dunn, Tracy E. Macaulay, Kelly M. Smith. (2009) Heart Failure Management Strategies in a Surgical Population. Orthopedics 32:6, 421-426
CrossRef236
Alain Cohen-Solal, Damien Logeart, Bidan Huang, Danlin Cai, Markku S. Nieminen, Alexandre Mebazaa. (2009) Lowered B-Type Natriuretic Peptide in Response to Levosimendan or Dobutamine Treatment Is Associated With Improved Survival in Patients With Severe Acutely Decompensated Heart Failure. Journal of the American College of Cardiology 53:25, 2343-2348
CrossRef237
Sean P. Collins, W. Frank Peacock, Christopher J. Lindsell, Paul Clopton, Deborah B. Diercks, Brian Hiestand, Chris Hogan, Michael C. Kontos, Christian Mueller, Richard Nowak, Wen-Jone Chen, Chien-Hua Huang, William T. Abraham, Ezra Amsterdam, Tobias Breidthardt, Lori Daniels, Ayesha Hasan, Mike Hudson, James McCord, Tehmina Naz, Lynne E. Wagoner, Alan Maisel. (2009) S3 Detection as a Diagnostic and Prognostic Aid in Emergency Department Patients With Acute Dyspnea. Annals of Emergency Medicine 53:6, 748-757
CrossRef238
A. Y.-M. Wang, C. W.-K. Lam, M. Wang, I. H.-S. Chan, S.-F. Lui, Y. Zhang, J. E. Sanderson. (2009) Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients. Nephrology Dialysis Transplantation 24:6, 1962-1969
CrossRef239
Adam J. Singer, Henry C. Thode, Jr, Gary B. Green, Robert Birkhahn, Nathan I. Shapiro, Charles Cairns, Brigitte M. Baumann, Richard Aghababian, Douglas Char, Judd E. Hollander. (2009) The Incremental Benefit of a Shortness-of-breath Biomarker Panel in Emergency Department Patients with Dyspnea. Academic Emergency Medicine 16:6, 488-494
CrossRef240
Xiao-juan Ma, Hui-jun Yin, Ke-ji Chen. (2009) Appraisal of the prognosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Chinese Journal of Integrative Medicine 15:3, 236-240
CrossRef241
Kensaku Shibazaki, Kazumi Kimura, Yoko Okada, Yasuyuki Iguchi, Yuka Terasawa, Junya Aoki. (2009) Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation. Journal of the Neurological Sciences 281:1-2, 55-57
CrossRef242
Michael Behnes, Martina Brueckmann, Parviz Ahmad-Nejad, Siegfried Lang, Christian Wolpert, Elif Elmas, Thorsten Kaelsch, Joachim Gruettner, Christel Weiβ, Martin Borggrefe, Michael Neumaier. (2009) Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema. International Journal of Cardiology 135:2, 165-174
CrossRef243
Astrid E. Lammers, Alison A. Hislop, Sheila G. Haworth. (2009) Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension. International Journal of Cardiology 135:1, 21-26
CrossRef244
Larry A. Allen, Adrian F. Hernandez, Christopher M. O'Connor, G. Michael Felker. (2009) End Points for Clinical Trials in Acute Heart Failure Syndromes. Journal of the American College of Cardiology 53:24, 2248-2258
CrossRef245
M. T. Maeder, M. H. Brutsche, D. Staub, N. G. Morgenthaler, A. Bergmann, M. Noveanu, K. Laule, T. Breidthardt, A. Christ, T. Klima, T. Reichlin, M. Potocki, C. Mueller. (2009) B-type natriuretic peptide and C-terminal-pro-endothelin-1 for the prediction of severely impaired peak oxygen consumption. Journal of Internal Medicine 265:5, 604-615
CrossRef246
Amandeep S. Dhaliwal, Anita Deswal, Allison Pritchett, David Aguilar, Biswajit Kar, Julianne Souchek, Biykem Bozkurt. (2009) Reduction in BNP Levels With Treatment of Decompensated Heart Failure and Future Clinical Events. Journal of Cardiac Failure 15:4, 293-299
CrossRef247
Saima Husain, Salpy V. Pamboukian, Josè A. Tallaj, David C. McGiffin, Robert C. Bourge. (2009) Invasive monitoring in patients with heart failure. Current Cardiology Reports 11:3, 159-166
CrossRef248
N. van der Burg-de Graauw, C.M. Cobbaert, C.J.F.M. Middelhoff, T.A. Bantje, C. van Guldener. (2009) The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea. European Journal of Internal Medicine 20:3, 301-306
CrossRef249
Barry McDonnell, Stephen Hearty, Paul Leonard, Richard O'Kennedy. (2009) Cardiac biomarkers and the case for point-of-care testing. Clinical Biochemistry 42:7-8, 549-561
CrossRef250
Sean P. Collins, Christopher J. Lindsell, Michael C. Kontos, Michel Zuber, Peter Kipfer, Christine Attenhofer Jost, Douglas Kosmicki, Andrew D. Michaels. (2009) Bedside prediction of increased filling pressure using acoustic electrocardiography. The American Journal of Emergency Medicine 27:4, 397-408
CrossRef251
Amanda A. Fox, Charles D. Collard, Stanton K. Shernan, Christine E. Seidman, Jonathan G. Seidman, Kuang-Yu Liu, Jochen D. Muehlschlegel, Tjorvi E. Perry, Sary F. Aranki, Christoph Lange, Daniel S. Herman, Thomas Meitinger, Peter Lichtner, Simon C. Body. (2009) Natriuretic Peptide System Gene Variants Are Associated with Ventricular Dysfunction after Coronary Artery Bypass Grafting. Anesthesiology 110:4, 738-747
CrossRef252
Francesco Dentali, Marco Donadini, Monica Gianni, Andrea Bertolini, Eva Lonn, Achille Venco, Gianpaolo Cattozzo, Walter Ageno. (2009) Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism. Internal and Emergency Medicine 4:2, 123-128
CrossRef253
Sharon Ann Hunt, William T. Abraham, Marshall H. Chin, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Mariell Jessup, Marvin A. Konstam, Donna M. Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy. (2009) 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology 53:15, e1-e90
CrossRef254
R. Cortés, M. Rivera, L. Martínez Dolz, E. Roselló-Lletí, M.J. Sancho-Tello, B. Sevilla, M. Portolés, J. Cosín. (2009) Niveles urinarios de péptido natriurético tipo B (BNP) y disfunción ventricular sistólica en pacientes con insuficiencia cardiaca. Revista Clínica Española 209:4, 168-175
CrossRef255
Mariell Jessup, William T. Abraham, Donald E. Casey, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Marvin A. Konstam, Donna M. Mancini, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy. (2009) 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology 53:15, 1343-1382
CrossRef256
Kambiz Norozi, Lutz Binder, Christoph Brack, Ludger Potthoff, Georg Hess, Armin Wessel. (2009) Intravenous luteinizing hormone-releasing hormone has no effect on serum N -terminal pro-brain natriuretic peptide in children and adolescents. Pediatrics International 51:2, 283-288
CrossRef257
James A. de Lemos, Darren K. McGuire, Amit Khera, Sandeep R. Das, Sabina A. Murphy, Torbjorn Omland, Mark H. Drazner. (2009) Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study. American Heart Journal 157:4, 746-753.e2
CrossRef258
Giuseppe Crescenzi, Giovanni Landoni, Elena Bignami, Ilaria Belloni, Camilla Biselli, Concetta Rosica, Fabio Guarracino, Giovanni Marino, Alberto Zangrillo. (2009) N-Terminal B-Natriuretic Peptide After Coronary Artery Bypass Graft Surgery. Journal of Cardiothoracic and Vascular Anesthesia 23:2, 147-150
CrossRef259
Andrew S. Liteplo, Keith A. Marill, Tomas Villen, Robert M. Miller, Alice F. Murray, Peter E. Croft, Roberta Capp, Vicki E. Noble. (2009) Emergency Thoracic Ultrasound in the Differentiation of the Etiology of Shortness of Breath (ETUDES): Sonographic B-lines and N-terminal Pro-brain-type Natriuretic Peptide in Diagnosing Congestive Heart Failure. Academic Emergency Medicine 16:3, 201-210
CrossRef260
Armand Mekontso Dessap, Laurent Brochard. (2009) B-Type Natriuretic Peptide and Weaning From Mechanical Ventilation. Clinical Pulmonary Medicine 16:2, 89-94
CrossRef261
Christian Mueller, Micha T. Maeder, Andreas Christ, Tobias Reichlin, Daniel Staub, Markus Noveanu, Tobias Breidthardt, Mihael Potocki, Martin H. Brutsche. (2009) B-Type Natriuretic Peptides for the Evaluation of Exercise Intolerance. The American Journal of Medicine 122:3, 265-272
CrossRef262
Niraj Parekh, Alan S Maisel. (2009) Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure. Current Opinion in Cardiology 24:2, 155-160
CrossRef263
Mitja Lainscak, Stephan von Haehling, Stefan D. Anker. (2009) Natriuretic peptides and other biomarkers in chronic heart failure: From BNP, NT-proBNP, and MR-proANP to routine biochemical markers. International Journal of Cardiology 132:3, 303-311
CrossRef264
Henry Krum, William T Abraham. (2009) Heart failure. The Lancet 373:9667, 941-955
CrossRef265
Roland R.J. van Kimmenade, James L. Januzzi, Jaap A. Bakker, Alphonse J. Houben, Roger Rennenberg, Abraham A. Kroon, Harry J.G.M. Crijns, Marja P. van Dieijen-Visser, Peter W. de Leeuw, Yigal M. Pinto. (2009) Renal Clearance of B-Type Natriuretic Peptide and Amino Terminal Pro-B-Type Natriuretic Peptide. Journal of the American College of Cardiology 53:10, 884-890
CrossRef266
Jutta Bergler-Klein. (2009) Natriuretic peptides in the management of aortic stenosis. Current Cardiology Reports 11:2, 85-93
CrossRef267
Roberto Bassan, Bernardo R. Tura, Alan S. Maisel. (2009) B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department. Coronary Artery Disease 20:2, 143-149
CrossRef268
Margherita Padeletti, Philip Green, Anne M. Mooney, Robert C. Basner, Donna M. Mancini. (2009) Sleep disordered breathing in patients with acutely decompensated heart failure. Sleep Medicine 10:3, 353-360
CrossRef269
J. T. Parissis, M. Nikolaou, D. Farmakis, I. A. Paraskevaidis, V. Bistola, K. Venetsanou, D. Katsaras, G. Filippatos, D. T. Kremastinos. (2009) Self-assessment of health status is associated with inflammatory activation and predicts long-term outcomes in chronic heart failure. European Journal of Heart Failure 11:2, 163-169
CrossRef270
Franck Lebourgeois, Caroline Bussy, Jacques Myara, Jean-Louis Golmard, François Piette, Joël Belmin. (2009) PLASMA BRAIN NATRIURETIC PEPTIDE MEASURED IN STABLE CONDITIONS IS RELATED TO MORTALITY IN FRAIL AND VERY OLD PATIENTS. Journal of the American Geriatrics Society 57:2, 365-366
CrossRef271
Claudio Passino, Alessandro Pingitore, Patrizia Landi, Marianna Fontana, Luc Zyw, Aldo Clerico, Michele Emdin, Giorgio Iervasi. (2009) Prognostic Value of Combined Measurement of Brain Natriuretic Peptide and Triiodothyronine in Heart Failure. Journal of Cardiac Failure 15:1, 35-40
CrossRef272
Jian Wang, Masaki Tsukashita, Takeshi Nishina, Akira Marui, Eiji Yoshikawa, Hiroyuki Muranaka, Satoshi Matsuoka, Tadashi Ikeda. (2009) Chronic partial unloading restores β-adrenergic responsiveness and reverses receptor downregulation in failing rat hearts. The Journal of Thoracic and Cardiovascular Surgery 137:2, 465-470
CrossRef273
Fábio Vilas-Boas. (2009) Modern approach to the treatment of decompensated heart failure. Expert Review of Cardiovascular Therapy 7:2, 159-167
CrossRef274
N. M. Hawkins, M. C. Petrie, P. S. Jhund, G. W. Chalmers, F. G. Dunn, J. J.V. McMurray. (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. European Journal of Heart Failure 11:2, 130-139
CrossRef275
Jonathan G. Howlett, Robert S. McKelvie, J Malcolm O. Arnold, Jeannine Costigan, Paul Dorian, Anique Ducharme, Estrellita Estrella-Holder, Justin A. Ezekowitz, Nadia Giannetti, Haissam Haddad, George A. Heckman, Anthony M. Herd, Debra Isaac, Philip Jong, Simon Kouz, Peter Liu, Elizabeth Mann, Gordon W. Moe, Ross T. Tsuyuki, Heather J. Ross, Michel White. (2009) Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Canadian Journal of Cardiology 25:2, 85-105
CrossRef276
R. N. Rodseth. (2009) B type natriuretic peptide - a diagnostic breakthrough in peri-operative cardiac risk assessment?. Anaesthesia 64:2, 165-178
CrossRef277
C. A. Marquette, F. Bouteille, B. P. Corgier, A. Degiuli, L. J. Blum. (2009) Disposable screen-printed chemiluminescent biochips for the simultaneous determination of four point-of-care relevant proteins. Analytical and Bioanalytical Chemistry 393:4, 1191-1198
CrossRef278
Saurabh Gupta, Andrew D. Michaels. (2009) Relationship Between Accurate Auscultation of the Fourth Heart Sound and the Level of Physician Experience. Clinical Cardiology 32:2, 69-75
CrossRef279
Luis R. Castellanos, Vikas Bhalla, Susan Isakson, Lori B. Daniels, Meenakshi A. Bhalla, Jeannette P. Lin, Paul Clopton, Nancy Gardetto, Max Hoshino, Albert Chiu, Robert Fitzgerald, Alan S. Maisel. (2009) B-Type Natriuretic Peptide and Impedance Cardiography at the Time of Routine Echocardiography Predict Subsequent Heart Failure Events. Journal of Cardiac Failure 15:1, 41-47
CrossRef280
J. K. Shim, Y. S. Choi, D. H. Chun, S. W. Hong, D. H. Kim, Y. L. Kwak. (2009) Relationship between echocardiographic index of ventricular filling pressure and intraoperative haemodynamic changes during off-pump coronary bypass surgery. British Journal of Anaesthesia 102:3, 316-321
CrossRef281
Anna Marie Chang, Alan S. Maisel, Judd E. Hollander. (2009) Diagnosis of Heart Failure. Heart Failure Clinics 5:1, 25-35
CrossRef282
Ekrem Cengiz Seyhan, Sedat Altin, Erdogan Cetinkaya, Sinem Sokucu, Mehmet Zeki Gunluoglu, Adalet Demir, Pelin Korkmaz, Halim Issever. (2009) The Importance of Pleural Fluid and Serum NT-proBNP Levels in Differentiating Pleural Effusion due to Heart Failure from Other Causes of Effusion. Internal Medicine 48:5, 287-293
CrossRef283
Ana Teresa Timóteo, Alexandra Toste, Ruben Ramos, Fernando Miranda, Maria Lurdes Ferreira, José Alberto Oliveira, Rui Cruz Ferreira. (2009) Does admission NT-proBNP increase the prognostic accuracy of GRACE risk score in the prediction of short-term mortality after acute coronary syndromes?. Acute Cardiac Care 11:4, 236-242
CrossRef284
Yasuko Takeda, Yutaka Takeda, Shogo Suzuki, Genjiro Kimura. (2009) Within-person variation of the plasma concentration of B-type natriuretic peptide: Safety range in stable patients with heart failure. American Heart Journal 157:1, 97-101
CrossRef285
W. Frank Peacock, Karina M. Soto-Ruiz. (2009) Risk stratification for suspected acute coronary syndromes and heart failure in the emergency department. Acute Cardiac Care 11:3, 138-145
CrossRef286
(2009) Transfusion-associated circulatory overload: the plot thickens. Transfusion 49:1, 2-4
CrossRef287
Mitsuaki Isobe. (2009) Nihon Shuchu Chiryo Igakukai zasshi 16:4, 439-445
CrossRef288
Kensaku Shibazaki, Kazumi Kimura, Yasuyuki Iguchi, Yoko Okada, Takeshi Inoue. (2009) Plasma Brain Natriuretic Peptide Can be a Biological Marker to Distinguish Cardioembolic Stroke from Other Stroke Types in Acute Ischemic Stroke. Internal Medicine 48:5, 259-264
CrossRef289
Jung Eun Lee, So Yeon Choi, Wooseong Huh, Seong Woo Park, Dae Joong Kim, Ha Young Oh, Yoon-Goo Kim. (2009) N-terminal Pro-Brain Natriuretic Peptide Levels Predict Left Ventricular Systolic Function in Patients with Chronic Kidney Disease. Journal of Korean Medical Science 24:Suppl 1, S63
CrossRef290
John T. Parissis, Maria Nikolaou, Dionysia Birmpa, Dimitrios Farmakis, Ioannis Paraskevaidis, Vassiliki Bistola, Theodoros Katsoulas, Gerasimos Filippatos, Dimitrios T. Kremastinos. (2009) Clinical and Prognostic Value of Duke's Activity Status Index Along With Plasma B-Type Natriuretic Peptide Levels in Chronic Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy. The American Journal of Cardiology 103:1, 73-75
CrossRef291
W. Frank Peacock, Gregg C. Fonarow, Douglas S. Ander, Sean P. Collins, Mihai Gheorghiade, J. Douglas Kirk, Gerasimos Filippatos, Deborah B. Diercks, Robin J. Trupp, Brian Hiestand, Ezra A. Amsterdam, William T. Abraham, Ezra A. Amsterdam, Gail Dodge, David F. Gaieski, Diane Gurney, Christy O. Hayes, Judd E. Hollander, Kay Holmes, James L. Januzzi, Phillip Levy, Alan Maisel, Chadwick D. Miller, Peter S. Pang, Elsie Selby, Alan B. Storrow, Neal L. Weintraub, Clyde W. Yancy, Raymond D. Bahr, Andra L. Blomkalns, James McCord, Richard M. Nowak, Robert J. Stomel. (2009) Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient—part 1. Acute Cardiac Care 11:1, 3-42
CrossRef292
Kazuhiro Yamamoto, Yasushi Sakata, Tomohito Ohtani, Yasuharu Takeda, Toshiaki Mano. (2009) Heart Failure With Preserved Ejection Fraction. Circulation Journal 73:3, 404-410
CrossRef293
Min-Soo Ahn, Byung-Su Yoo, Kyoung-Hoon Lee, Young-Jin Youn, Seong-Yoon Kim, Jang-Young Kim, Seung-Whan Lee, Junghan Yoon, Kyung-Hoon Choe. (2009) B-Type Natriuretic Peptide and Long-Term Prognosis in Low-Risk Patients With Unstable Angina. Korean Circulation Journal 39:1, 26
CrossRef294
Mehmet Kemal Aktas, Drew Allen, Wael A. Jaber, Hsuan-Hung Chuang, David O. Taylor, Mohamad H. Yamani. (2009) Relation of Brain Natriuretic Peptide Level to Extent of Left Ventricular Scarring in Patients With Chronic Heart Failure Secondary to Ischemic Cardiomyopathy. The American Journal of Cardiology 103:2, 243-245
CrossRef295
Yuzuru Inoue, Tomotaka Kawayama, Tomoaki Iwanaga, Hisamichi Aizawa. (2009) High Plasma Brain Natriuretic Peptide Levels in Stable COPD without Pulmonary Hypertension or Cor Pulmonale. Internal Medicine 48:7, 503-512
CrossRef296
Patrícia Lourenço, Ana Azevedo, José Paulo Araújo, Paulo Bettencourt. (2009) Natriuretic peptide system is not exhausted in severe heart failure. Journal of Cardiovascular Medicine 10:1, 39-43
CrossRef297
Savina Mannarino, Laura Ciardelli, Francesca Garofoli, Gianfranco Perotti, Elisa Mongini, Simona Damiano, Carmine Tinelli, Rosa Maria Cerbo, Giorgio Rondini, Mauro Stronati. (2009) Correlation between cord blood, perinatal BNP values and echocardiographic parameters in healthy Italian newborns. Early Human Development 85:1, 13-17
CrossRef298
Seung Jei Park, Kyoung Im Cho, Sun Jae Jung, Sung Won Choi, Jae Won Choi, Dong Won Lee, Hyeon Gook Lee, Tae Ik Kim. (2009) N-Terminal Pro-B-Type Natriuretic Peptide in Overweight and Obese Patients With and Without Diabetes: An Analysis Based on Body Mass Index and Left Ventricular Geometry. Korean Circulation Journal 39:12, 538
CrossRef299
Eiji Umegaki, Shinya Abe, Satoshi Tokioka, Nozomi Takeuchi, Toshihisa Takeuchi, Yukiko Yoda, Mitsuyuki Murano, Kazuhide Higuchi. (2009) Risk Management for Gastrointestinal Endoscopy in Elderly Patients: Questionnaire for Patients Undergoing Gastrointestinal Endoscopy. Journal of Clinical Biochemistry and Nutrition 46:1, 73-80
CrossRef300
Yuko Igarashi, Taishiro Chikamori, Satoshi Hida, Tadashi Nagao, Hirokazu Tanaka, Yasuhiro Usui, Tsuguhisa Hatano, Takayuki Morishima, Hidefumi Yanagisawa, Akira Yamashina. (2009) Comparative Impact of Scintigraphic Parameters and B-Type Natriuretic Peptide for the Prediction of Major Cardiac Events in the QGS-Prognostic Value in the Elderly (Q-PROVE) Study. Circulation Journal 73:9, 1655-1660
CrossRef301
J. Mangat, C. Carter, G. Riley, Y. Foo, M. Burch. (2009) The clinical utility of brain natriuretic peptide in paediatric left ventricular failure. European Journal of Heart Failure 11:1, 48-52
CrossRef302
J.-L. Teboul, D. Osman, X. Monnet. 2009. Eau pulmonaire extravasculaire. , 285-295.
CrossRef303
Mehmet G. Kaya, Ibrahim Ozdogru, Nihat Kalay, Ali Dogan, Tugrul Inanc, Ibrahim Gul, Ozgur Gunebakmaz, Abdurrahman Oguzhan. (2008) Plasma B-type natriuretic peptide in diagnosing inferior myocardial infarction with right ventricular involvement. Coronary Artery Disease 19:8, 609-613
CrossRef304
Paolo Mastandrea. (2008) Some heterogeneity factors affecting the B-type natriuretic peptides outcome: a meta-analysis. Clinical Chemistry and Laboratory Medicine 46:12, 1687-1695
CrossRef305
Angela Beatrice Scardovi, Renata Maria, Andrea Celestini, Claudio Coletta, Nadia Aspromonte, Silvia Perna, Marina Parolini, Roberto Ricci. (2008) Prognostic value of brain natriuretic peptide and enhanced ventilatory response to exercise in patients with chronic heart failure. Internal and Emergency Medicine 3:4, 331-337
CrossRef306
Kevin R. Kozak, Theodore S. Hong, Patrick M. Sluss, Elizabeth L. Lewandrowski, Samir L. Aleryani, Shannon M. MacDonald, Noah C. Choi, Torunn I. Yock. (2008) Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation. Lung Cancer 62:3, 351-355
CrossRef307
(2008) Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008). Revista Española de Cardiología 61:12, 1329.e1-1329.e70
CrossRef308
J. C Kelder, F. H Rutten, A. W Hoes. (2008) Clinically relevant diagnostic research in primary care: the example of B-type natriuretic peptides in the detection of heart failure. Family Practice 26:1, 69-74
CrossRef309
R. Sodi, E. Dubuis, A. Shenkin, G. Hart. (2008) B-type natriuretic peptide (BNP) attenuates the L-type calcium current and regulates ventricular myocyte function. Regulatory Peptides 151:1-3, 95-105
CrossRef310
Roland R. J. van Kimmenade, Ednan Bajwa, James L. Januzzi. (2008) Sepsis and those who are “weak of heart”*. Critical Care Medicine 36:11, 3108-3109
CrossRef311
R. N. Rodseth, L. Padayachee, B. M. Biccard. (2008) A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 63:11, 1226-1233
CrossRef312
Toshimasa Akazawa, Hiroko Nishihara, Hitomi Iwata, Kengo Warabi, Masayuki Ohshima, Eiichi Inada. (2008) Preoperative plasma brain natriuretic peptide level is an independent predictor of postoperative atrial fibrillation following off-pump coronary artery bypass surgery. Journal of Anesthesia 22:4, 347-353
CrossRef313
Aarif Y Khakoo, Edward TH Yeh. (2008) Therapy Insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy. Nature Clinical Practice Oncology 5:11, 655-667
CrossRef314
Markus Noveanu, Mihael Potocki, Christian Mueller. (2008) Natriuretic peptides and their evolving clinical applications. Future Cardiology 4:6, 593-598
CrossRef315
Jordi Ordonez-Llanos, Javier Merce-Muntanola, Miquel Santalo-Bel. (2008) Natriuretic peptide testing in emergency settings. Clinical Chemistry and Laboratory Medicine 46:11, 1543-1549
CrossRef316
Alpesh Amin. (2008) Hospitalized patients with acute decompensated heart failure: Recognition, risk stratification, and treatment review. Journal of Hospital Medicine 3:S6, S16-S24
CrossRef317
Rungroj Krittayaphong, Thananya Boonyasirinant, Pairash Saiviroonporn, Suthipol Udompunturak. (2008) NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study. Coronary Artery Disease 19:7, 481-487
CrossRef318
Rungroj Krittayaphong, Thananya Boonyasirinant, Pairash Saiviroonporn, Prajak Thanapiboonpol, Supaporn Nakyen, Suthipol Udompunturak. (2008) Correlation Between NT-Pro BNP Levels and Left Ventricular Wall Stress, Sphericity Index and Extent of Myocardial Damage: A Magnetic Resonance Imaging Study. Journal of Cardiac Failure 14:8, 687-694
CrossRef319
Ryoji Kurita, Kohei Nakamoto, Akio Ueda, Osamu Niwa. (2008) Comparison of Electrochemical and Surface Plasmon Resonance Immunosensor Responses on Single Thin Film. Electroanalysis 20:20, 2241-2246
CrossRef320
Tyler W. Barrett, David L. Schriger. (2008) Acutely Decompensated Heart Failure in a County Emergency Department: A Double-Blind Randomized Controlled Comparison of Nesiritide Versus Placebo Treatment. Annals of Emergency Medicine 52:4, 458-472
CrossRef321
Ayako Yoneyama, Jun Koyama, Takeshi Tomita, Setsuo Kumazaki, Hiroshi Tsutsui, Noboru Watanabe, Osamu Kinoshita, Uichi Ikeda. (2008) Relationship of plasma brain-type natriuretic peptide levels to left ventricular longitudinal function in patients with congestive heart failure assessed by strain Doppler imaging. International Journal of Cardiology 130:1, 56-63
CrossRef322
Piotr Kubler, Ewa A. Jankowska, Jacek Majda, Krzysztof Reczuch, Waldemar Banasiak, Piotr Ponikowski. (2008) Lack of decrease in plasma N-terminal pro-brain natriuretic peptide identifies acute heart failure patients with very poor outcome. International Journal of Cardiology 129:3, 373-378
CrossRef323
, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S. G. Priori, K. Swedberg, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , M. Tendera, A. Auricchio, J. Bax, M. Bohm, U. Corra, P. della Bella, P. M. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J.-L. Vachiery, F. W. A. Verheugt, J. L. Zamorano, F. Zannad. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 29:19, 2388-2442
CrossRef324
J.-E. BERDAL, K. STAVEM, T. OMLAND, C. HALL, N. SMITH-ERICHSSEN. (2008) Prognostic merit of N-terminal-proBNP and N-terminal-proANP in mechanically ventilated critically ill patients. Acta Anaesthesiologica Scandinavica 52:9, 1265-1272
CrossRef325
Kevin Jiang, Kevin Shah, Lori Daniels, Alan S Maisel. (2008) Review on natriuretic peptides: where we are, where we are going. Expert Opinion on Medical Diagnostics 2:10, 1137-1153
CrossRef326
Gloria Alvarez-Llamas, Fernando de la Cuesta, Maria Eugenia G Barderas, Veronica Darde, Luis R Padial, Fernando Vivanco. (2008) Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective. Expert Review of Proteomics 5:5, 679-691
CrossRef327
İlker Çetin, Kürşad Tokel, Birgül Varan, Utku Arman Örün, Mahmut Gökdemir, Nimet Cındık, Füsun Eyüboğlu, Gaye Ulubay, Sait Aşlamacı. (2008) Evaluation of Right Ventricular Functions and B-Type Natriuretic Peptide Levels by Cardiopulmonary Exercise Test in Patients with Pulmonary Regurgitation After Repair of Tetralogy of Fallot. Journal of Cardiac Surgery 23:5, 493-498
CrossRef328
R. Pfister, C. A. Schneider. (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. European Heart Journal 30:3, 382-383
CrossRef329
Robert E. Hobbs, Roger M. Mills. (2008) Endogenous B-type Natriuretic Peptide: A Limb of the Regulatory Response to Acutely Decompensated Heart Failure. Clinical Cardiology 31:9, 407-412
CrossRef330
Camille Chenevier-Gobeaux, Samuel Delerme, Jean-Christophe Allo, Martine Arthaud, Yann-Erick Claessens, Ohvanesse G. Ekindjian, Bruno Riou, Patrick Ray. (2008) B-type natriuretic peptides for the diagnosis of congestive heart failure in dyspneic oldest-old patients. Clinical Biochemistry 41:13, 1049-1054
CrossRef331
A. Rahman, S. Aydin, M. K. Bayar, İ. Sahin. (2008) Changes of ghrelin and brain natriuretic peptide levels in systemic vascular resistance after cardiopulmonary bypass. Journal of Physiology and Biochemistry 64:3, 221-230
CrossRef332
Jasmine Grewal, Robert S. McKelvie, Hans Persson, Peter Tait, Jonas Carlsson, Karl Swedberg, Jan Ostergren, Eva Lonn. (2008) Usefulness of N-Terminal Pro–Brain Natriuretic Peptide and Brain Natriuretic Peptide to Predict Cardiovascular Outcomes in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. The American Journal of Cardiology 102:6, 733-737
CrossRef333
Nancy J. Gardetto, Karen Greaney, Lisa Arai, April Brenner, Karen C. Carroll, Nancy M. Howerton, Melinda Lee, Laureen Pada, Marilynne Tseng, Alan S. Maisel. (2008) Critical Pathway for the Management of Acute Heart Failure at the Veterans Affairs San Diego Healthcare System. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 7:3, 153-172
CrossRef334
Romain Pirracchio, Nicolas Deye, Anne Claire Lukaszewicz, Alexandre Mebazaa, Bernard Cholley, Joaquim Matéo, Bruno Mégarbane, Jean Marie Launay, Jacqueline Peynet, Frédéric Baud, Didier Payen. (2008) Impaired plasma B-type natriuretic peptide clearance in human septic shock*. Critical Care Medicine 36:9, 2542-2546
CrossRef335
Giovanni Battista Pedrazzini, Serge Masson, Roberto Latini, Catherine Klersy, Maria Grazia Rossi, Elena Pasotti, Francesco Fulvio Faletra, Francesco Siclari, Fabrizio Minervini, Tiziano Moccetti, Angelo Auricchio. (2008) Comparison of Brain Natriuretic Peptide Plasma Levels Versus Logistic EuroSCORE in Predicting In-Hospital and Late Postoperative Mortality in Patients Undergoing Aortic Valve Replacement for Symptomatic Aortic Stenosis. The American Journal of Cardiology 102:6, 749-754
CrossRef336
Samo Zver, Vesna Zadnik, Peter Černelč, Mirta Koželj. (2008) Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation. International Journal of Hematology 88:2, 227-236
CrossRef337
KYLE LIEPPMAN, LORI KRAMER-CLARK, JOSEPH D. TOBIAS. (2008) Plasma B-type natriuretic peptide monitoring to evaluate cardiovascular function prior to organ procurement in patients with brain death. Pediatric Anesthesia 18:9, 852-856
CrossRef338
Salvatore Di Somma, Laura Magrini, Fabio Tabacco, Rossella Marino, Veronica Talucci, Francesca Marrocco, Patrizia Cardelli, Enrico Ferri, Valerio Pittoni. (2008) Brain Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide Show a Different Profile in Response to Acute Decompensated Heart Failure Treatment. Congestive Heart Failure 14:5, 245-250
CrossRef339
Evelyn Lechner, Roland Gitter, Rudolf Mair, Miklos Pinter, Elisabeth Schreier-Lechner, David Vondrys, Gerald Tulzer. (2008) Aminoterminal Brain Natriuretic Peptide Levels in Children and Adolescents After Fontan Operation Correlate with Congestive Heart Failure. Pediatric Cardiology 29:5, 901-905
CrossRef340
Johannes Steiner, Maya Guglin. (2008) BNP or NTproBNP? A clinician's perspective. International Journal of Cardiology 129:1, 5-14
CrossRef341
Stilianos Efstratiadis, Andrew D. Michaels. (2008) Computerized Acoustic Cardiographic Electromechanical Activation Time Correlates With Invasive and Echocardiographic Parameters of Left Ventricular Contractility. Journal of Cardiac Failure 14:7, 577-582
CrossRef342
Joost H.W. Rutten, Nathalie van der Velde, Tischa J.M. van der Cammen, Folkert J. ten Cate, Wim B. Vletter, Frans Boomsma, Anton H. van den Meiracker. (2008) Associations between plasma natriuretic peptides and echocardiographic abnormalities in geriatric outpatients. Archives of Gerontology and Geriatrics 47:2, 189-199
CrossRef343
Shafiq U. Rehman, James L. Januzzi. (2008) Natriuretic Peptide Testing in Clinical Medicine. Cardiology in Review 16:5, 240-249
CrossRef344
Anecita Fadol, Tito Mendoza, Ibrahima Gning, Jeanette Kernicki, Lene Symes, Charles S. Cleeland, Daniel Lenihan. (2008) Psychometric Testing of the MDASI-HF: A Symptom Assessment Instrument for Patients With Cancer and Concurrent Heart Failure. Journal of Cardiac Failure 14:6, 497-507
CrossRef345
Lori B. Daniels, Gail A. Laughlin, Paul Clopton, Alan S. Maisel, Elizabeth Barrett-Connor. (2008) Minimally Elevated Cardiac Troponin T and Elevated N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality in Older Adults. Journal of the American College of Cardiology 52:6, 450-459
CrossRef346
Christian Bruch, Claudia Fischer, Jürgen Sindermann, Jörg Stypmann, Günter Breithardt, Rainer Gradaus. (2008) Comparison of the Prognostic Usefulness of N-Terminal Pro–Brain Natriuretic Peptide in Patients With Heart Failure With Versus Without Chronic Kidney Disease. The American Journal of Cardiology 102:4, 469-474
CrossRef347
Ueli Studler, Martin Kretzschmar, Michael Christ, Tobias Breidthardt, Markus Noveanu, Andreas Schoetzau, André P. Perruchoud, Wolfgang Steinbrich, Christian Mueller. (2008) Accuracy of chest radiographs in the emergency diagnosis of heart failure. European Radiology 18:8, 1644-1652
CrossRef348
Alan S. Maisel, William F. Peacock, N. McMullin, Robert Jessie, Gregg C. Fonarow, Janet Wynne, Roger M. Mills. (2008) Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart Failure. Journal of the American College of Cardiology 52:7, 534-540
CrossRef349
Farzan Filsoufi, Parwis B. Rahmanian, Sacha Salzberg, Kai von Harbou, Carol A. Bodian, David H. Adams. (2008) B-Type Natriuretic Peptide (BNP) in Patients Undergoing Mitral Valve Surgery. Journal of Cardiac Surgery
CrossRef350
Stephane Arques, Emmanuel Roux, Pascal Sbragia, Bertrand Pieri, Richard Gelisse, Roger Luccioni, Pierre Ambrosi. (2008) Comparison of B-type natriuretic peptide with left atrial enlargement by echocardiography for the diagnosis of new-onset congestive heart failure with a preserved left ventricular systolic function in the setting of longstanding hypertension. International Journal of Cardiology 128:1, 123-125
CrossRef351
P. Ray, S. Delerme, P. Jourdain, C. Chenevier-Gobeaux. (2008) Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department. QJM 101:11, 831-843
CrossRef352
Theresa A. McDonagh, Kenneth McDonald, Alan S. Maisel. (2008) Screening for Asymptomatic Left Ventricular Dysfunction Using B-Type Natriuretic Peptide. Congestive Heart Failure 14, 5-8
CrossRef353
Dimitrios Farmakis, Gerasimos Filippatos, Marco Tubaro, W. Frank Peacock, Salvatore DiSomma, Christian Mueller, Dimitrios Th. Kremastinos, Alan S. Maisel. (2008) Natriuretic Peptides in Acute Coronary Syndromes: Prognostic Value and Clinical Implications. Congestive Heart Failure 14, 25-29
CrossRef354
W. Frank Peacock, Christian Mueller, Salvatore DiSomma, Alan Maisel. (2008) Emergency Department Perspectives on B-Type Natriuretic Peptide Utility. Congestive Heart Failure 14, 17-20
CrossRef355
Salvatore DiSomma, Laura Magrini, Valerio Pittoni, Rossella Marino, W. Frank Peacock, Alan Maisel. (2008) Usefulness of Serial Assessment of Natriuretic Peptides in the Emergency Department for Patients With Acute Decompensated Heart Failure. Congestive Heart Failure 14, 21-24
CrossRef356
P. Alter, H. Rupp, M. B. Rominger, A. Vollrath, F. Czerny, J. H. Figiel, P. Adams, F. Stoll, K. J. Klose, B. Maisch. (2008) B-type natriuretic peptide and wall stress in dilated human heart. Molecular and Cellular Biochemistry 314:1-2, 179-191
CrossRef357
Dimitrios Farmakis, Gerasimos Filippatos, Marco Tubaro, W. Frank Peacock, Salvatore DiSomma, Christian Mueller, Dimitrios Th. Kremastinos, Alan S. Maisel. (2008) Natriuretic Peptides in Acute Coronary Syndromes: Prognostic Value and Clinical Implications. Congestive Heart Failure 14:4, 25-29
CrossRef358
Joost H.W. Rutten, Ewout W. Steyerberg, Frans Boomsma, Jan L.C.M. van Saase, Jaap W. Deckers, Henk C. Hoogsteden, Jan Lindemans, Anton H. van den Meiracker. (2008) N-terminal pro–brain natriuretic peptide testing in the emergency department: Beneficial effects on hospitalization, costs, and outcome. American Heart Journal 156:1, 71-77
CrossRef359
Epaminondas Zakynthinos, Theodoros Kiropoulos, Konstantinos Gourgoulianis, Gerasimos Filippatos. (2008) Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases. Heart & Lung: The Journal of Acute and Critical Care 37:4, 275-285
CrossRef360
Hirofumi Ueno, Masafumi Nakayama, Sunao Kojima, Kenichi Kusuhara, Yasuhiro Nagayoshi, Megumi Yamamuro, Tsunenori Nishijima, Hiroki Usuku, Kouichi Kaikita, Hitoshi Sumida, Hiroshige Yamabe, Seigo Sugiyama, Michihiro Yoshimura, Hisao Ogawa. (2008) The synergistic combined effect of anemia with high plasma levels of B-type natriuretic peptide significantly predicts an enhanced risk for major adverse cardiac events. Heart and Vessels 23:4, 243-248
CrossRef361
Gloria Y. Yeh, Joseph E. Mietus, Chung-Kang Peng, Russell S. Phillips, Roger B. Davis, Peter M. Wayne, Ary L. Goldberger, Robert J. Thomas. (2008) Enhancement of sleep stability with Tai Chi exercise in chronic heart failure: Preliminary findings using an ECG-based spectrogram method. Sleep Medicine 9:5, 527-536
CrossRef362
Theresa A. McDonagh, Kenneth McDonald, Alan S. Maisel. (2008) Screening for Asymptomatic Left Ventricular Dysfunction Using B-Type Natriuretic Peptide. Congestive Heart Failure 14:4, 5-8
CrossRef363
Christina Dückelmann, Friedrich Mittermayer, Dominik G. Haider, Johann Altenberger, Michael Wolzt. (2008) Plasma asymmetric dimethylarginine and cardiovascular events in patients with acute decompensated heart failure. Translational Research 152:1, 24-30
CrossRef364
Stephanie Neuhold, Martin Huelsmann, Guido Strunk, Brigitte Stoiser, Joachim Struck, Nils G. Morgenthaler, Andreas Bergmann, Deddo Moertl, Rudolf Berger, Richard Pacher. (2008) Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart Failure. Journal of the American College of Cardiology 52:4, 266-272
CrossRef365
Salvatore DiSomma, Laura Magrini, Valerio Pittoni, Rossella Marino, W. Frank Peacock, Alan Maisel. (2008) Usefulness of Serial Assessment of Natriuretic Peptides in the Emergency Department for Patients With Acute Decompensated Heart Failure. Congestive Heart Failure 14:4, 21-24
CrossRef366
W. Frank Peacock, Christian Mueller, Salvatore DiSomma, Alan Maisel. (2008) Emergency Department Perspectives on B-Type Natriuretic Peptide Utility. Congestive Heart Failure 14:4, 17-20
CrossRef367
Camille Chenevier-Gobeaux, Jean-Christophe Allo, Martine Arthaud, R. Achkar, Yan-Eric Claessens, O.G. Ekindjian, Bruno Riou, Patrick Ray. (2008) N-Terminal pro B-type natriuretic peptide testing for short-term prognosis in breathless older adults. The American Journal of Emergency Medicine 26:5, 555-560
CrossRef368
Mauro Feola, Nadia Aspromonte, Loredano Milani, Marco Bobbio, Stefania Bardellotto, Sabrina Barro, Prospero Giovinazzo, Federica Noventa, Roberto Valle. (2008) Plasma Brain Natriuretic Peptide Predicts Short-Term Clinical Outcome in Heart Failure Patients With Restrictive Filling Pattern. Journal of Cardiac Failure 14:5, 420-425
CrossRef369
Matthias Wilhelm, Rueth Tobias, Fatima Asskali, Robert Kraehner, Simone Kuly, Lutz Klinghammer, Hansjosef Boehles, Werner Guenther Daniel. (2008) Red blood cell omega-3 fatty acids and the risk of ventricular arrhythmias in patients with heart failure. American Heart Journal 155:6, 971-977
CrossRef370
Aaron A.R. Tobian, Lori J. Sokoll, Daniel J. Tisch, Paul M. Ness, Hua Shan. (2008) N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 48:6, 1143-1150
CrossRef371
Mariusz Piechota, Maciej Banach, Anna Jacoń, Jacek Rysz. (2008) Natriuretic peptides in cardiovascular diseases. Cellular & Molecular Biology Letters 13:2, 155-181
CrossRef372
Roger M. Mills. (2008) Learning to Use a Biomarker. Journal of the American College of Cardiology 51:24, 2336-2338
CrossRef373
Andreas Synetos, Konstantinos Aznaouridis, Stamatios Lerakis. (2008) Brain Natriuretic Peptide in Cardiovascular Diseases. The American Journal of the Medical Sciences 335:6, 477-483
CrossRef374
Debra L Isaac. (2008) Biomarkers in heart failure management. Current Opinion in Internal Medicine 7:3, 226-232
CrossRef375
Giovanni Volpicelli, Valeria Caramello, Luciano Cardinale, Alessandro Mussa, Fabrizio Bar, Mauro F. Frascisco. (2008) Bedside ultrasound of the lung for the monitoring of acute decompensated heart failure. The American Journal of Emergency Medicine 26:5, 585-591
CrossRef376
Fekri Abroug, Lamia Ouanes-Besbes. (2008) Detection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptide. Current Opinion in Critical Care 14:3, 340-347
CrossRef377
Kellan E. Ashley, John M. Galla, Stephen J. Nicholls. (2008) Brain Natriuretic Peptides as Biomarkers for Atherosclerosis. Preventive Cardiology 11:3, 172-176
CrossRef378
Douglas S. Ander, Alan Maisel, Judd E. Hollander, James L. Januzzi, Clyde W. Yancy, Gregg C. Fonarow, W Frank Peacock. (2008) Diagnosis. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 7:2, 91-95
CrossRef379
Micha T. Maeder, Christian Mueller, Matthias E. Pfisterer, Peter T. Buser, Hans P. Brunner-La Rocca. (2008) Use of B-type natriuretic peptide outside of the emergency department. International Journal of Cardiology 127:1, 5-16
CrossRef380
Mototsugu Nishii, Takayuki Inomata, Hitoshi Takehana, Takashi Naruke, Tomoyoshi Yanagisawa, Masahiko Moriguchi, Sadao Takeda, Tohru Izumi. (2008) Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure. Journal of the American College of Cardiology 51:24, 2329-2335
CrossRef381
Braunwald, Eugene, . (2008) Biomarkers in Heart Failure. New England Journal of Medicine 358:20, 2148-2159
Full Text382
Fábio Vilas-Boas, Gilson Soares Feitosa, Milena B.P. Soares, Joel Alves Pinho-Filho, Thais Nascimento, Marcos M. Barojas, Marcus V.S. Andrade, Ricardo Ribeiro-dos-Santos, Edimar Bocchi. (2008) Invasive and Noninvasive Correlations of B-Type Natriuretic Peptide in Patients With Heart Failure Due to Chagas Cardiomyopathy. Congestive Heart Failure 14:3, 121-126
CrossRef383
Jung-Yien Chien, Mao-Shin Lin, Yuh-Chin T. Huang, Yu-Fen Chien, Chong-Jen Yu, Pan-Chyr Yang. (2008) Changes in B-type natriuretic peptide improve weaning outcome predicted by spontaneous breathing trial. Critical Care Medicine 36:5, 1421-1426
CrossRef384
Aurélie Lefebvre, Suzanne Kural-Menasché, Michael Darmon, Guillaume Thiéry, Jean-Paul Feugeas, Benoît Schlemmer, Élie Azoulay. (2008) Use of N-terminal pro-brain natriuretic peptide to detect cardiac origin in critically ill cancer patients with acute respiratory failure. Intensive Care Medicine 34:5, 833-839
CrossRef385
Tyler W. Barrett, David L. Schriger. (2008) Miller AH, Nazeer S, Pepe P, et al Acutely Decompensated Heart Failure in a County Emergency Department: A Double Blind Randomized Controlled Comparison of Nesiritide Versus Placebo Treatment. Annals of Emergency Medicine 51:5, 580-582
CrossRef386
Stephen W. Waldo, Jennifer Beede, Susan Isakson, Sylvie Villard-Saussine, Jeannette Fareh, Paul Clopton, Robert L. Fitzgerald, Alan S. Maisel. (2008) Pro-B-Type Natriuretic Peptide Levels in Acute Decompensated Heart Failure. Journal of the American College of Cardiology 51:19, 1874-1882
CrossRef387
Hideaki Imanaka, Muneyuki Takeuchi. (2008) Can B-type natriuretic peptide liberate us from the task of mechanical ventilation weaning?*. Critical Care Medicine 36:5, 1646-1647
CrossRef388
Michael Christ, Kirsten Laule, Theresia Klima, Willibald Hochholzer, Tobias Breidthardt, Andre P. Perruchoud, Christian Mueller. (2008) Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department. International Journal of Cardiology 126:1, 73-78
CrossRef389
Niels Holmark Andersen. 2008. Using Myocardial Imaging to Identify and Manage Subclinical Heart Disease in Diabetes Mellitus and Obesity. , 185-197.
CrossRef390
Leo H. B. Baur. (2008) Optimal screening of heart failure patients: tissue Doppler imaging or plasma NTpro BNP measurement?. The International Journal of Cardiovascular Imaging 24:4, 409-410
CrossRef391
Manuel Jiménez-Navarro, Juan Delgado Jiménez, Miguel Rivera Otero, Eulalia Roig Minguell, Javier Segovia Cubero, Luis Almenar Bonet, Manuel Anguita Sánchez, Antoni Bayés-Genís, María G. Crespo Leiro. (2008) Utilidad de los péptidos natriuréticos en la insuficiencia cardíaca. Medicina Clínica 130:15, 591-596
CrossRef392
Frans H. Rutten, Arno W. Hoes. (2008) B-type natriuretic peptide assays for detecting heart failure in the elderly: Same value as those in the younger?. International Journal of Cardiology 125:2, 161-165
CrossRef393
Roberto Valle, Nadia Aspromonte, Prospero Giovinazzo, Emanuele Carbonieri, Mario Chiatto, Giuseppe di Tano, Mauro Feola, Massimo Milli, Alessandra Fontebasso, Sabrina Barro, Stefania Bardellotto, Loredano Milani. (2008) B-Type Natriuretic Peptide–Guided Treatment for Predicting Outcome in Patients Hospitalized in Sub–Intensive Care Unit With Acute Heart Failure. Journal of Cardiac Failure 14:3, 219-224
CrossRef394
Cara A. Wasywich, Gillian A. Whalley, Helen A. Walsh, Greg D. Gamble, Robert N. Doughty. (2008) The relationship between BNP and E/Ea in patients hospitalized with acute heart failure. International Journal of Cardiology 125:2, 280-282
CrossRef395
Joana Mascarenhas, Patrícia Lourenço, Ricardo Lopes, Ana Azevedo, Paulo Bettencourt. (2008) Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications. American Heart Journal 155:3, 521-525
CrossRef396
Andrew Worster, Cynthia M. Balion, Stephen A. Hill, Pasqualina Santaguida, Afisi Ismaila, Robert McKelvie, Sonja M. Reichert, Matthew J. McQueen, Lynda Booker, Parminder S. Raina. (2008) Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: A systematic review. Clinical Biochemistry 41:4-5, 250-259
CrossRef397
Jun Oyamada, Manatomo Toyono, Shunsuke Shimada, Mieko Aoki-Okazaki, Masamichi Tamura, Tsutomu Takahashi, Kenji Harada. (2008) Noninvasive Estimation of Left Ventricular End-Diastolic Pressure Using Tissue Doppler Imaging Combined with Pulsed-Wave Doppler Echocardiography in Patients with Ventricular Septal Defects: A Comparison with the Plasma Levels of the B-Type Natriuretic Pe. Echocardiography 25:3, 270-277
CrossRef398
Patrick J Gallegos, Eric J MacLaughlin, Krystal K Haase. (2008) Serial Monitoring of Brain Natriuretic Peptide Concentrations for Drug Therapy Management in Patients with Chronic Heart Failure. Pharmacotherapy 28:3, 343-355
CrossRef399
Alan S Maisel. (2008) Natriuretic peptide levels: what’s on the horizon?. Future Cardiology 4:2, 107-109
CrossRef400
Fred S. Apple, Alan H.B. Wu, Allan S. Jaffe, Mauro Panteghini, Robert H. Christenson, Robert H. Christenson, Fred S. Apple, Christopher P. Cannon, Gary S. Frances, Robert L. Jesse, David A. Morrow, L. Kristen Newby, Alan B. Storrow, W. H. Wlison Tang, Alan H.B. Wu, Fred S. Apple, Christopher P. Cannon, Allan S. Jaffe, Franca Pagani, Jillian Tate, Jordi Ordonez-Llanos, Johannes Mair. (2008) National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biomarkers of Heart Failure. Clinical Biochemistry 41:4-5, 222-226
CrossRef401
W.H. Wilson Tang, Gary S. Francis, David A. Morrow, L. Kristin Newby, Christopher P. Cannon, Robert L. Jesse, Alan B. Storrow, Robert H. Christenson, Robert H. Christenson, Fred S. Apple, Christopher P. Cannon, Gary S. Francis, Robert L. Jesse, David A. Morrow, L. Kristin Newby, Alan B. Storrow, W. H. Wilson Tang, Alan H.B. Wu. (2008) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure. Clinical Biochemistry 41:4-5, 210-221
CrossRef402
Gino Soldati, Luna Gargani, Fernando R. Silva. (2008) Acute heart failure: new diagnostic perspectives for the emergency physician. Internal and Emergency Medicine 3:1, 37-41
CrossRef403
Cynthia M. Balion, Pasqualina Santaguida, Robert McKelvie, Stephen A. Hill, Matthew J. McQueen, Andrew Worster, Parminder S. Raina. (2008) Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP. Clinical Biochemistry 41:4-5, 231-239
CrossRef404
Daniel C. Lu, Devin K. Binder, Bonnie Chien, Alan Maisel, Geoffrey T. Manley. (2008) Cerebral salt wasting and elevated brain natriuretic peptide levels after traumatic brain injury: 2 case reports. Surgical Neurology 69:3, 226-229
CrossRef405
Torbjørn Omland. (2008) B-type natriuretic peptides: prognostic markers in stable coronary artery disease. Expert Review of Molecular Diagnostics 8:2, 217-225
CrossRef406
Cynthia L. Dakin. (2008) New Approaches to Heart Failure in the ED. AJN, American Journal of Nursing 108:3, 68-71
CrossRef407
Darshan Godkar, Kalyan Bachu, Bijal Dave, Selva Niranjan, Ashok Khanna. (2008) B-Type Natriuretic Peptide (BNP) and ProBNP: Role of Emerging Markers to Guide Therapy and Determine Prognosis in Cardiovascular Disorders. American Journal of Therapeutics 15:2, 150-156
CrossRef408
Debra L Isaac. (2008) Biomarkers in heart failure management. Current Opinion in Cardiology 23:2, 127-133
CrossRef409
K. Knobloch, J. Tepe, R. Lichtinghagen, H.J. Luck, P.M. Vogt. (2008) Simultaneous hemodynamic and serological cardiotoxicity monitoring during immunotherapy with trastuzumab. International Journal of Cardiology 125:1, 113-115
CrossRef410
J. P. Dal-Bianco, A. S. Jaffe, M. R. Bell, J. K. Oh. (2008) Cardiac Function and Brain-Type Natriuretic Peptide in First-Time Flash Pulmonary Edema. Mayo Clinic Proceedings 83:3, 289-296
CrossRef411
B. Ewald, D. Ewald, A. Thakkinstian, J. Attia. (2008) Meta-analysis of B type natriuretic peptide and N-terminal pro B natriuretic peptide in the diagnosis of clinical heart failure and population screening for left ventricular systolic dysfunction. Internal Medicine Journal 38:2, 101-113
CrossRef412
S.-Q. Zhao, Y.-M. Hu, Q. Li, X.-R. Liu, M. Wang, W.-Y. Zhang, T. Wu, X.-L. Nie, N. Zhao, L.-R. Wang. (2008) The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea. International Journal of Clinical Practice 62:2, 214-220
CrossRef413
P. O. Collinson. (2008) Message in a bottle - natriuretic peptide determination as a noninvasive measurement of pulmonary capillary wedge pressure?. International Journal of Clinical Practice 62:2, 177-178
CrossRef414
Dan Rusinaru, Imen Saaidi, Stephanie Godard, Haïfa Mahjoub, Caroline Battle, Christophe Tribouilloy. (2008) Impact of Chronic Obstructive Pulmonary Disease on Long-Term Outcome of Patients Hospitalized for Heart Failure. The American Journal of Cardiology 101:3, 353-358
CrossRef415
M. Imazio, A. Cotroneo, G. Gaschino, A. Chinaglia, P. Gareri, R. Lacava, T. D. Voci, R. Trinchero. (2008) Management of heart failure in elderly people. International Journal of Clinical Practice 62:2, 270-280
CrossRef416
Ahmed Chaudhry, Adam J. Singer, Jasmine Chohan, Valerie Russo, Christopher Lee. (2008) Interrater reliability of hemodynamic profiling of patients with heart failure in the ED. The American Journal of Emergency Medicine 26:2, 196-201
CrossRef417
I. A. Scott, P. B. Greenberg, P. J. Poole. (2008) Cautionary tales in the clinical interpretation of studies of diagnostic tests. Internal Medicine Journal 38:2, 120-129
CrossRef418
Melanie D Everitt, Anji T Yetman. (2008) Congestive heart failure in the pediatric patient with congenital heart disease. Pediatric Health 2:1, 33-45
CrossRef419
Joanna C. Porter. 2008. Dyspnea. , 293-309.
CrossRef420
Torbjørn Omland. (2008) Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Critical Care Medicine 36:Suppl, S17-S27
CrossRef421
Florim Cuculi, Brigitte Walz, Michel Zuber, Markus Roos, Paul Erne. (2008) Clinical Correlates of Very High Brain Natriuretic Peptide Levels in Hospitalized Patients. The American Heart Hospital Journal 6:1, 37-41
CrossRef422
Jolanta Gutkowska, Marek Jankowski. (2008) Human B-type natriuretic peptide – a survey of the patent literature. Expert Opinion on Therapeutic Patents 18:1, 61-68
CrossRef423
Christian Müller. (2008) The Potential of Cardiac Markers to Improve Patient Management. Journal of Medical Biochemistry 27:2, 109-113
CrossRef424
Trygve Brügger-Andersen, Hildegunn Aarsetøy, Heidi Grundt, Harry Staines, Dennis W.T. Nilsen. (2008) The long-term prognostic value of multiple biomarkers following a myocardial infarction. Thrombosis Research 123:1, 60-66
CrossRef425
Tetsutaro Matayoshi, Toako Kato, Hajime Nakahama, Hiroto Nakata, Fumiki Yoshihara, Kei Kamide, Takeshi Horio, Satoko Nakamura, Yuhei Kawano. (2008) Brain Natriuretic Peptide in Hemodialysis Patients: Predictive Value for Hemodynamic Change during Hemodialysis and Cardiac Function. American Journal of Nephrology 28:1, 122-127
CrossRef426
Shin-Jae Kim, Eun-Seok Shin, Sang-Gon Lee. (2008) N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusions. The Korean Journal of Internal Medicine 23:2, 78
CrossRef427
Peter Kabunga, Gerry Coghlan. (2008) Endothelin Receptor Antagonism. Drugs 68:12, 1635-1645
CrossRef428
RICHARD W. TROUGHTON, JAY RITZEMA-CARTER, M. GARY NICHOLLS. 2008. Role of Neurohormones. , 345-366.
CrossRef429
Shinji Takada, Kanako Kurogi, Yoko Takahashi, Atsuomi Tomita, Takehiko Nagaoka, Kentaro Ino, Shigeho Morita. (2008) Nihon Shuchu Chiryo Igakukai zasshi 15:4, 549-553
CrossRef430
J.-P. Emeriau, F. Lamouliatte. (2008) Gestione dell’insufficienza cardiaca delle persone anziane. EMC - AKOS - Trattato di Medicina 10:2, 1-10
CrossRef431
Andreas M.E. Koch, Stefan Zink, Helmut Singer. (2008) B-Type Natriuretic Peptide in Patients with Systemic Right Ventricle. Cardiology 110:1, 1-7
CrossRef432
Rowan Walsh, Clark Boyer, Jared LaCorte, Vincent Parnell, Cristina Sison, Devyani Chowdhury, Kaie Ojamaa. (2008) N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery. The Journal of Thoracic and Cardiovascular Surgery 135:1, 98-105
CrossRef433
Hidekatsu Fukuta, Nobuyuki Ohte, Seiji Mukai, Tomoaki Saeki, Kenji Kobayashi, Genjiro Kimura. (2008) Anemia is an Independent Predictor for Elevated Plasma Levels of Natriuretic Peptides in Patients Undergoing Cardiac Catheterization for Coronary Artery Disease. Circulation Journal 72:2, 212-217
CrossRef434
James L. Januzzi, Kent B. Lewandrowski, George Bashirians, Shari Jackson, Deb Freyler, Katrina Smith, Maryann M. Murakami, Fred S. Apple. (2008) Analytical and clinical performance of the Ortho-Clinical Diagnostics VITROS® amino-terminal pro-B type natriuretic peptide assay. Clinica Chimica Acta 387:1-2, 48-54
CrossRef435
Hirofumi TOMITA, Norifumi METOKI, Genta SAITOH, Toshihiro ASHITATE, Takashi ECHIZEN, Chisato KATOH, Michitaka FUKUDA, Minoru YASUJIMA, Tomohiro OSANAI, Ken OKUMURA. (2008) Elevated Plasma Brain Natriuretic Peptide Levels Independent of Heart Disease in Acute Ischemic Stroke: Correlation with Stroke Severity. Hypertension Research 31:9, 1695-1702
CrossRef436
R. Garrick. (2008) The Characteristics and Prognostic Importance of NT-ProBNP Concentrations in Critically Ill Patients. Yearbook of Medicine 2008, 245-246
CrossRef437
P. Bertora, D. Torzillo, G. Baldi, T. Vago, C. Mariani. (2008) Brain natriuretic peptide as a marker of cardiac toxicity in patients with multiple sclerosis treated with mitoxantrone. Journal of Neurology 255:1, 140-141
CrossRef438
Ralf Geiger, Angelika Hammerer-Lercher, Christoph Url, Ulrich Schweigmann, Bernd Puschendorf, Rudolf Sommer, Joerg Ingolf Stein, Johannes Mair. (2007) NT-proBNP concentrations indicate cardiac disease in pediatric patients. International Journal of Cardiology 123:1, 63-65
CrossRef439
Lori B. Daniels, Alan S. Maisel. (2007) Natriuretic Peptides. Journal of the American College of Cardiology 50:25, 2357-2368
CrossRef440
Wolfgang Herrmann, Markus Herrmann, Jacob Joseph, Suresh C. Tyagi. (2007) Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review. Clinical Chemistry and Laboratory Medicine 45:12, 1633-1644
CrossRef441
A Mark Richards. (2007) Does NT-proBNP testing reduce costs and improve accuracy in the diagnosis of heart failure?. Nature Clinical Practice Cardiovascular Medicine 4:12, 652-653
CrossRef442
Richard D. Mainwaring, Carol Parise, Stanley B. Wright, Andrew L. Juris, Robert A. Achtel, Hessam Fallah. (2007) Brain Natriuretic Peptide Levels Before and After Ventricular Septal Defect Repair. The Annals of Thoracic Surgery 84:6, 2066-2069
CrossRef443
Keiichi Jingu, Kenji Nemoto, Tomohiro Kaneta, Minako Oikawa, Yoshihiro Ogawa, Hisanori Ariga, Ken Takeda, Toru Sakayauchi, Keisuke Fujimoto, Kakutaro Narazaki, Yoshihiro Takai, Eiko Nakata, Hiroshi Fukuda, Shoki Takahashi, Shogo Yamada. (2007) Temporal Change in Brain Natriuretic Peptide After Radiotherapy for Thoracic Esophageal Cancer. International Journal of Radiation Oncology*Biology*Physics 69:5, 1417-1423
CrossRef444
Bik-ling Man, Yiu-fai Cheung. (2007) Plasma brain natriuretic peptide and systemic ventricular function in asymptomatic patients late after the Fontan procedure. Heart and Vessels 22:6, 398-403
CrossRef445
Stefan Krüger, Jana Papassotiriou, Reinhard Marre, Klaus Richter, Christian Schumann, Heike Baum, Nils G. Morgenthaler, Norbert Suttorp, Tobias Welte, . (2007) Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia. Intensive Care Medicine 33:12, 2069-2078
CrossRef446
A. Boswood, J. Dukes-McEwan, J. Loureiro, R. A. James, M. Martin, M. Stafford-Johnson, P. Smith, C. Little, S. Attree. (2007) The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease. Journal of Small Animal Practice 0:0, 071115145027004-???
CrossRef447
Michelle O’Donoghue, Patrick Kenney, Eveline Oestreicher, Saif Anwaruddin, Aaron L. Baggish, Daniel G. Krauser, Annabel Chen, Roderick Tung, Renee Cameron, James L. Januzzi. (2007) Usefulness of Aminoterminal Pro-Brain Natriuretic Peptide Testing for the Diagnostic and Prognostic Evaluation of Dyspneic Patients With Diabetes Mellitus Seen in the Emergency Department (from the PRIDE Study). The American Journal of Cardiology 100:9, 1336-1340
CrossRef448
M. Christ, A. Thuerlimann, K. Laule, T. Klima, W. Hochholzer, A. P. Perruchoud, C. Mueller. (2007) Long-term prognostic value of B-type natriuretic peptide in cardiac and non-cardiac causes of acute dyspnoea. European Journal of Clinical Investigation 37:11, 834-841
CrossRef449
Jay Suntharalingam, Kimberley Goldsmith, Mark Toshner, Natalie Doughty, Karen K. Sheares, Rodney Hughes, David Jenkins, Joanna Pepke-Zaba. (2007) Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension. Respiratory Medicine 101:11, 2254-2262
CrossRef450
Olena Dotsenko, Julia Chackathayil, Gregory YH Lip. (2007) Cardiac biomarkers: myths, facts and future horizons. Expert Review of Molecular Diagnostics 7:6, 693-697
CrossRef451
Salpy V Pamboukian. (2007) The future of implantable hemodynamic monitors. Future Cardiology 3:6, 579-582
CrossRef452
Christoph M. Birner, Coskun Ulucan, Sabine Fredersdorf, Munhie Rihm, Hannelore Löwel, Jan Stritzke, Heribert Schunkert, Christian Hengstenberg, Stephan Holmer, Günter Riegger, Andreas Luchner. (2007) Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP. Cytokine 40:2, 89-97
CrossRef453
Clifford Rubin, Thomas D Nolin, Jonathan Himmelfarb. (2007) Are biomarkers useful for assessing cardiovascular risk in patients with chronic kidney disease?. Current Opinion in Nephrology and Hypertension 16:6, 506-511
CrossRef454
Abigail May, Thomas J Wang. (2007) Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin. Expert Review of Molecular Diagnostics 7:6, 793-804
CrossRef455
Loretta Brentana, Pier Luigi Temporelli, Ugo Corrà, Marinella Gattone, Massimo Pistono, Alessandro Imparato, Marco Gnemmi, Pantaleo Giannuzzi. (2007) Low plasma levels of brain natriuretic peptide in severe acute heart failure: Merely a case?. International Journal of Cardiology 122:3, e18-e20
CrossRef456
Christian Mueller. (2007) B-Type Natriuretic Peptides and the General Practitioner
CrossRef457
Brigitte Meyer, Martin Huelsmann, Paul Wexberg, Georg Delle Karth, Rudolf Berger, Deddo Moertl, Thomas Szekeres, Richard Pacher, Gottfried Heinz. (2007) N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients*. Critical Care Medicine 35:10, 2268-2273
CrossRef458
Robert D. Stevens, Paul A. Nyquist. (2007) The systemic implications of aneurysmal subarachnoid hemorrhage. Journal of the Neurological Sciences 261:1-2, 143-156
CrossRef459
Eddie W.Y. Cheung, Wendy W.M. Lam, Clement S.W. Chiu, Adolphus K.T. Chau, Stephen C.W. Cheung, Yiu-fai Cheung. (2007) Plasma brain natriuretic peptide levels, right ventricular volume overload and exercise capacity in adolescents after surgical repair of tetralogy of Fallot. International Journal of Cardiology 121:2, 155-162
CrossRef460
George O.A. Naik, Gordon W. Moe. (2007) Use of a solid-phase extraction with radioimmunoassay to identify the proportional bias of clinical B-type natriuretic peptide immunoassay: the impact of plasma matrix and antibody multispecificity. Clinical Chemistry and Laboratory Medicine 45:10, 1353-1359
CrossRef461
Yoshitaka Iwanaga, Yasuki Kihara, Shinichiro Niizuma, Teruo Noguchi, Hiroshi Nonogi, Toru Kita, Yoichi Goto. (2007) BNP in Overweight and Obese Patients With Heart Failure: An Analysis Based on the BNP-LV Diastolic Wall Stress Relationship. Journal of Cardiac Failure 13:8, 663-667
CrossRef462
Yoshihiro J. Akashi, Jochen Springer, Mitja Lainscak, Stefan D. Anker. (2007) Atrial natriuretic peptide and related peptides. Clinical Chemistry and Laboratory Medicine 45:10, 1259-1267
CrossRef463
Siddhartha Annamraju, Brian Sheitman, Susan Saik, Anne Stephenson. (2007) Early Recognition of Clozapine-Induced Myocarditis. Journal of Clinical Psychopharmacology 27:5, 479-483
CrossRef464
Hisham Dokainish. (2007) Combining tissue Doppler echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: Review of the literature and clinical recommendations. Canadian Journal of Cardiology 23:12, 983-989
CrossRef465
David Stewart, Kenneth Waxman, C Alan Brown, Rob Schuster, Lynn Schuster, Eva Marie Hvingelby, Kelly Kam, Salvador Becerra. (2007) B-Type Natriuretic Peptide Levels May Be Elevated in the Critically Injured Trauma Patient Without Congestive Heart Failure. The Journal of Trauma: Injury, Infection, and Critical Care 63:4, 747-750
CrossRef466
Rasmus Mogelvang, Jens P. Goetze, Peter Schnohr, Peter Lange, Peter Sogaard, Jens F. Rehfeld, Jan S. Jensen. (2007) Discriminating Between Cardiac and Pulmonary Dysfunction in the General Population With Dyspnea by Plasma Pro-B-Type Natriuretic Peptide. Journal of the American College of Cardiology 50:17, 1694-1701
CrossRef467
Namık Kemal Eryol, Ali Dogan, Ibrahim Ozdogru, Mehmet Tugrul Inanc, Mehmet Gungor Kaya, Nihat Kalay. (2007) The relationship between the level of plasma B-type natriuretic peptide and mitral stenosis. The International Journal of Cardiovascular Imaging 23:5, 569-574
CrossRef468
John T. Parissis, Constantinos Papadopoulos, Maria Nikolaou, Vassiliki Bistola, Dimitrios Farmakis, Ioannis Paraskevaidis, Gerasimos Filippatos, Dimitrios Kremastinos. (2007) Effects of Levosimendan on Quality of Life and Emotional Stress in Advanced Heart Failure Patients. Cardiovascular Drugs and Therapy 21:4, 263-268
CrossRef469
Antoni Bayes-Genis, Domingo Pascual-Figal, Jordi Fabregat, Maite Domingo, Francesc Planas, Teresa Casas, Jordi Ordoñez-Llanos, Mariano Valdes, Juan Cinca. (2007) Serial NT-proBNP monitoring and outcomes in outpatients with decompensation of heart failure. International Journal of Cardiology 120:3, 338-343
CrossRef470
Alan Maisel. (2007) Biomarkers in Heart Failure. Journal of the American College of Cardiology 50:11, 1061-1063
CrossRef471
M. Seifert, M. Schlegl, W. Hoersch, E. Fleck, A. Doelger, M. Stockburger, C. Butter. (2007) Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients. International Journal of Cardiology 121:1, 68-73
CrossRef472
D Collin-Chavagnac, C Traulle, H Bernon, M Manchon. (2007) False-positive BNP results in a 78-year-old man caused by monoclonal IgM-κ: A case report. Clinica Chimica Acta 384:1-2, 179
CrossRef473
Stephan Budweiser, Andreas Luchner, Rudolf A. Jörres, Frank Heinemann, André P. Hitzl, Kathrin Schmidbauer, Günter Riegger, Michael Pfeifer. (2007) NT-proBNP in chronic hypercapnic respiratory failure: A marker of disease severity, treatment effect and prognosis. Respiratory Medicine 101:9, 2003-2010
CrossRef474
Raquel Cortés, Miguel Rivera, Antonio Salvador, Fernando García de Burgos, Vicente Bertomeu, Esther Roselló-Lletí, Luís Martínez-Dolz, Rafael Payá, Luis Almenar, Manuel Portolés. (2007) Urinary B-Type Natriuretic Peptide Levels in the Diagnosis and Prognosis of Heart Failure. Journal of Cardiac Failure 13:7, 549-555
CrossRef475
Lin-Hua Tan, John L. Jefferies, Jian-Feng Liang, Susan W. Denfield, William J. Dreyer, Antonio R. Mott, Michelle A. Grenier, Heather A. Dickerson, Jack F. Price, Jeffrey A. Towbin, Ching-Nan Ou, Anthony C. Chang. (2007) Concentrations of brain natriuretic peptide in the plasma predicts outcomes of treatment of children with decompensated heart failure admitted to the Intensive Care unit. Cardiology in the Young 17:04, 397
CrossRef476
Gjin Ndrepepa, Siegmund Braun, Albert Schömig, Adnan Kastrati. (2007) Accuracy of N-Terminal Pro-Brain Natriuretic Peptide to Predict Mortality in Various Subsets of Patients With Coronary Artery Disease. The American Journal of Cardiology 100:4, 575-578
CrossRef477
James L. Januzzi, W. Frank Peacock, Alan S. Maisel, Claudia U. Chae, Robert L. Jesse, Aaron L. Baggish, Michelle O’Donoghue, Rahul Sakhuja, Annabel A. Chen, Roland R.J. van Kimmenade, Kent B. Lewandrowski, Donald M. Lloyd-Jones, Alan H.B. Wu. (2007) Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea. Journal of the American College of Cardiology 50:7, 607-613
CrossRef478
Senay Arikan, Alpaslan Tuzcu, Deniz Gokalp, Mithat Bahceci, Ramazan Danis. (2007) Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction. Clinical Endocrinology 67:2, 202-207
CrossRef479
JOSEPH D. TOBIAS, CHRISTOPHER L. LINDBLADE, MARCUS S. SCHAMBERGER. (2007) B-type natriuretic peptide monitoring in the Pediatric ICU population. Pediatric Anesthesia 17:8, 793-799
CrossRef480
Franck Maziere, Sophie Birolleau, Sassi Medimagh, Martine Arthaud, Mohamed Bennaceur, Bruno Riou, Patrick Ray. (2007) Comparison of troponin I and N-terminal-pro B-type natriuretic peptide for risk stratification in patients with pulmonary embolism. European Journal of Emergency Medicine 14:4, 207-211
CrossRef481
A M Abdulle, N J D Nagelkerke, A Adem, S Abouchacra, J Y Pathan, M Al-Rukhaimi, M N Suleiman, M C Mathew, M G Nicholls, E N Obineche. (2007) Plasma N terminal pro-brain natriuretic peptide levels and its determinants in a multi-ethnic population. Journal of Human Hypertension 21:8, 647-653
CrossRef482
P. Alter, H. Rupp, M.B. Rominger, A. Vollrath, F. Czerny, K.J. Klose, B. Maisch. (2007) Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy. Canadian Journal of Physiology and Pharmacology 85:8, 790-799
CrossRef483
Roy S Gardner, Kwok S Chong, Theresa A McDonagh. (2007) B-type natriuretic peptides in heart failure. Biomarkers in Medicine 1:2, 243-250
CrossRef484
Amir Ben Tov, Gideon Paret, Ben-Ami Sela, Hannah Blau, Julius Hegesh, Ori Efrati, Yaacov Yahav, Arie Augarten. (2007) N-terminal pro B-type natriuretic peptide (N-BNP) levels in cystic fibrosis patients. Pediatric Pulmonology 42:8, 699-703
CrossRef485
D. M. Musher, A. M. Rueda, A. S. Kaka, S. M. Mapara. (2007) The Association between Pneumococcal Pneumonia and Acute Cardiac Events. Clinical Infectious Diseases 45:2, 158-165
CrossRef486
Leon Su, Hany Kamel. (2007) How do we investigate and manage donors associated with a suspected case of transfusion-related acute lung injury. Transfusion 47:7, 1118-1124
CrossRef487
S. C. Gibson, C. J. Payne, D. S. Byrne, C. Berry, H. J. Dargie, D. B. Kingsmore. (2007) B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. British Journal of Surgery 94:7, 903-909
CrossRef488
Hidekatsu Fukuta, William C. Little. (2007) Elevated Left Ventricular Filling Pressure after Maximal Exercise Predicts Increased Plasma B-type Natriuretic Peptide Levels in Patients with Impaired Relaxation Pattern of Diastolic Filling. Journal of the American Society of Echocardiography 20:7, 832-837
CrossRef489
Torbjørn Omland, Marc S. Sabatine, Kathleen A. Jablonski, Madeline Murguia Rice, Judith Hsia, Ragnhild Wergeland, Sverre Landaas, Jean L. Rouleau, Michael J. Domanski, Christian Hall, Marc A. Pfeffer, Eugene Braunwald. (2007) Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease. Journal of the American College of Cardiology 50:3, 205-214
CrossRef490
Steen Hvitfeldt Poulsen, Peter Søgaard, Jens Erik Nielsen-Kudsk, Henrik Egeblad. (2007) Recovery of Left Ventricular Systolic Longitudinal Strain After Valve Replacement in Aortic Stenosis and Relation to Natriuretic Peptides. Journal of the American Society of Echocardiography 20:7, 877-884
CrossRef491
Michael E. Ezzie, Scott K. Aberegg, James M. O'Brien. (2007) Laboratory Testing in the Intensive Care Unit. Critical Care Clinics 23:3, 435-465
CrossRef492
Leonardo Luca, Gregg C. Fonarow, Kirkwood F. Adams, Alexandre Mebazaa, Luigi Tavazzi, Karl Swedberg, Mihai Gheorghiade. (2007) Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy. Heart Failure Reviews 12:2, 97-104
CrossRef493
Elisabeth Mahla, Anneliese Baumann, Peter Rehak, Norbert Watzinger, Martin N. Vicenzi, Robert Maier, Kurt Tiesenhausen, Helfried Metzler, Wolfgang Toller. (2007) N-Terminal Pro-brain Natriuretic Peptide Identifies Patients at High Risk for Adverse Cardiac Outcome after Vascular Surgery. Anesthesiology 106:6, 1088-1095
CrossRef494
Aaron L. Baggish, Roland van Kimmenade, Antoni Bayes-Genis, Mark Davis, John G. Lainchbury, Chris Frampton, Yigal Pinto, Mark A. Richards, James L. Januzzi. (2007) Hemoglobin and N-terminal pro-brain natriuretic peptide: Independent and synergistic predictors of mortality in patients with acute heart failure. Clinica Chimica Acta 381:2, 145-150
CrossRef495
C. Davidson. (2007) Heart failure: a disease for the Internist. La Revue de Médecine Interne 28, S27-S29
CrossRef496
Sukesh C. Burjonroppa, Ann T. Tong, Lian-Chun Xiao, Marcella M. Johnson, S Wamique Yusuf, Daniel J. Lenihan. (2007) Cancer Patients With Markedly Elevated B-Type Natriuretic Peptide May Not Have Volume Overload. American Journal of Clinical Oncology 30:3, 287-293
CrossRef497
A. M. Mengistu, M. W. Wolf, J. Boldt, K. D. Röhm, S. W. Suttner, S. N. Piper. (2007) Influence of controlled hypotension using esmolol and sodium nitroprusside on natriuretic peptides in patients undergoing endonasal sinus surgery. European Journal of Anaesthesiology 24:6, 529-534
CrossRef498
Randall S. Friese, Sean Dineen, Andrew Jennings, Jeffrey Pruitt, Dara McBride, Shahid Shafi, Heidi Frankel, Larry M. Gentilello. (2007) Serum B-Type Natriuretic Peptide: a Marker of Fluid Resuscitation After Injury?. The Journal of Trauma: Injury, Infection, and Critical Care 62:6, 1346-1351
CrossRef499
J. A. Wagner, S. Störk, F. Weidemann, J. Strotmann, C. Fiedel, G. Ertl, W. Voelker. (2007) Natriuretic peptides and myocardial oxygen supply-to-demand ratio in patients with aortic stenosis. European Journal of Clinical Investigation 37:6, 463-471
CrossRef500
Scott M. Silvers, John M. Howell, Joshua M. Kosowsky, Ivan C. Rokos, Andy S. Jagoda. (2007) Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department with Acute Heart Failure Syndromes. Annals of Emergency Medicine 49:5, 627-669
CrossRef501
Kambiz Norozi, Armin Wessel, Valentin Alpers, Jan O. Arnhold, Lutz Binder, Siegfried Geyer, Monika Zoege, Reiner Buchhorn. (2007) Chronotropic Incompetence in Adolescents and Adults With Congenital Heart Disease After Cardiac Surgery. Journal of Cardiac Failure 13:4, 263-268
CrossRef502
Cecile Gorissen, Ruben Baumgarten, Monique de Groot, Eric van Haren, Hans Kragten, Mathie Leers. (2007) Analytical and clinical performance of three natriuretic peptide tests in the emergency room. Clinical Chemistry and Laboratory Medicine 45:5, 678-684
CrossRef503
Gregg C. Fonarow, William F. Peacock, Christopher O. Phillips, Michael M. Givertz, Margarita Lopatin. (2007) Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure. Journal of the American College of Cardiology 49:19, 1943-1950
CrossRef504
Luis Beck-da-Silva, Luis E. Rohde, Livia Goldraich, Nadine Clausell. (2007) Clinical Findings, Natriuretic Peptides, and Echocardiography: Integrating Tools to Optimize Heart Failure Management. Congestive Heart Failure 13:3, 158-163
CrossRef505
Maxime Cannesson, Clara Bionda, Bruno Gostoli, Olivier Raisky, Sylvie di Filippo, Dominique Bompard, Catherine V??drinne, Robert Rousson, Jean Ninet, Jean Neidecker, Jean-Jacques Lehot. (2007) Time Course and Prognostic Value of Plasma B-type Natriuretic Peptide Concentration in Neonates Undergoing the Arterial Switch Operation. Anesthesia & Analgesia 104:5, 1059-1065
CrossRef506
T. CHUNG, D. CONNOR, J. JOSEPH, L. EMMETT, R. MANSBERG, M. PETERS, D. MA, L. KRITHARIDES. (2007) Platelet activation in acute pulmonary embolism. Journal of Thrombosis and Haemostasis 5:5, 918-924
CrossRef507
Michael A. Burke, William G. Cotts. (2007) Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Failure Reviews 12:1, 23-36
CrossRef508
Gh. Zaid, A. Tanchilevitch, E. Rivlin, R. Gropper, U. Rosenschein, A. Lanir, E. Goldhammer. (2007) Diagnostic accuracy of serum B-type natriuretic peptide for myocardial ischemia detection during exercise testing with Spect perfusion imaging. International Journal of Cardiology 117:2, 157-164
CrossRef509
Brian Moyers, Mia Shapiro, Gregory M. Marcus, Ivor L. Gerber, Barry H. McKeown, Joshua C. Vessey, Mark V. Jordan, Michele Huddleston, Elyse Foster, Kanu Chatterjee, Andrew D. Michaels. (2007) Performance of Phonoelectrocardiographic Left Ventricular Systolic Time Intervals and B-Type Natriuretic Peptide Levels in the Diagnosis of Left Ventricular Dysfunction. Annals of Noninvasive Electrocardiology 12:2, 89-97
CrossRef510
Paulo Bettencourt, Ana Azevedo, Luísa Fonseca, José P. Araújo, Susana Ferreira, Rui Almeida, Francisco Rocha-Goncalves, António Ferreira. (2007) Prognosis of decompensated heart failure patients with preserved systolic function is predicted by NT-proBNP variations during hospitalization. International Journal of Cardiology 117:1, 75-79
CrossRef511
Michael J Lipinski, Antonio Abbate, Valentin Fuster, George W Vetrovec. (2007) Drug Insight: statins for nonischemic heart failure—evidence and potential mechanisms. Nature Clinical Practice Cardiovascular Medicine 4:4, 196-205
CrossRef512
Patrick Jourdain, Guillaume Jondeau, François Funck, Pascal Gueffet, Alain Le Helloco, Erwan Donal, Jean F. Aupetit, Marie C. Aumont, Michel Galinier, Jean C. Eicher, Alain Cohen-Solal, Yves Juillière. (2007) Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure. Journal of the American College of Cardiology 49:16, 1733-1739
CrossRef513
L CHEN, T WEI, L WANG. (2007) Relationship between Pericardial Fluid B-type Natriuretic Peptide and Ventricular Structure and Function. Archives of Medical Research 38:3, 326-329
CrossRef514
Anil-Martin Sinha, Ole-Alexander Breithardt, Johannes Brachmann. (2007) Brain natriuretic peptide: does it play a role in post-cardiac surgery patients?. Future Cardiology 3:2, 109-113
CrossRef515
Teresa C. DeFrancesco, John E. Rush, Elizabeth A. Rozanski, Bernard D. Hansen, Bruce W. Keene, Dominic T. Moore, Clarke E. Atkins. (2007) Prospective Clinical Evaluation of an ELISA B-Type Natriuretic Peptide Assay in the Diagnosis of Congestive Heart Failure in Dogs Presenting with Cough or Dyspnea. Journal of Veterinary Internal Medicine 21:2, 243-250
CrossRef516
Michael W Rich. (2007) Advances in the treatment of acute decompensated heart failure in the elderly. Future Cardiology 3:2, 165-174
CrossRef517
Manuel Méndez Bailón, Nuria Muñoz Rivas, Carlos Romero Román, Carlos Pérez de Oteyza, Pedro Conthe Gutiérrez, Luis Audibert Mena. (2007) Determinación del fragmento N-terminal del propéptido natriurético cerebral (NTproBNP) en pacientes de edad avanzada con disnea aguda: valor diagnóstico y pronóstico. Medicina Clínica 128:12, 453-455
CrossRef518
T. Sun, L. Wang, Y. Zhang. (2007) Prognostic value of B-type natriuretic peptide in patients with chronic and advanced heart failure. Internal Medicine Journal 37:3, 168-171
CrossRef519
Yohannes Gebreegziabher, Amgad N Makaryus, John N Makaryus, Samy I McFarlane. (2007) Heart failure: metabolic derangements and therapeutic rationale. Expert Review of Cardiovascular Therapy 5:2, 331-343
CrossRef520
James L. Januzzi, Carlos A. Camargo, Roderick Tung. (2007) Response to “Getting the Right Message”. Annals of Emergency Medicine 49:3, 381-383
CrossRef521
Faquan Liang, Jessica O’Rear, Ute Schellenberger, Lungkuo Tai, Michael Lasecki, George F. Schreiner, Fred S. Apple, Alan S. Maisel, N. Stephen Pollitt, Andrew A. Protter. (2007) Evidence for Functional Heterogeneity of Circulating B-Type Natriuretic Peptide. Journal of the American College of Cardiology 49:10, 1071-1078
CrossRef522
S. M. Marcovina, F. Crea, J. Davignon, J. C. Kaski, W. Koenig, U. Landmesser, P. L. Pieri, J. Schulz-Menger, L. J. Shaw, J. Sobesky. (2007) Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic tools. Journal of Internal Medicine 261:3, 214-234
CrossRef523
Salvatore Di Somma, Laura Magrini, Marinella Mazzone, Raffaella De Leva, Fabio Tabacco, Rossella Marino, Veronica Talucci, Enrico Ferri, Paola Forte, Patrizia Cardelli, Nicola Gentiloni, Valerio Pittoni. (2007) Decrease in NTproBNP plasma levels indicates clinical improvement of acute decompensated heart failure. The American Journal of Emergency Medicine 25:3, 335-339
CrossRef524
Mária Lengyel. (2007) B-típusú natriuretikus hormon a diagnosztikus és prognosztikus cardiovascularis biomarker. Orvosi Hetilap 148:5, 217-221
CrossRef525
Robert C. Hawkins, Kenneth Ng Kwan Chung. (2007) B-type natriuretic peptide testing is associated with reduced cost in patients with secondary diagnosis of heart failure. Clinica Chimica Acta 377:1-2, 276-278
CrossRef526
Mia Shapiro, Brian Moyers, Gregory M. Marcus, Ivor L. Gerber, Barry H. McKeown, Joshua C. Vessey, Mark V. Jordan, Michele Huddleston, Elyse Foster, Kanu Chatterjee, Andrew D. Michaels. (2007) Diagnostic Characteristics of Combining Phonocardiographic Third Heart Sound and Systolic Time Intervals for the Prediction of Left Ventricular Dysfunction. Journal of Cardiac Failure 13:1, 18-24
CrossRef527
John R. Kapoor, Mark A. Perazella. (2007) Diagnostic and Therapeutic Approach to Acute Decompensated Heart Failure. The American Journal of Medicine 120:2, 121-127
CrossRef528
Guillaume Dautin, Samir Boudjeltia, Zaara Soltani, Philippe Gambert, Laurence Duvillard. (2007) The changes in NT-proBNP plasma concentrations during dialysis are highly dependent of the dialysis membrane ultrafiltration coefficient. Clinica Chimica Acta 376:1-2, 237-239
CrossRef529
Min-Soo Ahn, Byung-Su Yoo. (2007) Serial Monitoring of B-Type Natriuretic Peptide in Heart Failure Patients. Korean Circulation Journal 37:9, 393
CrossRef530
W. H. Wilson Tang. (2007) B-Type Natriuretic Peptide: A Critical Review. Congestive Heart Failure 13:1, 48-52
CrossRef531
Satoru Sakuragi, Keisuke Okawa, Jun Iwasaki, Naoto Tokunaga, Mikio Kakishita, Toru Ohe. (2007) Aortic Stiffness Is an Independent Determinant of B-Type Natriuretic Peptide in Patients with Coronary Artery Disease. Cardiology 107:2, 140-146
CrossRef532
Serpil Eroglu, Aylin Yildirir, Huseyin Bozbas, Alp Aydinalp, Gaye Ulubay, Olcay Eldem, Vahide Simsek, Bulent Ozin, Haldun Muderrisoglu. (2007) Brain Natriuretic Peptide Levels and Cardiac Functional Capacity in Patients With Dyspnea and Isolated Diastolic Dysfunction. International Heart Journal 48:1, 97-106
CrossRef533
Alan S. Maisel, Salvatore DiSomma. (2007) B-type natriuretic peptide-guided therapy and prognosis in acutely ill patients with pulmonary disease*. Critical Care Medicine 35:1, 301-303
CrossRef534
(2007) N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection Study. Journal of the American College of Cardiology 49:3, 311-319
CrossRef535
Hiroshi Sakai, Takayoshi Tsutamoto, Chitose Ishikawa, Toshinari Tanaka, Masanori Fujii, Takashi Yamamoto, Hiroyuki Takashima, Minoru Horie. (2007) Direct Comparison of Brain Natriuretic Peptide (BNP) and N-Terminal Pro-BNP Secretion and Extent of Coronary Artery Stenosis in Patients With Stable Coronary Artery Disease. Circulation Journal 71:4, 499-505
CrossRef536
Andreas Koch, Tobias Kitzsteiner, Stefan Zink, Robert Cesnjevar, Helmut Singer. (2007) Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease. International Journal of Cardiology 114:3, 339-344
CrossRef537
Salvatore Grasso, Antonio Leone, Michele De Michele, Roberto Anaclerio, Aldo Cafarelli, Giovanni Ancona, Tania Stripoli, Francesco Bruno, Paolo Pugliese, Michele Dambrosio, Lidia Dalfino, Francesca Di Serio, Tommaso Fiore. (2007) Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease*. Critical Care Medicine 35:1, 96-105
CrossRef538
Ji Yong Choi. (2007) The Role of Brain Natriuretic Peptide in the Patients with Acute Dyspnea in the Emergency Department. Korean Circulation Journal 37:10, 464
CrossRef539
J. Malcolm O. Arnold, Jonathan G. Howlett, Paul Dorian, Anique Ducharme, Nadia Giannetti, Haissam Haddad, George A. Heckman, Andrew Ignaszewski, Debra Isaac, Philip Jong, Peter Liu, Elizabeth Mann, Robert S. McKelvie, Gordon W. Moe, John D. Parker, Anna M. Svendsen, Ross T. Tsuyuki, Kelly O’Halloran, Heather J. Ross, Vivek Rao, Errol J. Sequeira, Michel White. (2007) Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Canadian Journal of Cardiology 23:1, 21-45
CrossRef540
Yasuo Okumura, Ichiro Watanabe, Sonoko Ashino, Masayoshi Kofune, Yasuhiro Takagi, Tatsuya Kofune, Kimie Okubo, Kenichi Hashimoto, Atsushi Shindo, Hidezou Sugimura, Toshiko Nakai, Yuji Kasamaki, Satoshi Saito. (2007) Electrophysiological Properties of the Atrium After Cardioversion of Chronic Atrial Fibrillation. International Heart Journal 48:4, 485-496
CrossRef541
Leonardo De Luca, Gregg C. Fonarow, Alexandre Mebazaa, David D. Shin, Sean P. Collins, Karl Swedberg, Mihai Gheorghiade. (2007) Early pharmacological treatment of acute heart failure syndromes: A systematic review of clinical trials. Acute Cardiac Care 9:1, 10-21
CrossRef542
Rogerio Souza, Carlos Jardim, Caio Julio Cesar Fernandes, Monica Silveira Lapa, Rogerio Rabelo, Marc Humbert. (2007) NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension. Respiratory Medicine 101:1, 69-75
CrossRef543
David F. Stroncek. (2007) Pulmonary Transfusion Reactions. Seminars in Hematology 44:1, 2-14
CrossRef544
Amiram Nir. (2007) ABCs of Natriuretic Peptides: Cardiac Aspects. Hormone Research 67:1, 77-80
CrossRef545
2007. H. , 90-108.
CrossRef546
Yasuhide Kuwabara, Yukihito Sato, Tadashi Miyamoto, Ryoji Taniguchi, Tatsuhiko Matsuoka, Kei Isoda, Keiichirou Yamane, Kiyoto Nishi, Hisayoshi Fujiwara, Yoshiki Takatsu. (2007) Persistently Increased Serum Concentrations of Cardiac Troponin in Patients With Acutely Decompensated Heart Failure are Predictive of Adverse Outcomes. Circulation Journal 71:7, 1047-1051
CrossRef547
Chin Kook Rhee, Young Bin Joo, Seok Chan Kim, Sung Hak Park, Sook Young Lee, Yoon Seok Koh, Young Kyoon Kim. (2007) Utility of B-type Natriuretic Peptide in Patients with Acute Respiratory Distress Syndrome. Tuberculosis and Respiratory Diseases 62:5, 389
CrossRef548
Goutam Ghosh, Kakali De, Sangeeta Maity, Debashis Bandyopadhyay, Samir Bhattacharya, Russel J Reiter, Arun Bandyopadhyay. (2007) Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart. Journal of Pineal Research 42:1, 71-82
CrossRef549
Ken Nagao, Takeo Mukoyama, Kimio Kikushima, Kazuhiro Watanabe, Eizo Tachibana, Kiyoshi Iida, Sigemasa Tani, Ikuyoshi Watanabe, Nariyuki Hayashi, Katsuo Kanmatsuse. (2007) Resuscitative Value of B-Type Natriuretic Peptide in Comatose Survivors Treated With Hypothermia After Out-of-Hospital Cardiac Arrest due to Cardiac Causes. Circulation Journal 71:3, 370-376
CrossRef550
Vera Jelic, Goran Milasinovic, Sinisa Pavlovic, Vladimir Kanjuh, Mirjana Zivkovic. (2007) Brain natriuretic peptide as a predictor of heart failure in patients with permanent pacemaker. Srpski arhiv za celokupno lekarstvo 135:1-2, 21-25
CrossRef551
EDMOND VARTANY, MICHAEL IMEVBORE, MARY O'MALLEY, CHRISTOPHER MANFREDI, CAROL PASQUARELLA, LEONARD SCINTO, JONATHAN FINE. (2006) N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome. Journal of Sleep Research 15:4, 424-429
CrossRef552
Stephen H. Loring, Sean R. Townsend, Diana C. Gallagher, Heidi L. Matus, Elizabeth O. Tegins, David Feller-Kopman, Richard M. Schwartzstein. (2006) Expiratory Abdominal Rounding in Acute Dyspnea Suggests Congestive Heart Failure. Lung 184:6, 324-329
CrossRef553
S. Karuppiah, F. Graham, M. Ledwidge, C. Conlon, J. Cahill, C. O’Loughlin, J. McManus, K. McDonald. (2006) Elevated BNP with normal systolic function in asymptomatic individuals at-risk for heart failure: a marker of diastolic dysfunction and clinical risk. Irish Journal of Medical Science 175:4, 5-13
CrossRef554
Jill M. Gelow, James C. Fang. (2006) Update in the Approach to and Management of Heart Failure. Southern Medical Journal 99:12, 1346-1355
CrossRef555
Todd Brown, Jay Hollman. (2006) B-type natriuretic peptide level in a patient with constrictive pericarditis. Catheterization and Cardiovascular Interventions 68:6, 832-834
CrossRef556
Michael Christ, Kirsten Laule-Kilian, Willibald Hochholzer, Theresia Klima, Tobias Breidthardt, Andre P. Perruchoud, Christian Mueller. (2006) Gender-Specific Risk Stratification With B-Type Natriuretic Peptide Levels in Patients With AcuteDyspnea. Journal of the American College of Cardiology 48:9, 1808-1812
CrossRef557
P. Ray, Y. Lefort. (2006) Intérêt du dosage des peptides natriurétiques en urgence. La Revue de Médecine Interne 27:11, 858-864
CrossRef558
Susan R Isakson, Nancy J Gardetto, Alan S Maisel. (2006) Natriuretic peptides: diagnostic tools and predictors of heart failure outcome. Future Cardiology 2:6, 667-676
CrossRef559
Michele Emdin, Claudio Passino, Aldo Clerico. (2006) Cardiac natriuretic hormones as clinical markers: instructions for use. Future Cardiology 2:6, 619-622
CrossRef560
Philipp Bismarck, Tobias Ankermann, Paul Eggert, Alexander Claviez, Michael J. Fritsch, Martin F. Krause. (2006) Diagnosis and management of cerebral salt wasting (CSW) in children: the role of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP). Child's Nervous System 22:10, 1275-1281
CrossRef561
Roland R.J. van Kimmenade, James L. Januzzi, Aaron L. Baggish, John G. Lainchbury, Antoni Bayes-Genis, A. Mark Richards, Yigal M. Pinto. (2006) Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure. Journal of the American College of Cardiology 48:8, 1621-1627
CrossRef562
Ingegerd ODAR-CEDERLÖF, Per BJELLERUP, Amy WILLIAMS, Christopher R. BLAGG, Zbylut TWARDOWSKI, George TING, Carl M. KJELLSTRAND. (2006) Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction. Hemodialysis International 10:4, 394-398
CrossRef563
Sunghyuk Choi, Doyoung Park, Nakhoon Kim, Sungwoo Lee, Yunsik Hong. (2006) Normal range of B-type natriuretic peptide and factors associated with high B-type natriuretic peptide in patients visiting an emergency department in Korea. European Journal of Emergency Medicine 13:5, A1
CrossRef564
SHAILJA V. PARIKH, JAMES A. DE LEMOS. (2006) Biomarkers in Cardiovascular Disease: Integrating Pathophysiology into Clinical Practice. The American Journal of the Medical Sciences 332:4, 186-197
CrossRef565
A. Ben halima, Z. Ibn el Hadj, R. Chrigui, I. Kammoun, A. Lefi, S. Chine, S. Gargouri, H. Keskes, S. Kachboura. (2006) Place du BNP dans l'évaluation du pronostic au décours de l'infarctus du myocarde. Annales de Cardiologie et d'Angéiologie 55:5, 264-270
CrossRef566
C. Zeng, T. Wei, L. Jin, L. Wang. (2006) Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients. Internal Medicine Journal 36:9, 552-557
CrossRef567
James L. Januzzi, Donald M. Lloyd-Jones, Saif Anwaruddin. (2006) Reply. Journal of the American College of Cardiology 48:5, 1061
CrossRef568
Roland R. van Kimmenade, James L. Januzzi, Patrick T. Ellinor, Umesh C. Sharma, Jaap A. Bakker, Adrian F. Low, Abelardo Martinez, Harry J. Crijns, Calum A. MacRae, Paul P. Menheere, Yigal M. Pinto. (2006) Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure. Journal of the American College of Cardiology 48:6, 1217-1224
CrossRef569
Michael W. Rich. (2006) Heart Failure in Older Adults. Medical Clinics of North America 90:5, 863-885
CrossRef570
Angela M Morello, James L Januzzi. (2006) Amino-terminal pro-brain natriuretic peptide: a biomarker for diagnosis, prognosis and management of heart failure. Expert Review of Molecular Diagnostics 6:5, 649-662
CrossRef571
Alain Rudiger, Stefan Gasser, Manuel Fischler, Thorsten Hornemann, Arnold von Eckardstein, Marco Maggiorini. (2006) Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure*. Critical Care Medicine 34:8, 2140-2144
CrossRef572
David L. Garbers, Ted D. Chrisman, Phi Wiegn, Takeshi Katafuchi, Joseph P. Albanesi, Vincent Bielinski, Barbara Barylko, Margaret M. Redfield, John C. Burnett. (2006) Membrane guanylyl cyclase receptors: an update. Trends in Endocrinology & Metabolism 17:6, 251-258
CrossRef573
Brian T. Edelson, George J. Despotis, Douglas M. Lublin. (2006) B-type natriuretic peptide measured during transfusion-related acute lung injury. Transfusion 46:8, 1453-1454
CrossRef574
Alfons Gegenhuber, Thomas Mueller, Benjamin Dieplinger, Werner Poelz, Richard Pacher, Meinhard Haltmayer. (2006) B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure. Clinica Chimica Acta 370:1-2, 174-179
CrossRef575
Sheng-Jing Dong, Lisa de las Fuentes, Angela L. Brown, Alan D. Waggoner, Gregory A. Ewald, Víctor G. Dávila-Román. (2006) N-terminal Pro B-type Natriuretic Peptide Levels: Correlation with Echocardiographically Determined Left Ventricular Diastolic Function in an Ambulatory Cohort. Journal of the American Society of Echocardiography 19:8, 1017-1025
CrossRef576
Takeshi Yamamoto, Naoki Sato, Masahiro Yasutake, Hiromichi Takagi, Norishige Morita, Koichi Akutsu, Masahiro Fujii, Nobuhiko Fujita, Keiji Tanaka, Teruo Takano. (2006) B-type natriuretic peptide as an integrated risk marker in non-ST elevation acute coronary syndromes. International Journal of Cardiology 111:2, 224-230
CrossRef577
Irma B. Ancheta. (2006) B-type Natriuretic Peptide Rapid Assay. Dimensions of Critical Care Nursing 25:4, 149-154
CrossRef578
Angelika Hammerer-Lercher, Bernd Puschendorf, Johannes Mair. (2006) B-type natriuretic peptides as powerful markers in cardiac diseases – analytical and clinical aspects / B-Typ natriuretische Peptide als aussagekräftige Marker bei kardialen Erkrankungen – analytische und klinische Aspekte. LaboratoriumsMedizin 30:3, 165-184
CrossRef579
Roberto Valle, Carolina Prevaldi, Alessandra D'Eri, Alessandra Fontebasso, Prospero Giovinazzo, Federica Noventa, Sabrina Barro, Emanuele Carbonieri, Loredano Milani, Nadia Aspromonte. (2006) B-Type Natriuretic Peptide Predicts Postdischarge Prognosis in Elderly Patients Admitted Due to Cardiogenic Pulmonary Edema. The American Journal of Geriatric Cardiology 15:4, 202-207
CrossRef580
John M. Costello, Denise M. Goodman, Thomas P. Green. (2006) A review of the natriuretic hormone system??s diagnostic and therapeutic potential in critically ill children*. Pediatric Critical Care Medicine 7:4, 308-318
CrossRef581
W. Frank Peacock, Alex Harrison, Donald Moffa. (2006) Clinical and Economic Benefits of Using AUDICOR S 3 Detection for Diagnosis and Treatment of Acute Decompensated Heart Failure. Congestive Heart Failure 12:s4, 32-36
CrossRef582
Daniel P. Schuster. (2006) Is measuring B-type natriuretic peptide in critically ill patients ever useful?*. Critical Care Medicine 34:7, 2019-2020
CrossRef583
Rimki Rana, Nicholas E. Vlahakis, Craig E. Daniels, Allan S. Jaffe, George G. Klee, Rolf D. Hubmayr, Ognjen Gajic. (2006) B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema*. Critical Care Medicine 34:7, 1941-1946
CrossRef584
C R Parikh, J Mishra, H Thiessen-Philbrook, B Dursun, Q Ma, C Kelly, C Dent, P Devarajan, C L Edelstein. (2006) Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney International 70:1, 199-203
CrossRef585
W. Frank Peacock, Alex Harrison, Donald Moffa. (2006) Clinical and Economic Benefits of Using AUDICOR S3 Detection for Diagnosis and Treatment of Acute Decompensated Heart Failure. Congestive Heart Failure 12, 32-36
CrossRef586
Olaf Forster, Aftab A Ansari, Karen Sliwa. (2006) Current issues in the diagnosis and management of peripartum cardiomyopathy. Women's Health 2:4, 587-596
CrossRef587
Andreas M.E. Koch, Manfred Rauh, Stefan Zink, Helmut Singer. (2006) Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age. Acta Paediatrica 95:7, 805-809
CrossRef588
Mahmoud Eskafi, Charles Cline, Maria Nilner, Bo Israelsson. (2006) Treatment of sleep apnea in congestive heart failure with a dental device. Sleep and Breathing 10:2, 90-97
CrossRef589
Lori B Daniels, Alan Maisel. (2006) B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice. Journal of Cardiovascular Medicine 7:6, 414-415
CrossRef590
AXEL BUOB, JENS JUNG, STEPHANOS SIAPLAOURAS, HANS-RUPRECHT NEUBERGER, CHRISTIAN MEWIS. (2006) Discordant Regulation of CRP and NT-proBNP Plasma Levels After Electrical Cardioversion of Persistent Atrial Fibrillation. Pacing and Clinical Electrophysiology 29:6, 559-563
CrossRef591
Nadia Aspromonte, Mauro Feola, Angela Beatrice Scardovi, Claudio Coletta, Alessandra DʼEri, Prospero Giovinazzo, Alessandro Carunchio, Antonella Chiera, Renato Fanelli, Tiziana Di Giacomo, Roberto Ricci, Vincenzo Ceci, Loredano Milani, Roberto Valle. (2006) Early diagnosis of congestive heart failure: clinical utility of B-type natriuretic peptide testing associated with Doppler echocardiography. Journal of Cardiovascular Medicine 7:6, 406-413
CrossRef592
Élie Azoulay, Benoît Schlemmer. (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Medicine 32:6, 808-822
CrossRef593
Chlodwig Kirchhoff, Julia Stegmaier, Viktoria Bogner, Sonja Buhmann, Thomas Mussack, Uwe Kreimeier, Wolf Mutschler, Peter Biberthaler. (2006) Intrathecal and Systemic Concentration of NT-proBNP in Patients with Severe Traumatic Brain Injury. Journal of Neurotrauma 23:6, 943-949
CrossRef594
Shu-Chien Huang, En-Ting Wu, Wen-Je Ko, Ling-Ping Lai, Juin Hsu, Chung-I. Chang, Ing-Sh Chiu, Shoei-Shen Wang, Mei-Hwan Wu, Fang-Yue Lin, Yih-Sharng Chen. (2006) Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support. The Annals of Thoracic Surgery 81:6, 2267-2272
CrossRef595
Cândida Fonseca. (2006) Diagnosis of heart failure in primary care. Heart Failure Reviews 11:2, 95-107
CrossRef596
D Conen, M Pfisterer, B Martina. (2006) Substantial intraindividual variability of BNP concentrations in patients with hypertension. Journal of Human Hypertension 20:6, 387-391
CrossRef597
Ralph G. Brindis, Edward Fischer, Gary Besinque, Alan Gjedsted, Philip C. Lee, Tom Padgett, Michael Petru, Jenni Raley, Eleanor Levin, Anita Strohmeier. (2006) Acute Coronary Syndromes Clinical Practice Guidelines. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 5:2, 69-102
CrossRef598
Jingtian Li, Lexin Wang. (2006) B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart and Vessels 21:3, 137-140
CrossRef599
Sean P. Collins, Christopher J. Lindsell, W. Frank Peacock, Virginia D. Hedger, Jeff Askew, Daniel C. Eckert, Alan B. Storrow. (2006) The Combined Utility of an S3 Heart Sound and B-Type Natriuretic Peptide Levels in Emergency Department Patients With Dyspnea. Journal of Cardiac Failure 12:4, 286-292
CrossRef600
Costas Tsioufis, Pavlos Stougiannos, Efstathios Taxiarchou, Ioannis Skiadas, Dimitrios Chatzis, Costas Thomopoulos, Spyros Lalos, Christodoulos Stefanadis, Ioannis Kallikazaros. (2006) The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension. Journal of Hypertension 24:5, 965-972
CrossRef601
Marc A. Silver, W. Franklin Peacock, Deborah B. Diercks. (2006) Optimizing Treatment and Outcomes in Acute Heart Failure: Beyond Initial Triage. Congestive Heart Failure 12:3, 137-145
CrossRef602
Salpy V. Pamboukian, Melissa C. Smallfield, Robert C. Bourge. (2006) Implantable hemodynamic monitoring devices in heart failure. Current Cardiology Reports 8:3, 187-190
CrossRef603
Melvin R. Pratter, Thaddeus Bartter, Stephen M. Akers, Jonathan Kass. (2006) A Clinical Approach to Chronic Dyspnea. Clinical Pulmonary Medicine 13:3, 149-163
CrossRef604
Lori B. Daniels, Vikas Bhalla, Paul Clopton, Judd E. Hollander, David Guss, Peter A. McCullough, Richard Nowak, Gary Green, Mitchell Saltzberg, Stefanie R. Ellison, Meenakshi Awasthi Bhalla, Robert Jesse, Alan Maisel. (2006) B-Type Natriuretic Peptide (BNP) Levels and Ethnic Disparities in Perceived Severity of Heart Failure. Journal of Cardiac Failure 12:4, 281-285
CrossRef605
Ognjen Gajic, Michael A. Gropper, Rolf D. Hubmayr. (2006) Pulmonary edema after transfusion: How to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Critical Care Medicine 34:Suppl, S109-S113
CrossRef606
Tongwen Sun, Lexin Wang, Yanzhou Zhang. (2006) Prognostic Value of B-type Natriuretic Peptide in Patients with Acute Coronary Syndromes. Archives of Medical Research 37:4, 502-505
CrossRef607
W. Frank Peacock, Richard L. Summers, Jody Vogel, Charles E. Emerman. (2006) Impact of Impedance Cardiography on Diagnosis and Therapy of Emergent Dyspnea: The ED-IMPACT Trial. Academic Emergency Medicine 13:4, 365-371
CrossRef608
A.-M. Sinha, O.-A. Breithardt. (2006) Sind neurohumorale Blutparameter wegweisend für die Effizienz der kardialen Resynchronisationstherapie?. Herzschrittmachertherapie & Elektrophysiologie 17:S1, i51-i55
CrossRef609
Julien Charpentier, Alain Cariou. (2006) Biological evaluation of perioperative cardiac stress: A two-way approach*. Critical Care Medicine 34:4, 1259-1260
CrossRef610
T.S. Mir, C. Haun, C. Lilje, S. Läer, J. Weil. (2006) Utility of N-Terminal Brain Natriuretic Peptide Plasma Concentrations in Comparison to Lactate and Troponin in Children with Congenital Heart Disease Following Open-Heart Surgery. Pediatric Cardiology 27:2, 209-216
CrossRef611
Robert Chircop, George A Jelinek. (2006) B-type natriuretic peptide in the diagnosis of heart failure in the emergency department. Emergency Medicine Australasia 18:2, 170-179
CrossRef612
C. Angermann, C. Hoyer, G. Ertl. (2006) Abklärung von Luftnot. Clinical Research in Cardiology 95:S4, 57-71
CrossRef613
C. Mueller, K. Laule-Kilian, A. Christ, A. P. Perruchoud. (2006) The use of B-type natriuretic peptide in the management of patients with diabetes and acute dyspnoea. Diabetologia 49:4, 629-636
CrossRef614
Meera Srivastava, Ofer Eidelman, Catherine Jozwik, Cloud Paweletz, Wei Huang, Pamela L. Zeitlin, Harvey B. Pollard. (2006) Serum proteomic signature for cystic fibrosis using an antibody microarray platform. Molecular Genetics and Metabolism 87:4, 303-310
CrossRef615
David W. Markham, G. Michael Felker. 2006. Vasodilators in the Management of Heart Failure. , 99-112.
CrossRef616
M. SOHNE, M. TEN WOLDE, F. BOOMSMA, J. B. REITSMA, J. D. DOUKETIS, H. R. BULLER. (2006) Brain natriuretic peptide in hemodynamically stable acute pulmonary embolism. Journal of Thrombosis and Haemostasis 4:3, 552-556
CrossRef617
Stuart D. Russell. 2006. Acute Heart Failure. , 203-226.
CrossRef618
Susan Isakson, Alan Maisel. (2006) Update on Natriuretic Peptides. Point of Care: The Journal of Near-Patient Testing & Technology 5:1, 6-12
CrossRef619
L. Bal, S. Thierry, E. Brocas, A. Van de Louw, J. Pottecher, S. Hours, M. H. Moreau, D. Perrin Gachadoat, A. Tenaillon. (2006) B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress. Acta Anaesthesiologica Scandinavica 50:3, 340-347
CrossRef620
Srinivas Iyengar, Mallikarjun R. Thatipelli, Deborah S. Armentano, Rose M. Chumita, Garrie J. Haas. (2006) Brain Natriuretic Peptide Levels and Left Ventricular Functional Recovery in a Chronic Heart Failure Population. Congestive Heart Failure 12:2, 80-84
CrossRef621
Aaron L. Baggish, James L. Januzzi. (2006) Cost Effectiveness of Natriuretic Peptide Measurement in the Primary Care Setting: Have We Found the Gatekeeper for the Evaluation of Dyspneic Outpatients?. Congestive Heart Failure 12:2, 108-109
CrossRef622
Kiran K. Khush, Ivor L. Gerber, Barry McKeown, Gregory Marcus, Joshua Vessey, Elyse Foster, Kanu Chatterjee, Andrew D. Michaels. (2006) Obese Patients Have Lower B-Type and Atrial Natriuretic Peptide Levels Compared With Nonobese. Congestive Heart Failure 12:2, 85-90
CrossRef623
Paul O. Collinson. (2006) The Cost Effectiveness of B-Type Natriuretic Peptide Measurement in the Primary Care Setting?A UK Perspective. Congestive Heart Failure 12:2, 103-107
CrossRef624
Gurbir S. Bhatia, Michael D. Sosin, Jeetesh V. Patel, Karl A. Grindulis, Fazal H. Khattak, Elizabeth A. Hughes, Gregory Y.H. Lip, Russell C. Davis. (2006) Left Ventricular Systolic Dysfunction in Rheumatoid Disease. Journal of the American College of Cardiology 47:6, 1169-1174
CrossRef625
T.S. Mir, M. Flato, J. Falkenberg, M. Haddad, R. Budden, J. Weil, S. Albers, S. Laer. (2006) Plasma Concentrations of N-Terminal Brain Natriuretic Peptide in Healthy Children, Adolescents, and Young Adults: Effect of Age and Gender. Pediatric Cardiology 27:1, 73-77
CrossRef626
Anju Nohria, Michael M. Givertz. (2006) B-Type Natriuretic Peptide and the Stressed Heart
CrossRef627
Takayoshi Tsutamoto, Atsuyuki Wada, Hiroshi Sakai, Chitose Ishikawa, Toshinari Tanaka, Masaru Hayashi, Masanori Fujii, Takashi Yamamoto, Tomohiro Dohke, Masato Ohnishi, Hiroyuki Takashima, Masahiko Kinoshita, Minoru Horie. (2006) Relationship Between Renal Function and Plasma Brain Natriuretic Peptide in Patients With Heart Failure. Journal of the American College of Cardiology 47:3, 582-586
CrossRef628
Heart Failure Society of America. (2006) Section 12: Evaluation and Management of Patients With Acute Decompensated Heart Failure. Journal of Cardiac Failure 12:1, e86-e103
CrossRef629
Yoshitaka Iwanaga, Isao Nishi, Shinichi Furuichi, Teruo Noguchi, Kazuhiro Sase, Yasuki Kihara, Yoichi Goto, Hiroshi Nonogi. (2006) B-Type Natriuretic Peptide Strongly Reflects Diastolic Wall Stress in Patients With Chronic Heart Failure. Journal of the American College of Cardiology 47:4, 742-748
CrossRef630
Heart Failure Society of America. (2006) Section 11: Evaluation and Management of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction. Journal of Cardiac Failure 12:1, e80-e85
CrossRef631
Annette H. Bruggink, Nicolaas de Jonge, Matthijs F.M. van Oosterhout, Dick F. Van Wichen, Erica de Koning, Jaap R. Lahpor, Hans Kemperman, Frits H.J. Gmelig-Meyling, Roel A. de Weger. (2006) Brain Natriuretic Peptide is Produced Both by Cardiomyocytes and Cells Infiltrating the Heart in Patients with Severe Heart Failure Supported by a Left Ventricular Assist Device. The Journal of Heart and Lung Transplantation 25:2, 174-180
CrossRef632
Paul A. Heidenreich, John A. Spertus, Philip G. Jones, William S. Weintraub, John S. Rumsfeld, Saif S. Rathore, Eric D. Peterson, Frederick A. Masoudi, Harlan M. Krumholz, Edward P. Havranek, Mark W. Conard, Randall E. Williams. (2006) Health Status Identifies Heart Failure Outpatients at Risk for Hospitalization or Death. Journal of the American College of Cardiology 47:4, 752-756
CrossRef633
Cedric Moro, Michel Berlan. (2006) Cardiovascular and metabolic effects of natriuretic peptides. Fundamental and Clinical Pharmacology 20:1, 41-49
CrossRef634
Heart Failure Society of America. (2006) Section 4: Evaluation of Patients for Ventricular Dysfunction and Heart Failure. Journal of Cardiac Failure 12:1, e16-e25
CrossRef635
Renate Schnabel, Edith Lubos, Hans J. Rupprecht, Christine Espinola-Klein, Christoph Bickel, Karl J. Lackner, François Cambien, Laurence Tiret, Thomas Münzel, Stefan Blankenberg. (2006) B-Type Natriuretic Peptide and the Risk of Cardiovascular Events and Death in Patients With Stable Angina. Journal of the American College of Cardiology 47:3, 552-558
CrossRef636
Roy S Gardner, Theresa A McDonagh. (2006) The prognostic value of anemia, right-heart catheterization and neurohormones in chronic heart failure. Expert Review of Cardiovascular Therapy 4:1, 51-57
CrossRef637
Saif Anwaruddin, Donald M. Lloyd-Jones, Aaron Baggish, Annabel Chen, Daniel Krauser, Roderick Tung, Claudia Chae, James L. Januzzi. (2006) Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement. Journal of the American College of Cardiology 47:1, 91-97
CrossRef638
Tamara B. Horwich, Michele A. Hamilton, Gregg C. Fonarow. (2006) B-Type Natriuretic Peptide Levels in Obese Patients With Advanced Heart Failure. Journal of the American College of Cardiology 47:1, 85-90
CrossRef639
Yu-Sheng Lin, Pao-Hsien Chu, Ming-Chung Kuo, Shih-Ming Jung, Kun-Eng Lim, Chi-Tai Kuo, Lee-Yung Shih. (2006) Use of a B-Type Natriuretic Peptide in Evaluating the Treatment Response of a Relapsed Lymphoma with Cardiac Involvement. International Journal of Hematology 83:1, 44-46
CrossRef640
Bin Hong, Kyung A. Kang. (2006) Biocompatible, nanogold-particle fluorescence enhancer for fluorophore mediated, optical immunosensor. Biosensors and Bioelectronics 21:7, 1333-1338
CrossRef641
Liang Tang, Yongjie Ren, Bin Hong, Kyung A. Kang. (2006) Fluorophore-mediated, fiber-optic, multi-analyte, immunosensing system for rapid diagnosis and prognosis of cardiovascular diseases. Journal of Biomedical Optics 11:2, 021011
CrossRef642
Alan Maisel. (2006) The Coming of Age of Natriuretic Peptides. Journal of the American College of Cardiology 47:1, 61-64
CrossRef643
J. Malcolm O. Arnold, Peter Liu, Catherine Demers, Paul Dorian, Nadia Giannetti, Haissam Haddad, George A. Heckman, Jonathan G. Howlett, Andrew Ignaszewski, David E. Johnstone, Philip Jong, Robert S. McKelvie, Gordon W. Moe, John D. Parker, Vivek Rao, Heather J. Ross, Errol J. Sequeira, Anna M. Svendsen, Koon Teo, Ross T. Tsuyuki, Michel White. (2006) Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Canadian Journal of Cardiology 22:1, 23-45
CrossRef644
Angelika Hammerer-Lercher, Bernd Puschendorf, Johannes Mair. (2006) B-type natriuretic peptides as powerful markers in cardiac diseases: Analytical and clinical aspects. Jugoslovenska medicinska biohemija 25:4, 287-308
CrossRef645
Jens Peter Goetze, Jens F. Rehfeld, Jørn Carlsen, Regitze Videbaek, Claus B. Andersen, Soeren Boesgaard, Lennart Friis-Hansen. (2006) Apelin: A new plasma marker of cardiopulmonary disease. Regulatory Peptides 133:1-3, 134-138
CrossRef646
Robert Ackerman, Rachel L. Waldron. (2006) Difficulty Breathing: Agreement of Paramedic andEmergency Physician Diagnoses. Prehospital Emergency Care 10:1, 77-80
CrossRef647
Koichi Chida, Hiroki Otani, Masahiro Kohzuki, Haruo Saito, Yutaka Kagaya, Yoshihiro Takai, Shoki Takahashi, Shogo Yamada, Masayuki Zuguchi. (2006) The Relationship between Plasma BNP Level and the Myocardial Phosphocreatine/Adenosine Triphosphate Ratio Determined by Phosphorus-31 Magnetic Resonance Spectroscopy in Patients with Dilated Cardiomyopathy. Cardiology 106:3, 132-136
CrossRef648
Mark Richards, M. Gary Nicholls, Eric A. Espiner, John G. Lainchbury, Richard W. Troughton, John Elliott, Christopher M. Frampton, Ian G. Crozier, Timothy G. Yandle, Robert Doughty, Stephen MacMahon, Norman Sharpe. (2006) Comparison of B-Type Natriuretic Peptides for Assessment of Cardiac Function and Prognosis in Stable Ischemic Heart Disease. Journal of the American College of Cardiology 47:1, 52-60
CrossRef649
J.K. Jensen, H. Mickley, S. Bak, L. Korsholm, S.R. Kristensen. (2006) Serial Measurements of N-Terminal pro-Brain Natriuretic Peptide after Acute Ischemic Stroke. Cerebrovascular Diseases 22:5-6, 439-444
CrossRef650
Alan S Maisel, Vikas Bhalla, Eugene Braunwald. (2006) Cardiac biomarkers: a contemporary status report. Nature Clinical Practice Cardiovascular Medicine 3:1, 24-34
CrossRef651
Ostidimma Ugwu, George Chrysochoou, Manjule Ashok, Jennifer Waxler, Daniel Shine. (2006) Assigning Patients With Heart Failure to Observation Status: B-Type Natriuretic Peptide, Ejection Fraction, or Physician Judgment. Congestive Heart Failure 12:1, 26-31
CrossRef652
Angelika Hammerer-Lercher, Bernd Puschendorf, Johannes Mair. (2006) B-type natriuretic peptides as powerful markers in cardiac diseases: Analytical and clinical aspects. Jugoslovenska medicinska biohemija 25:4, 287-308
CrossRef653
Ware, Lorraine B., Matthay, Michael A., . (2005) Acute Pulmonary Edema. New England Journal of Medicine 353:26, 2788-2796
Full Text654
S Beer, S Golay, D Bardy, F Feihl, RC Gaillard, C Bachmann, B Waeber, J Ruiz. (2005) Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications. Diabetes & Metabolism 31:6, 567-573
CrossRef655
D.-I. Shin, K. Jaekel, Ph. Schley, A. Sause, M. Müller, R. Fueth, T. Scheffold, H. Guelker, M. Horlitz. (2005) Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Zeitschrift für Kardiologie 94:12, 795-800
CrossRef656
Christopher J. Hogan, Michael L. Hess, Kevin R. Ward, Chris Gennings. (2005) The Utility of Microvascular Perfusion Assessment in Heart Failure: A Pilot Study. Journal of Cardiac Failure 11:9, 713-719
CrossRef657
Frans Rutten, Maarten-Jan Cramer, Diederick Grobbee, Alfred Sachs, Johannes Kirkels, Jan-Willem Lammers, Arno Hoes. (2005) Niet-herkend hartfalen bij oudere patiënten met chronisch obstructieve longziekte. Huisarts en Wetenschap 48:12, 122-128
CrossRef658
Nandan S. Anavekar, Nagesh S. Anavekar. (2005) Clinical modifiers for heart failure following myocardial infarction. Current Heart Failure Reports 2:4, 165-173
CrossRef659
Hao-Min Cheng, Shao-Yuan Chuang, Pai-Feng Hsu, Pesus Chou, Chen-Huan Chen. (2005) Systolic time intervals revisited: correlations with N-terminal pro-brain natriuretic peptide in a community population. Heart and Vessels 20:6, 256-263
CrossRef660
Amal Mattu, Joseph P. Martinez, Brian S. Kelly. (2005) Modern Management of Cardiogenic Pulmonary Edema. Emergency Medicine Clinics of North America 23:4, 1105-1125
CrossRef661
Miles D. Witham, Neil D. Gillespie, Stuart D. Hutcheon, Allan D. Struthers, Marion E. T. McMurdo. (2005) B-Type Natriuretic Peptide Is Associated with Mortality in Older Functionally Impaired Patients. Journal of the American Geriatrics Society 53:11, 1991-1995
CrossRef662
Matthew G. Nessmith, Hidekatsu Fukuta, Steffen Brucks, William C. Little. (2005) Usefulness of an Elevated B-Type Natriuretic Peptide in Predicting Survival in Patients With Aortic Stenosis Treated Without Surgery. The American Journal of Cardiology 96:10, 1445-1448
CrossRef663
Jennifer M. Aviles, Ronnier J. Aviles. (2005) Advances in Cardiac Biomarkers. Emergency Medicine Clinics of North America 23:4, 959-975
CrossRef664
Geoffrey S. Ginsburg, Mark P. Donahue, L. Kristin Newby. (2005) Prospects for Personalized Cardiovascular Medicine. Journal of the American College of Cardiology 46:9, 1615-1627
CrossRef665
James McCord, Richard M. Nowak, Gordon Jacobsen, John A. Sallach, Alan H.B. Wu, Alberto Perez, Torbjørn Omland, Cathrine Wold Knudsen, Arne Westheim, Philippe Duc, Philippe G. Steg, Judd E. Hollander, Howard C. Herrmann, Alan B. Storrow, William T. Abraham, Sumant Lamba, Peter A. McCullough, Alan Maisel. (2005) B-Type Natriuretic Peptide Levels in Patients in the Emergency Department With Possible Heart Failure and Previous Stable Angina Pectoris and/or Healed Myocardial Infarction. The American Journal of Cardiology 96:10, 1370-1373
CrossRef666
Sanjeev Sanjeev, Michael Pettersen, Jorge Lua, Ronald Thomas, Seetha Shankaran, Thomas L'Ecuyer. (2005) Role of Plasma B-Type Natriuretic Peptide in Screening for Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates. Journal of Perinatology 25:11, 709-713
CrossRef667
Alan H.B. Wu, Torbjørn Omland, Cathrine Wold Knudsen, James McCord, Richard M. Nowak, Judd E. Hollander, Philippe Duc, Alan B. Storrow, William T. Abraham, Paul Clopton, Alan S. Maisel, Peter A. McCullough for the Breathing Not Pr. (2005) Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: A substudy from the Breathing Not Properly (BNP) Multinational Study. American Journal of Hematology 80:3, 174-180
CrossRef668
M.G. Crespo Leiro, R. Marzoa Rivas, M.J. Paniagua Martín, A. Castro Beiras. (2005) Protocolo diagnóstico del paciente con insuficiencia cardíaca. Medicine - Programa de Formación Médica Continuada Acreditado 9:42, 2821-2823
CrossRef669
C. Mueller, K. Laule-Kilian, A. Scholer, A. P. Perruchoud. (2005) B-type natriuretic peptide for risk stratification in community-acquired pneumonia. Journal of Internal Medicine 258:4, 391-393
CrossRef670
Joshua C. Denny, Jeffrey D. Smithers, Brian Armstrong, Anderson Spickard. (2005) "Where Do We Teach What?". Finding Broad Concepts In The Medical School Curriculum. Journal of General Internal Medicine 20:10, 943-946
CrossRef671
Anthony S McLean, Stephen J Huang. (2005) The applications of B-type natriuretic peptide measurement in the intensive care unit. Current Opinion in Critical Care 11:5, 406-412
CrossRef672
Domingo A. Pascual Figal, María C. Cerdán Sánchez, José A. Noguera Velasco, Teresa Casas Pina, Luis Muñoz Gimeno, Rosa García Rodríguez, Juan A. Ruipérez Abizanda, Pedro Martínez Hernández, Mariano Valdés Chávarri. (2005) Utilidad del NTproBNP en el manejo urgente del paciente con disnea severa y diagnóstico dudoso de insuficiencia cardíaca. Revista Española de Cardiología 58:10, 1155-1161
CrossRef673
Phua Jason, Lim Tow Keang, Lee Kang Hoe. (2005) B-type natriuretic peptide: Issues for the intensivist and pulmonologist. Critical Care Medicine 33:9, 2094-2013
CrossRef674
Reshma Parab, Abu Vasudevan, Jeffrey Brensilver, Bernard Gitler. (2005) Utility of Brain Natriuritic Peptide as a Diagnostic Tool for Congestive Heart Failure in the Elderly. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 4:3, 140-144
CrossRef675
John M. Costello, Carl L. Backer, Paul A. Checchia, Constantine Mavroudis, Ralf G. Seipelt, Denise M. Goodman. (2005) Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children. The Journal of Thoracic and Cardiovascular Surgery 130:3, 822-829
CrossRef676
Cathrine Wold Knudsen, Torbjørn Omland, Paul Clopton, Arne Westheim, Alan H.B. Wu, Philippe Duc, James McCord, Richard M. Nowak, Judd E. Hollander, Alan B. Storrow, William T. Abraham, Peter A. McCullough, Alan Maisel. (2005) Impact of Atrial Fibrillation on the Diagnostic Performance of B-Type Natriuretic Peptide Concentration in Dyspneic Patients. Journal of the American College of Cardiology 46:5, 838-844
CrossRef677
(2005) Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca crónica. Versión resumida (actualización 2005). Revista Española de Cardiología 58:9, 1062-1092
CrossRef678
Arthur P. DeMarzo, James E. Calvin, Russell F. Kelly, Thomas D. Stamos. (2005) Using Impedance Cardiography to Assess Left Ventricular Systolic Function via Postural Change in Patients With Heart Failure. Progress in Cardiovascular Nursing 20:4, 163-167
CrossRef679
Jonathan G Howlett. (2005) Acutely decompensated congestive heart failure: new therapies for an old problem. Expert Review of Cardiovascular Therapy 3:5, 925-936
CrossRef680
U. Wagner, C. Vogelmeier. (2005) Akute Dyspnoe. Der Internist 46:9, 965-973
CrossRef681
Stefan Suttner, Katrin Lang, Swen N. Piper, Harald Schultz, Kerstin D. R??hm, Joachim Boldt. (2005) Continuous Intra- and Postoperative Thoracic Epidural Analgesia Attenuates Brain Natriuretic Peptide Release After Major Abdominal Surgery. Anesthesia & Analgesia 101:3, 896-903
CrossRef682
Thomas S. Mir, Jan Falkenberg, Bernd Friedrich, Urda Gottschalk, Throng Phi Lê, Stephanie Laer, Jochen Weil. (2005) Levels of brain natriuretic peptide in children with right ventricular overload due to congenital cardiac disease. Cardiology in the Young 15:4, 396-401
CrossRef683
Y. Juillière. (2005) Stratification du risque dans l'insuffisance cardiaque chronique. Annales de Cardiologie et d'Angéiologie 54:4, 172-178
CrossRef684
Jamie L. Resnik, Christina Hong, Robert Resnik, Radmila Kazanegra, Jennifer Beede, Vikas Bhalla, Alan Maisel. (2005) Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. American Journal of Obstetrics and Gynecology 193:2, 450-454
CrossRef685
John L. Jefferies, Anthony C. Chang. (2005) The neurohormonal axis and biochemical markers of heart failure. Cardiology in the Young 15:4, 333-344
CrossRef686
T. Wei, C. Zeng, L. Chen, Q. Chen, R. Zhao, G. Lu, C. Lu, L. Wang. (2005) Systolic and diastolic heart failure are associated with different plasma levels of B-type natriuretic peptide. International Journal of Clinical Practice 59:8, 891-894
CrossRef687
Alphons J.H.M. Houben, Kim Zander, Peter W. Leeuw. (2005) Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundamental and Clinical Pharmacology 19:4, 411-419
CrossRef688
P. M. McKie, J. C. Burnett. (2005) B-Type Natriuretic Peptide as a Biomarker Beyond Heart Failure: Speculations and Opportunities. Mayo Clinic Proceedings 80:8, 1029-1036
CrossRef689
James K McCord. (2005) Cardiac markers in acute coronary syndrome. Future Cardiology 1:4, 489-494
CrossRef690
Hiroaki Matsuura, Yukari Sato, Osamu Niwa, Fumio Mizutani. (2005) Surface electrochemical enzyme immunoassay for the highly sensitive measurement of B-type natriureric peptide. Sensors and Actuators B: Chemical 108:1-2, 603-607
CrossRef691
Lan Zhou, Donald Giacherio, Laura Cooling, Robertson D. Davenport. (2005) Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 45:7, 1056-1063
CrossRef692
Jos?? Manuel Porcel. (2005) The use of probrain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions resulting from heart failure. Current Opinion in Pulmonary Medicine 11:4, 329-333
CrossRef693
Ricarda M. White. (2005) The Role of Brain Natriuretic Peptide in Systolic Heart Failure. Dimensions of Critical Care Nursing 24:4, 171-174
CrossRef694
C. MUELLER, K. LAULE-KILIAN, B. FRANA, D. RODRIGUEZ, J. RUDEZ, A. SCHOLER, P. BUSER, M. PFISTERER, A. P. PERRUCHOUD. (2005) The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea. Journal of Internal Medicine 258:1, 77-85
CrossRef695
Christopher R. deFilippi, Jeffrey C. Fink, Caitlin M. Nass, Hegang Chen, Robert Christenson. (2005) N-Terminal Pro-B-Type Natriuretic Peptide for Predicting Coronary Disease and Left Ventricular Hypertrophy in Asymptomatic CKD Not Requiring Dialysis. American Journal of Kidney Diseases 46:1, 35-44
CrossRef696
Ankie Amos, L. Kristin Newby. (2005) Using biomarkers to assess risk and consider treatment strategies in non-ST-segment elevation acute coronary syndromes. Current Cardiology Reports 7:4, 263-269
CrossRef697
Stephen A Morse, Paco E Bravo, Malika C Morse, Efrain Reisin. (2005) The heart in obesity-hypertension. Expert Review of Cardiovascular Therapy 3:4, 647-658
CrossRef698
Chester Andrzejewski, Mark A. Popovsky. (2005) Transfusion-associated adverse pulmonary sequelae: widening our perspective. Transfusion 45:7, 1048-1050
CrossRef699
Walid Hassan, Fayez ElShaer, Mohamed Eid Fawzy, Sumaya Al Helaly, Hesham Hegazy, Nathem Akhras. (2005) Cardiac Unilateral Pulmonary Edema: Is It Really a Rare Presentation?. Congestive Heart Failure 11:4, 220-223
CrossRef700
T. Bocek, N. G. Morgenthaler, D. Staub, C. Nusbaumer, A. Christ, M. J. Zellweger, J. Mueller-Brand, B. Mueller, A. P. Perruchoud, C. Mueller. (2005) Use of pro-atrial natriuretic peptide in the detection of myocardial ischaemia. European Journal of Clinical Investigation 35:7, 450-456
CrossRef701
Michelle O'Donoghue, Annabel Chen, Aaron L. Baggish, Saif Anwaruddin, Daniel G. Krauser, Roderick Tung, James L. Januzzi. (2005) The Effects of Ejection Fraction on N-Terminal ProBNP and BNP Levels in Patients With Acute CHF: Analysis From the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. Journal of Cardiac Failure 11:5, S9-S14
CrossRef702
Thomas E. Auble, Margaret Hsieh, William Gardner, Gregory F. Cooper, Roslyn A. Stone, Julie B. McCausland, Donald M. Yealy. (2005) A Prediction Rule to Identify Low-risk Patients with Heart Failure. Academic Emergency Medicine 12:6, 514-521
CrossRef703
Nicolas Lellouche, Romain Berthier, Armand Mekontso-Dessap, François Braconnier, Jean-Luc Monin, Anne-Marie Duval, Jean Luc Dubois-Randé, Pascal Guéret, Jérôme Garot. (2005) Usefulness of Plasma B-Type Natriuretic Peptide in Predicting Recurrence of Atrial Fibrillation One Year After External Cardioversion. The American Journal of Cardiology 95:11, 1380-1382
CrossRef704
Cheuk-Man Yu, Jeffrey Wing-Hong Fung, Qing Zhang, Chi-Kin Chan, Iris Chan, Yat-Sun Chan, Shun-Ling Kong, John E. Sanderson, Christopher Wai-Kei Lam. (2005) Improvement of Serum NT-ProBNP Predicts Improvement in Cardiac Function and Favorable Prognosis After Cardiac Resynchronization Therapy for Heart Failure. Journal of Cardiac Failure 11:5, S42-S46
CrossRef705
Fabian Knebel, Ingolf Schimke, Kathleen Pliet, Sebastian Schattke, Salim Martin, Adrian C. Borges, Gert Baumann. (2005) NT-ProBNP in Acute Heart Failure: Correlation With Invasively Measured Hemodynamic Parameters During Recompensation. Journal of Cardiac Failure 11:5, S38-S41
CrossRef706
Cathrine W. Knudsen, Paul Clopton, Arne Westheim, Tor Ole Klemsdal, Alan H.B. Wu, Philippe Duc, James McCord, Richard M. Nowak, Judd E. Hollander, Alan B. Storrow, William T. Abraham, Peter A. McCullough, Alan S. Maisel, Torbjørn Omland. (2005) Predictors of Elevated B-Type Natriuretic Peptide Concentrations in Dyspneic Patients Without Heart Failure: An Analysis From the Breathing Not Properly Multinational Study. Annals of Emergency Medicine 45:6, 573-580
CrossRef707
Eric Schwam. (2005) Reply. Academic Emergency Medicine 12:6, 573-574
CrossRef708
Kiang-Teck J. Yeo, Kimberly E. Dumont, Timothy Brough. (2005) Elecsys NT-ProBNP and BNP Assays: Are There Analytically and Clinically Relevant Differences?. Journal of Cardiac Failure 11:5, S84-S88
CrossRef709
A. Mark Richards, Richard Troughton, John Lainchbury, Rob Doughty, Sue Wright. (2005) Guiding and Monitoring of Heart Failure Therapy With NT-ProBNP: Concepts and Clinical Studies. Journal of Cardiac Failure 11:5, S34-S37
CrossRef710
Alan S. Maisel, Julie Doyle. (2005) B-Type Natriuretic Peptide in the Emergency Department: A Valuable Diagnostic Aid. Academic Emergency Medicine 12:6, 572-573
CrossRef711
Douglas S Lee, Ramachandran S Vasan. (2005) Novel markers for heart failure diagnosis and prognosis. Current Opinion in Cardiology 20:3, 201-210
CrossRef712
John JV McMurray, Marc A Pfeffer. (2005) Heart failure. The Lancet 365:9474, 1877-1889
CrossRef713
Antoine Roch, J??r??me Allardet-Servent, Pierre Michelet, Christiane Oddoze, Jean-Marie Forel, Karine Barrau, Anderson Loundou, Gilles Perrin, Jean-Pierre Auffray, Henri Portugal, Laurent Papazian. (2005) NH2 terminal pro???brain natriuretic peptide plasma level as an early marker of prognosis and cardiac dysfunction in septic shock patients*. Critical Care Medicine 33:5, 1001-1007
CrossRef714
M. Pfeifer. (2005) Dyspnoe. Der Pneumologe 2:3, 177-187
CrossRef715
Paul R. Forfia, Stanley P. Watkins, J. Eduardo Rame, Kerry J. Stewart, Edward P. Shapiro. (2005) Relationship Between B-Type Natriuretic Peptides and Pulmonary Capillary Wedge Pressure in the Intensive Care Unit. Journal of the American College of Cardiology 45:10, 1667-1671
CrossRef716
Michelle O’Donoghue, James L Januzzi. (2005) N-terminal proBNP: a novel biomarker for the diagnosis, risk stratification and management of congestive heart failure. Expert Review of Cardiovascular Therapy 3:3, 487-496
CrossRef717
Albertus Beishuizen, Koen J. Hartemink, István Vermes, AB Johan Groeneveld. (2005) Circulating cardiovascular markers and mediators in acute illness: an update. Clinica Chimica Acta 354:1-2, 21-34
CrossRef718
Patrick Ray, Martine Arthaud, Sophie Birolleau, Richard Isnard, Yannick Lefort, Jacques Boddaert, Bruno Riou, . (2005) Comparison of Brain Natriuretic Peptide and Probrain Natriuretic Peptide in the Diagnosis of Cardiogenic Pulmonary Edema in Patients Aged 65 and Older. Journal of the American Geriatrics Society 53:4, 643-648
CrossRef719
(2005) Guías de Práctica Clínica sobre el diagnóstico y tratamiento de la insuficiencia cardíaca aguda. Versión resumida. Revista Española de Cardiología 58:4, 389-429
CrossRef720
Hisham Dokainish, William A. Zoghbi, Nasser M. Lakkis, Eunice Ambriz, Rajnikant Patel, Miguel A. Quinones, Sherif F. Nagueh. (2005) Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. Journal of the American College of Cardiology 45:8, 1223-1226
CrossRef721
Sungeun Cho, Gilja Shin, Kisook Hong. (2005) Evaluation of the B-Type Natriuretic Peptide Level in Identifying Patients with Cardiovascular Diseases in South Korea. Point of Care: The Journal of Near-Patient Testing & Technology 4:1, 15-19
CrossRef722
Qihang Zhang, Jacob Moalem, James Tse, Peter M. Scholz, Harvey R. Weiss. (2005) Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling. European Journal of Pharmacology 510:3, 209-215
CrossRef723
Frank H. Wians, Betty Anne Wilson, Andrew Grant, Jonathan Bailey, Ionela Gheorghiu, Carla Conarpe, Henry Mindicino, Kiran Thakur, Alexander Belenky, Normand Despres, Barry Bluestein. (2005) Evaluation of the analytical performance characteristics of the Bayer ACS:180® B-type natriuretic peptide (BNP) assay. Clinica Chimica Acta 353:1-2, 147-155
CrossRef724
Joanne Simpson, Angel Lopez-Candales. (2005) Elevated Brain Natriuretic Peptide and Troponin I in a Woman with Generalized Weakness and Chest Pain. Echocardiography 22:3, 267-271
CrossRef725
Alan B. Storrow, Sean P. Collins, Michael S. Lyons, Lynne E. Wagoner, W. Brian Gibler, Christopher J. Lindsell. (2005) Emergency Department Observation of Heart Failure: Preliminary Analysis of Safety and Cost. Congestive Heart Failure 11:2, 68-72
CrossRef726
Eyal Herzog, Cathleen Varley, Marrick Kukin. (2005) Pathway for the Management of Acute Heart Failure. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 4:1, 37-42
CrossRef727
Mandeep R. Mehra, Alan Maisel. (2005) B-Type Natriuretic Peptide in Heart Failure. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 4:1, 10-20
CrossRef728
N. H. Andersen, S. H. Poulsen, S. T. Knudsen, L. Heickendorff, C. E. Mogensen. (2005) NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus. Diabetic Medicine 22:2, 188-195
CrossRef729
Bertil Lindahl, Johan Lindbäck, Tomas Jernberg, Nina Johnston, Mats Stridsberg, Per Venge, Lars Wallentin. (2005) Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non–ST-segment elevation acute coronary syndromes. Journal of the American College of Cardiology 45:4, 533-541
CrossRef730
Roger M. Mills. (2005) Warning! Context-sensitive data* *Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 45:4, 542-543
CrossRef731
Teresa M. Seccia, Gian Paolo Rossi. (2005) Clinical Use and Pathogenetic Basis of Laboratory Tests for the Evaluation of Primary Arterial Hypertension. Critical Reviews in Clinical Laboratory Sciences 42:5-6, 393-452
CrossRef732
Alan Maisel, Mandeep R. Mehra. (2005) Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure. Clinical Cornerstone 7, S7-S17
CrossRef733
Yasmin Alibay, Alain Beauchet, Rami El Mahmoud, Caroline Schmitt, Dominique Brun-Ney, Marie-Odile Benoit, Olivier Dubourg, Catherine Boileau, Guillaume Jondeau, Hervé Puy. (2005) Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea. Biomedicine & Pharmacotherapy 59:1-2, 20-24
CrossRef734
Patrick T. Ellinor, Adrian F. Low, Kristen K. Patton, Marisa A. Shea, Calum A. MacRae. (2005) Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. Journal of the American College of Cardiology 45:1, 82-86
CrossRef735
Christian Mueller, Kirsten Laule-Kilian, Andre Scholer, Charly Nusbaumer, Thomas Zeller, Daniel Staub, Andre P. Perruchoud. (2005) B-type natriuretic peptide for acute dyspnea in patients with kidney disease: Insights from a randomized comparison. Kidney International 67:1, 278-284
CrossRef736
Cara A Wasywich, Gillian A Whalley, Robert N Doughty. (2005) Brain natriuretic peptide in the contemporary management of congestive heart failure. Expert Review of Cardiovascular Therapy 3:1, 71-84
CrossRef737
L. Tarnow, P. Hildebrandt, B. V. Hansen, K. Borch-Johnsen, H.-H. Parving. (2005) Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathy. Diabetologia 48:1, 149-155
CrossRef738
Hisham Dokainish, Manu Pillai, Sabina A. Murphy, Peter M. DiBattiste, Marc J. Schweiger, Amir Lotfi, David A. Morrow, Christopher P. Cannon, Eugene Braunwald, Nasser Lakkis. (2005) Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease. Journal of the American College of Cardiology 45:1, 19-24
CrossRef739
John C. Burnett. (2005) Introduction. Clinical Cornerstone 7, S5-S6
CrossRef740
Jung Hyun Chang. (2005) Dyspnea. Journal of the Korean Medical Association 48:3, 254
CrossRef741
Radomir Matunovic, Aleksandar Stojanovic, Milorad Damjanovic. (2005) Natriuretski peptidi u kliničkoj praksi. Vojnosanitetski pregled 62:2, 147-153
CrossRef742
Patrick Ray, Martine Arthaud, Yannick Lefort, Sophie Birolleau, Catherine Beigelman, Bruno Riou, . (2004) Usefulness of B-type natriuretic peptide in elderly patients with acute dyspnea. Intensive Care Medicine 30:12, 2230-2236
CrossRef743
E. Hery, P. Jourdain, F. Funck, M. Bellorini, J. Loiret, B. Thebault, N. Guillard, A. El Hallak, M. Desnos. (2004) Prédiction du risque d’intolérance du traitement bêtabloquant chez l’insuffisant cardiaque chronique par le dosage du BNP. Annales de Cardiologie et d'Angéiologie 53:6, 298-304
CrossRef744
Robert E Hobbs. (2004) Management of Decompensated Heart Failure. American Journal of Therapeutics 11:6, 473-479
CrossRef745
Marc S. Sabatine, David A. Morrow, James A. de Lemos, Torbjorn Omland, Milind Y. Desai, Milenko Tanasijevic, Christian Hall, Carolyn H. McCabe, Eugene Braunwald. (2004) Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. Journal of the American College of Cardiology 44:10, 1988-1995
CrossRef746
R. Pfister, C.A. Schneider. (2004) Natriuretic peptides BNP and NT-pro-BNP: established laboratory markers in clinical practice or just perspectives?. Clinica Chimica Acta 349:1-2, 25-38
CrossRef747
John V Wylie, Lana Tsao. (2004) Nesiritide for the treatment of decompensated heart failure. Expert Review of Cardiovascular Therapy 2:6, 803-813
CrossRef748
Adrian Boswood. (2004) The Rise and Fall of the Cardiac Biomarker. Journal of Veterinary Internal Medicine 18:6, 797-799
CrossRef749
Robert E Hobbs. (2004) Guidelines for the Diagnosis and Management of Heart Failure. American Journal of Therapeutics 11:6, 467-472
CrossRef750
Yasmin Alibay, Alain Beauchet, Rami El Mahmoud, Dominique Brun-Ney, Jeanne-Armelle Alexandre, Marie-Odile Benoit, Olivier Dubourg, Philippe Aegerter, Catherine Boileau, Guillaume Jondeau, Hervé Puy. (2004) Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspnea. Clinical Biochemistry 37:10, 933-936
CrossRef751
S. Konstantinides, G. Hasenfu
. (2004) Akutes Cor pulmonale bei Lungenembolie. Der Internist 45:10, 1155-1162
CrossRef752
Stefan W Suttner, Joachim Boldt. (2004) Natriuretic peptide system: physiology and clinical utility. Current Opinion in Critical Care 10:5, 336-341
CrossRef753
Abram H. Burgher, Deniz Aslan, Noel Laudi, Robert J. Bowman. (2004) Use of brain natriuretic peptide to evaluate transfusion-related acute lung injury. Transfusion 44:10, 1533-1534
CrossRef754
Lok B. Yap, Houman Ashrafian, Dev Mukerjee, John G. Coghlan, Peter M. Timms. (2004) The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension. Clinical Biochemistry 37:10, 847-856
CrossRef755
Markus Rothenburger, Thomas Wichter, Christof Schmid, Jörg Stypmann, Tonny D.T. Tjan, Elmar Berendes, Christian Etz, Aurélien Pioux, Andreas Löher, Frauke Wenzelburger, Gabriele Drees, Andreas Hoffmeier, Gönter Breithardt, Hans Heinrich Scheld. (2004) Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. The Journal of Heart and Lung Transplantation 23:10, 1189-1197
CrossRef756
(2004) Congress of Clinical Chemistry and Laboratory Medicine Annual meeting of the German United Society for Clinical Chemistry and Laboratory Medicine (DGKL), Düsseldorf, Germany, November 22-24, 2004. Clinical Chemistry and Laboratory Medicine 42:10, A101-A161
CrossRef757
Marc A. Silver, Alan Maisel, Clyde W. Yancy, Peter A. McCullough, John C. Burnett, Gary S. Francis, Mandeep R. Mehra, Gregg Fonarow, W. Brian Gibler, David A. Morrow, Judd Hollander. (2004) BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases. Congestive Heart Failure 10:s5, 1-30
CrossRef758
Alan Maisel, Judd E. Hollander, David Guss, Peter McCullough, Richard Nowak, Gary Green, Mitchell Saltzberg, Stefanie R. Ellison, Meenakshi Awasthi Bhalla, Vikas Bhalla, Paul Clopton, Robert Jesse. (2004) Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). Journal of the American College of Cardiology 44:6, 1328-1333
CrossRef759
Alan Maisel. (2004) Updated Algorithms for Using B-Type Natriuretic Peptide (BNP) Levels in the Diagnosis and Management of Congestive Heart Failure. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 3:3, 144-149
CrossRef760
Michael J. Gallagher, Peter A. McCullough. (2004) The emerging role of natriuretic peptides in the diagnosis and treatment of decompensated heart failure. Current Heart Failure Reports 1:3, 129-135
CrossRef761
S Cosson. (2004) Usefulness of B-type Natriuretic Peptide (BNP) as a screen for left ventricular abnormalities in diabetes mellitus. Diabetes & Metabolism 30:4, 381-386
CrossRef762
Torbjørn Omland. (2004) Heart failure in the emergency department. Journal of the American College of Cardiology 44:6, 1334-1336
CrossRef763
James Kevin McCord. (2004) The Future of Cardiac Markers in the Emergency Department. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 3:3, 107-109
CrossRef764
Daniel M. Spevack, Arthur Schwartzbard. (2004) B-type natriuretic peptide measurement in heart failure. Clinical Cardiology 27:9, 489-494
CrossRef765
Myung H. Park, Robert L. Scott, Patricia A. Uber, Hector O. Ventura, Mandeep R. Mehra. (2004) Usefulness of B-Type Natriuretic Peptide as a Predictor of Treatment Outcome in Pulmonary Arterial Hypertension. Congestive Heart Failure 10:5, 221-225
CrossRef766
Stephen D Wiviott, James A de Lemos, David A Morrow. (2004) Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Clinica Chimica Acta 346:2, 119-128
CrossRef767
Roderick H. Tung, Christine Garcia, Alexander M. Morss, Richard M. Pino, Michael A. Fifer, B Taylor Thompson, Kent Lewandrowski, Elizabeth Lee-Lewandrowski, James L. Januzzi. (2004) Utility of B-type natriuretic peptide for the evaluation of intensive care unit shock*. Critical Care Medicine 32:8, 1643-1647
CrossRef768
Vikas Bhalla, Alan S. Maisel, Meenakshi A. Bhalla. (2004) Evolution of B-type natriuretic peptide in evaluation of intensive care unit shock*. Critical Care Medicine 32:8, 1787-1789
CrossRef769
Akihiro Yoshizawa, Tsutomu Yoshikawa, Iwao Nakamura, Toru Satoh, Kazunori Moritani, Masahiro Suzuki, Akiyasu Baba, Shiro Iwanaga, Hideo Mitamura, Satoshi Ogawa. (2004) Brain natriuretic peptide response is heterogeneous during β-blocker therapy for congestive heart failure. Journal of Cardiac Failure 10:4, 310-315
CrossRef770
Richard J. Rodeheffer. (2004) Measuring plasma B-type natriuretic peptide in heart failure. Journal of the American College of Cardiology 44:4, 740-749
CrossRef771
Erin Barcarse, Radmila Kazanegra, Amy Chen, Albert Chiu, Paul Clopton, Alan Maisel. (2004) Combination of B-Type Natriuretic Peptide Levels and Non-Invasive Hemodynamic Parameters in Diagnosing Congestive Heart Failure in the Emergency Department. Congestive Heart Failure 10:4, 171-176
CrossRef772
Jessica L. Mega, David A. Morrow, James A. de Lemos, Marc S. Sabatine, Sabina A. Murphy, Nader Rifai, C.Michael Gibson, Elliott M. Antman, Eugene Braunwald. (2004) B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 44:2, 335-339
CrossRef773
P Jourdain, F Funck, M Bellorini. (2004) Brain Natriuretic Peptide et insuffisance cardiaque, de la recherche à la pratique clinique. Annales de Cardiologie et d'Angéiologie 53:4, 193-199
CrossRef774
Francis Dumler, Peter A McCullough. (2004) Optimal dialysis for the end-stage renal disease patient with cardiovascular disease. Advances in Chronic Kidney Disease 11:3, 261-273
CrossRef775
A Cohen Solal, J.-M Tartière, C Chavelas, F Beauvais, D Logeart. (2004) Traitement médical de l'insuffisance cardiaque aiguë décompensée. Annales de Cardiologie et d'Angéiologie 53:4, 200-208
CrossRef776
Eric Schwam. (2004) B-type Natriuretic Peptide for Diagnosis of Heart Failure in Emergency Department Patients: A Critical Appraisal. Academic Emergency Medicine 11:6, 686-691
CrossRef777
Lev Lubarsky, Kenneth Mandell, Neil L. Coplan. (2004) B-Type Natriuretic Peptide: Practical Diagnostic Use for Evaluating Ventricular Dysfunction. Congestive Heart Failure 10:3, 140-143
CrossRef778
Marc Wolf, David Juncker, Bruno Michel, Patrick Hunziker, Emmanuel Delamarche. (2004) Simultaneous detection of C-reactive protein and other cardiac markers in human plasma using micromosaic immunoassays and self-regulating microfluidic networks. Biosensors and Bioelectronics 19:10, 1193-1202
CrossRef779
A. Mark Richards, John G. Lainchbury, Richard W. Troughton, Eric A. Espiner, M. Gary Nicholls. (2004) Clinical applications of B-type natriuretic peptides. Trends in Endocrinology & Metabolism 15:4, 170-174
CrossRef780
Eric Schwam. (2004) B-type Natriuretic Peptide for Diagnosis of Heart Failure in Emergency Department Patients: A Critical Appraisal. Academic Emergency Medicine 11:5, 686-691
CrossRef781
James O. O'Neill, David O. Taylor. (2004) Recent advances in the diagnosis of heart failure. Current Cardiology Reports 6:3, 205-210
CrossRef782
Madan Sharma, John R. Teerlink. (2004) A rational approach for the treatment of acute heart failure: current strategies and future options. Current Opinion in Cardiology 19:3, 254-263
CrossRef783
Mandeep R Mehra, Patricia A Uber, Myung H Park, Robert L Scott, Hector O Ventura, Bobbett C Harris, Edward D Frohlich. (2004) Obesity and suppressed B-type natriuretic peptide levels in heart failure. Journal of the American College of Cardiology 43:9, 1590-1595
CrossRef784
Ryan Hutfless, Radmila Kazanegra, Michael Madani, Meenakshi Awasthi Bhalla, Alisi Tulua-Tata, Amelia Chen, Paul Clopton, Cherimarie James, Albert Chiu, Alan S Maisel. (2004) Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. Journal of the American College of Cardiology 43:10, 1873-1879
CrossRef785
J M Zuetenhorst, C M Korse, J M G Bonfrer, R H Bakker, B G Taal. (2004) Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease. British Journal of Cancer
CrossRef786
Alexandre Teboul, Alain Gaffinel, Christophe Meune, Agnès Greffet, Patrick Sauval, Pierre Carli. (2004) Management of acute dyspnoea: use and feasibility of brain natriuretic peptide (BNP) assay in the prehospital setting. Resuscitation 61:1, 91-96
CrossRef787
B Granel. (2004) Le peptide natriurétique de type b. La Revue de Médecine Interne 25:4, 299-302
CrossRef788
Alberto Palazzuoli, Arcangelo Carrera, Paolo Calabria, Monica Pastore, Ilaria Quatrini, Lucia Vecchiato, Maria Stella Campagna, Vincenzo Palazzuoli, Ranuccio Nuti. (2004) Brain natriuretic peptide levels during cardiac reperfusion: comparison between percutaneous coronary angioplasty and aorto-coronaric bypass. Clinica Chimica Acta 342:1-2, 87-92
CrossRef789
Thomas Mueller, Alfons Gegenhuber, Werner Poelz, Meinhard Haltmayer. (2004) Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clinica Chimica Acta 341:1-2, 41-48
CrossRef790
Nina Johnston, Tomas Jernberg, Bertil Lindahl, Johan Lindbäck, Mats Stridsberg, Anders Larsson, Per Venge, Lars Wallentin. (2004) Biochemical indicators of cardiac and renal function in a healthy elderly population. Clinical Biochemistry 37:3, 210-216
CrossRef791
Julien Charpentier, Charles-Edouard Luyt, Yvonne Fulla, Christophe Vinsonneau, Alain Cariou, Sophie Grabar, Jean-François Dhainaut, Jean-Paul Mira, Jean-Daniel Chiche. (2004) Brain natriuretic peptide: A marker of myocardial dysfunction and prognosis during severe sepsis. Critical Care Medicine 32:3, 660-665
CrossRef792
Kris Vijayaraghavan, Sue Crum, Sangita Cherukuri, Leslie Barnett-Avery. (2004) Association of Impedance Cardiography Parameters With Changes in Functional and Quality-of-Life Measures in Patients With Chronic Heart Failure. Congestive Heart Failure 10:s2, 22-27
CrossRef793
Donald Silverberg, Dov Wexler, Miriam Blum, Doron Schwartz, Adrian Iaina. (2004) The association between congestive heart failure and chronic renal disease. Current Opinion in Nephrology and Hypertension 13:2, 163-170
CrossRef794
Mark, Daniel B., Felker, G. Michael, . (2004) B-Type Natriuretic Peptide — A Biomarker for All Seasons?. New England Journal of Medicine 350:7, 718-720
Full Text795
Wang, Thomas J., Larson, Martin G., Levy, Daniel, Benjamin, Emelia J., Leip, Eric P., Omland, Torbjorn, Wolf, Philip A., Vasan, Ramachandran S., . (2004) Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death. New England Journal of Medicine 350:7, 655-663
Full Text796
Mueller, Christian, Scholer, André, Laule-Kilian, Kirsten, Martina, Benedict, Schindler, Christian, Buser, Peter, Pfisterer, Matthias, Perruchoud, André P., . (2004) Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea. New England Journal of Medicine 350:7, 647-654
Full Text797
Damien Logeart, Gabriel Thabut, Patrick Jourdain, Christophe Chavelas, Pascale Beyne, Florence Beauvais, Erik Bouvier, Alain Cohen Solal. (2004) Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. Journal of the American College of Cardiology 43:4, 635-641
CrossRef798
Richard W Troughton, David L Prior, Jeremy J Pereira, Maureen Martin, Annette Fogarty, Annitta Morehead, Timothy G Yandle, A.Mark Richards, Randall C Starling, James B Young, James D Thomas, Allan L Klein. (2004) Plasma B-type natriuretic peptide levels in systolic heart failure. Journal of the American College of Cardiology 43:3, 416-422
CrossRef799
Vikas Bhalla, Scott Willis, Alan S. Maisel. (2004) B-Type Natriuretic Peptide: The Level and the Drug?Partners in the Diagnosis and Management of Congestive Heart Failure. Congestive Heart Failure 10:s1, 3-27
CrossRef800
Rikimaru Oyama, Kazuya Murata, Nobuaki Tanaka, Akira Takaki, Kayo Ueda, Jinyao Liu, Yasuaki Wada, Nozomu Harada, Shinichi Okuda, Yoko Hamada, Masunori Matsuzaki. (2004) Is the Ratio of Transmitral Peak E-Wave Velocity to Color Flow Propagation Velocity Useful for Evaluating the Severity of Heart Failure in Atrial Fibrillation?. Circulation Journal 68:12, 1132-1138
CrossRef801
Ken Nagao, Nariyuki Hayashi, Katsuo Kanmatsuse, Satoru Kikuchi, Kimio Kikushima, Kazuhiro Watanabe, Takeo Mukouyama. (2004) B-Type Natriuretic Peptide as a Marker of Resuscitation in Patients With Cardiac Arrest Outside the Hospital. Circulation Journal 68:5, 477-482
CrossRef802
Sameer K. Mehta, Kathleen H. Toto, Lauren L. Nelson, Mark H. Drazner. (2004) Therapy of Heart Failure in African Americans: Lessons From an Urban Public Hospital. Congestive Heart Failure 10:1, 40-43
CrossRef803
Shuta Ishibe, Aldo J. Peixoto. (2004) Methods of Assessment of Volume Status and Intercompartmental Fluid Shifts in Hemodialysis Patients: Implications in Clinical Practice. Seminars in Dialysis 17:1, 37-43
CrossRef804
Sandra L. Lowery, Regina Massaro, Clyde W. Yancy,. (2004) Advances in the Management of Acute and Chronic Decompensated Heart Failure. Lippincott's Case Management 9:1, 4-18
CrossRef805
Marianne Schultz, Jens Faber, Caroline Kistorp, Anne Jarlov, Frants Pedersen, Niels Wiinberg, Per Hildebrandt. (2004) N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. Clinical Endocrinology 60:1, 54-59
CrossRef806
Matthew I. Worthley, Roberto Corti, Stephen G. Worthley. (2004) Vasopeptidase inhibitors: will they have a role in clinical practice?. British Journal of Clinical Pharmacology 57:1, 27-36
CrossRef807
Kanu Chatterjee. (2004) All Patients Older Than Age 60 Years Should Not Undergo a B-Type Natriuretic Peptide Screening Test. The American Heart Hospital Journal 2:1, 49-51
CrossRef808
Jens Peter Goetze, Regitze Videbaek, Soren Boesgaard, Jan Aldershvile, Jens F Rehfeld, Jorn Carlsen. (2004) Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. The Journal of Heart and Lung Transplantation 23:1, 80-87
CrossRef809
Kiang-Teck J. Yeo, Alan H.B. Wu, Fred S. Apple, Martin H. Kroll, Robert H. Christenson, Kent B. Lewandrowski, Frank A. Sedor, Anthony W. Butch. (2003) Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clinica Chimica Acta 338:1-2, 107-115
CrossRef810
Jill N. Howie, Mary A. Caldwell, Kathleen Dracup. (2003) The Measurement of Brain Natriuretic Peptide in Heart Failure. AACN Clinical Issues: Advanced Practice in Acute and Critical Care 14:4, 520-531
CrossRef811
Evangelos Giannitsis, Hugo A. Katus. (2003) Still unresolved issues with brain-type natriuretic peptide measurement in the critically ill patient *. Critical Care Medicine 31:11, 2703
CrossRef812
Susan P. Wright, Robert N. Doughty, Ann Pearl, Greg D. Gamble, Gillian A. Whalley, Helen J. Walsh, Gary Gordon, Warwick Bagg, Helen Oxenham, Tim Yandle, Mark Richards, Norman Sharpe. (2003) Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care. Journal of the American College of Cardiology 42:10, 1793-1800
CrossRef813
D Mukerjee, L.B Yap, A.M Holmes, D Nair, P Ayrton, C.M Black, J.G Coghlan. (2003) Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension. Respiratory Medicine 97:11, 1230-1236
CrossRef814
P Jourdain, F Funck, M Bellorini, B Thebault, J Loiret, N Guillard, M Desnos. (2003) BNP, insuffisance cardiaque et sujet âgé. Annales de Cardiologie et d'Angéiologie 52:5, 285-289
CrossRef815
DANIEL K??NIG, YORK OLAF SCHUMACHER, LOTHAR HEINRICH, ANDREAS SCHMID, ALOYS BERG, HANS-HERMANN DICKHUTH. (2003) Myocardial Stress after Competitive Exercise in Professional Road Cyclists. Medicine & Science in Sports & Exercise 35:10, 1679-1683
CrossRef816
K CRISPELL. (2003) Common cardiovascular issues encountered in geriatric critical care. Critical Care Clinics 19:4, 677-691
CrossRef817
W. Frank Peacock, John Allegra, Douglas Ander, Sean Collins, Deborah Diercks, Charles Emerman, Douglas J. Kirk, Randall C. Starling, Marc Silver, Richard Summers. (2003) Management of Acute Decompensated Heart Failure in the Emergency Department. Congestive Heart Failure 9:s5, 3-18
CrossRef818
Caboral Meriam, Judith Mitchell. (2003) B-Type Natriuretic Peptide: a New Tool in the Armamentarium Used to Accurately Diagnose Heart Failure. Progress in Cardiovascular Nursing 18:4, 190-193
CrossRef819
John G Lainchbury, Elizabeth Campbell, Christopher M Frampton, Timothy G Yandle, M.Gary Nicholls, A.Mark Richards. (2003) Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. Journal of the American College of Cardiology 42:4, 728-735
CrossRef820
Rajat Deo, James A. Lemos. (2003) B-type natriuretic peptide in ischemic heart disease. Current Cardiology Reports 5:4, 271-277
CrossRef821
James A de Lemos, Darren K McGuire, Mark H Drazner. (2003) B-type natriuretic peptide in cardiovascular disease. The Lancet 362:9380, 316-322
CrossRef822
Barry M Massie. (2003) Natriuretic peptide measurements for the diagnosis of “nonsystolic” heart failure. Journal of the American College of Cardiology 41:11, 2018-2021
CrossRef823
Timothy M Sutton, Ralph A.H Stewart, Ivor L Gerber, Teena M West, A.Mark Richards, Timothy G Yandle, Andrew J Kerr. (2003) Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. Journal of the American College of Cardiology 41:12, 2280-2287
CrossRef824
Marc A. Silver, Carol Pisano. (2003) High Incidence of Elevated B-Type Natriuretic Peptide Levels and Risk Factors for Heart Failure in an Unselected At-Risk Population (Stage A): Implications for Heart Failure Screening Programs. Congestive Heart Failure 9:3, 127-132
CrossRef825
George Stoupakis, Marc Klapholz. (2003) Natriuretic Peptides. Heart Disease 5:3, 215-223
CrossRef826
Roger Kerzner, Michael W. Rich. (2003) Management of heart failure in the elderly. Current Cardiology Reports 5:3, 223-228
CrossRef827
David A. Morrow, James A. de Lemos, Marc S. Sabatine, Sabina A. Murphy, Laura A. Demopoulos, Peter M. DiBattiste, Carolyn H. McCabe, C.Michael Gibson, Christopher P. Cannon, Eugene Braunwald. (2003) Evaluation of B-type natriuretic peptide for risk assessment in unstable Angina/Non–ST-elevation myocardial infarction. Journal of the American College of Cardiology 41:8, 1264-1272
CrossRef828
B. P. Shapiro, H. H. Chen, J. C. Burnett, M. M. Redfield. (2003) Use of Plasma Brain Natriuretic Peptide Concentration to Aid in the Diagnosis of Heart Failure. Mayo Clinic Proceedings 78:4, 481-486
CrossRef829
James P. Maloney. (2003) Advances in the treatment of secondary pulmonary hypertension. Current Opinion in Pulmonary Medicine 9:2, 139-143
CrossRef830
Peter A. McCullough, Judd E. Hollander, Richard M. Nowak, Alan B. Storrow, Philippe Duc, Torbjørn Omland, James McCord, Howard C. Herrmann, Philippe G. Steg, Arne Westheim, Cathrine Wold Knudsen, William T. Abraham, Sumant Lamba, Alan H.B. Wu, Alberto Perez, Paul Clopton, Padma Krishnaswamy, Radmila Kazanegra, Alan S. Maisel. (2003) Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency Department. Academic Emergency Medicine 10:3, 198-204
CrossRef831
Ronald Zolty. (2003) BNP, a New Tool for Managing Congestive Heart Failure. Primary Care Case Reviews 6:1, 21-28
CrossRef832
Gene R. Pesola. (2003) The Use of B-type Natriuretic Peptide (BNP) to Distinguish Heart Failure from Lung Disease in Patients Presenting with Dyspnea to the Emergency Department. Academic Emergency Medicine 10:3, 275-277
CrossRef833
Brian D. Le, Tayo Addo, James A. de Lemos. (2003) The Endocrine Heart: B-type Natriuretic Peptide as a Diagnostic and Therapeutic Agent in Cardiovascular Disease. The Endocrinologist 13:2, 97-105
CrossRef834
Judith A. Crook, Fausta A. Woody. (2003) Rapidly identify CHF with POC advances. Nursing Management (Springhouse) 34:1, 48-49
CrossRef835
Vincent N. Mosesso, James Dunford, Thomas Blackwell, John K. Griswell. (2003) P REHOSPITAL T HERAPY FOR A CUTE C ONGESTIVE H EART F AILURE : S TATE OF THE A RT. Prehospital Emergency Care 7:1, 13-23
CrossRef836
(2002) B-Type Natriuretic Peptide in Heart Failure. New England Journal of Medicine 347:24, 1976-1978
Full Text837
Elizabeth Trinity, Fred S. Apple. (2002) Diagnosis And Management Of Congestive Heart Failure. Point of Care: The Journal of Near-Patient Testing & Technology 1:4, 246-252
CrossRef838
Elizabeth Trinity, Fred S. Apple. (2002) Brain Natriuretic Peptide in the Diagnosis and Management of Congestive Heart Failure. Laboratory Medicine 33:10, 793-796
CrossRef839
Baughman, Kenneth L., . (2002) B-Type Natriuretic Peptide — A Window to the Heart. New England Journal of Medicine 347:3, 158-159
Full Text
- Letters
